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Abstract
Fumonisins, mycotoxins primarily produced by Fusarium verticillioides and Fusarium proliferatum, occur
predominantly in cereal grains, especially in maize. The European Commission asked EFSA for a
scientiﬁc opinion on the risk to animal health related to fumonisins and their modiﬁed and hidden
forms in feed. Fumonisin B1 (FB1), FB2 and FB3 are the most common forms of fumonisins in
feedstuffs and thus were included in the assessment. FB1, FB2 and FB3 have the same mode of action
and were considered as having similar toxicological proﬁle and potencies. For fumonisins, the EFSA
Panel on Contaminants in the Food Chain (CONTAM) identiﬁed no-observed-adverse-effect levels
(NOAELs) for cattle, pig, poultry (chicken, ducks and turkeys), horse, and lowest-observed-adverse-
effect levels (LOAELs) for ﬁsh (extrapolated from carp) and rabbits. No reference points could be
identiﬁed for sheep, goats, dogs, cats and mink. The dietary exposure was estimated on 18,140 feed
samples on FB1–3 representing most of the feed commodities with potential presence of fumonisins.
Samples were collected between 2003 and 2016 from 19 different European countries, but most of
them from four Member States. To take into account the possible occurrence of hidden forms, an
additional factor of 1.6, derived from the literature, was applied to the occurrence data. Modiﬁed forms
of fumonisins, for which no data were identiﬁed concerning both the occurrence and the toxicity, were
not included in the assessment. Based on mean exposure estimates, the risk of adverse health effects
of feeds containing FB1–3 was considered very low for ruminants, low for poultry, horse, rabbits, ﬁsh
and of potential concern for pigs. The same conclusions apply to the sum of FB1–3 and their hidden
forms, except for pigs for which the risk of adverse health effect was considered of concern.
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Summary
Following a request from the European Commission, the EFSA Panel on Contaminants in the Food
Chain (CONTAM) assessed the risk to animal health related to the presence of Fumonisins and their
modiﬁed and hidden forms in feed. The CONTAM Panel was asked to consider all relevant adverse
health effects, and in particular to address the co-occurrence of fumonisins and their modiﬁed and
hidden forms, and to estimate the dietary exposure of different animal species.
Previous risk assessments from the European Food Safety Authority (EFSA) on fumonisins in feed
(2005), modiﬁed forms of certain mycotoxins in food and feed (2014) and on the appropriateness to
set a group health-based guidance value for fumonisins and their modiﬁed forms (2018) have been
used as a starting point for the present assessment.
Fumonisins are mycotoxins produced predominantly by Fusarium verticillioides and Fusarium
proliferatum. In terms of chemical structure, fumonisins are long-chain aminopolyols with two
tricarballylic acid side chains. The most relevant compounds are the B-type fumonisins (FBs), FB1, FB2
and FB3 which differ in the number and position of hydroxy groups at the backbone. The most relevant
modiﬁed forms are hydrolysed fumonisins B (HFBs) and partially hydrolysed fumonisins B (pHFBs). FBs
may react during food processing, giving rise to the formation of Maillard-type modiﬁed forms, such as
NCM-FBs and NDF-FBs.
Due to the chemical structure, FBs may strongly interact through non-covalent binding with the
matrix macroconstituents, giving rise to the so-called hidden FBs. Hidden forms may be disrupted upon
digestion, leading to the release of the unchanged parent forms of FBs in the gastrointestinal tract.
Analytical methods for FB1–3 are well established and are mainly based on mass spectrometry (MS).
Modiﬁed forms of FB1 are commonly analysed under the same conditions as their parent compound.
However, the strong physical interaction of fumonisins with the food matrix, which is well documented
in the literature, may signiﬁcantly affect the analytical performance in a matrix-related way. For the
determination of hidden fumonisins, the food/feed matrix is usually treated under alkaline conditions
prior to the analysis. Only FB1–3 are available on the market as calibrant solutions. Except for HFB1,
analytical standards for modiﬁed forms are not commercially available.
There is poor information on the absorption, distribution, metabolism and excretion (ADME) of
fumonisins in farm animal species, and the available studies are almost limited to FB1. In orally
exposed animals, fumonisins are in general poorly bioavailable, rapidly distributed mainly to liver and
kidney, extensively biotransformed and rapidly excreted mostly via the faecal route. Hydrolytic
biotransformations largely prevail; the main metabolites are pHFB1 and HFB1; both may be found in
limited amounts in tissues. Unlike in rats, no further metabolites (e.g. N-acyl derivatives of FB1 and its
hydrolysed forms) have been detected in farm and companion animals. A very limited excretion of
fumonisins in milk and negligible excretion in eggs have been documented. No information on FB1–3
kinetics could be identiﬁed for farmed rabbits, ﬁsh, horses, farmed mink, dogs and cats.
In ruminants, the scant information available data indicate a very limited oral bioavailability and a
remarkable biotransformation to the hydrolysed pHFB1 and HFB1. Hydrolytic biotransformation appear
not occur in rumen or liver. Excretion in milk has been investigated and only been documented in cows.
In pigs, FB1–3 are poorly bioavailable but extensively hydrolysed to pHFB1 and HFB1 in the enteric
tract. Measurable amounts of the toxin and of both hydrolysed metabolites are detectable in livers and
kidneys up to several days after treatment cessation. The faecal excretion largely outweighs the
urinary one; the extent of biliary excretion might vary according to the dose and the duration of the
exposure. The bioavailability of FB2 is likely to be much lower than that of FB1.
There is very limited knowledge on FB1–3 kinetics in avian species, with no information of FB1
biotransformations. Oral bioavailability is poor and in the order turkey>duck>chicken. Kinetic studies
point to a more rapid elimination in ducks and chickens than in turkeys. In birds fed with feed at, or
approaching the European Union (EU) recommended guidance, residues were detected only in the liver.
The kinetics of FB2 in ducks and turkeys is similar to that of FB1, with evidence of a lower bioavailability.
Fumonisins are structural analogues of sphingoid bases and they inhibit ceramide synthase. This
induces a disruption of sphingolipid metabolism and pathological changes. Even if the disruption of the
sphingolipid metabolism at an early stage is closely related with fumonisin toxicity, there is no evidence
that fumonisin-induced ceramide synthase inhibition is in itself an adverse effect. Therefore, reference
points for fumonisins have been derived using endpoints other than the sole alteration of sphingolipid
ratio in serum or organs. The implication of the disruption of sphingolipid metabolism in some of the
observed critical adverse effects still remains to be established. At the cellular level, FB1, FB2 and FB3
have the same mode of action and are considered as having similar toxicological proﬁles and potencies.
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Ruminants are considered less sensitive than horses and pigs. Gross and histopathological lesions,
as well as changes in serum enzymes and biochemistry indicate an impairment of liver and possibly
kidney function. Taking as endpoints the increase in serum enzymes, cholesterol and bilirubin as well
as the decrease in lymphocyte blastogenesis a no-observed-adverse-effect level (NOAEL) of (31 mg
FB1–3/kg feed) could be set only for cattle. However, a very limited data set indicates that sheep and
goats would not seem to be more susceptible to fumonisins than cattle.
Porcine pulmonary oedema syndrome is the speciﬁc effect produced by FB1 in pigs and
cardiovascular toxic effects of FBs could play a role in the development of this abnormality. Increased
sphinganine/sphingosine (Sa/So) ratio in serum and tissues, liver and kidney toxicity, delay in sexual
maturity and reproductive functionality alterations, impairment of innate and acquired immune
response, histological lesions in internal organs as well as alterations of brain physiology have been
reported in many studies irrespective of the FBs concentration. A NOAEL of 1 mg FBs/kg feed and a
lowest-observed-adverse-effect level (LOAEL) of 5 mg/kg feed could be identiﬁed for pigs based on
lung lesions.
Fumonisins affect the liver and the immune system in investigated poultry species. In addition,
decreases in feed intake and body weight gain were reported from feeding studies with ducks and
Japanese quail, but not from studies with chickens and turkeys. Increased Sa and Sa/So levels have
also been reported from low feed concentrations (2 mg FB1/kg feed) in investigated poultry species. A
NOAEL of 8 mg/kg feed based on alterations of liver enzymes indicative of liver toxicity was identiﬁed
for ducks. A NOAEL of 20 mg/kg feed, corresponding to 2 mg/kg body weight (bw) per day was
identiﬁed for chickens. This NOAEL was identiﬁed based on an increase in liver lipids which was
considered as an adverse effect taking into consideration the observed liver toxicity in all investigated
species. A NOAEL of 20 mg/kg feed per day was also identiﬁed for turkeys. This was the highest dose
used in the studies published since the last EFSA opinion and no adverse effects were observed in
these studies.
A NOAEL of 0.2 mg FB1/kg bw per day, recalculated from an intravenous (i.v.) study (corresponding
to 8.8 mg FB1/kg feed) was identiﬁed for horses, based on neurological and cardiovascular effects.
Decreased performance, biochemical alterations in serum and blood formula, liver and kidney
congestion, impaired spermatogenesis and delay of the onset of puberty as well as increased Sa level
and the Sa/So ratio in urine, serum and liver were associated with exposure of rabbits to FBs. A LOAEL
of 5 mg FBs/kg feed was identiﬁed based on alterations in liver.
There is limited information available from feeding studies with ﬁsh, and no information is available
on the effects of FBs on salmonids. Observed effects of FBs in ﬁsh species include pathological
damages in several organs, reduced body weight gain and haematological and immunological
alterations. A NOAEL of 10 mg/kg feed has been identiﬁed for Nile tilapia based on reduced weight
gain. This corresponds to 0.4 mg/kg bw per day. Similarly, a LOAEL of 10 mg/kg feed was identiﬁed
for carp, corresponding to 0.5 mg/kg bw per day. This LOAEL was based on pathological alterations,
changes in haematological parameters and reduced body weight gain. A NOAEL of 20 mg/kg feed was
identiﬁed for catﬁsh. This was based on reduced body weight gain and microscopic liver lesions.
No data could be identiﬁed concerning the effects of FBs in cats, dogs or farmed mink.
No data were available to establish a reference point for any modiﬁed form of fumonisin, for any of
the animal species considered.
The dietary exposure was estimated using a ﬁnal data set of 18,140 feed samples on FBs (i.e. FB1,
FB2 and FB3) representing most of the feed commodities with potential presence of fumonisin.
Samples were collected between 2003 and 2016 in 19 different European countries, but most of them
came from four Member States. The total concentration of FBs was estimated by summing available
analytical concentrations for each sample. For samples for which no concentration was available, the
levels were estimated by using the mean concentration of available data.
The percentage of left-censored data reported (results below limit of detection and/or limit of
quantiﬁcation) was high (~ 80%). The highest number of reported analytical results were in the feed
group ‘Cereal grains’ (~ 47%) and in particular for maize, wheat and barley. Other feed groups
included forages, land animal products, legume seeds, minerals, oil seeds and tubers. High quantiﬁed
values were reported for maize wheat and compound feed. The compound feeds with highest levels
were for unspeciﬁed species and were therefore not used for the exposure assessment. The animal
exposure was presented as dietary concentrations because the animal risk characterisation was carried
out on a feed concentration basis. Exposure to FBs and the hidden forms is primarily from the
consumption of maize (corn) and its by-products. Except for forage maize, and maize silage produced
from it, levels on forages are generally low.
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The highest estimated dietary concentrations to FBs by cattle was for lactating dairy cows on a
maize silage-based diet (mean lower bound (LB) = 368 and 95th percentile upper bound
(UB) = 1,894 lg/kg feed), reﬂecting both the high levels of FBs in forage maize and the inclusion of
cereal grains in the complementary compound feeds. For other cattle, the lowest overall dietary
concentration was for beef cattle on a straw-based ration (LB mean = 14 UB P95 = 270 lg/kg feed).
For sheep and goats, the calculated lowest LB to highest UB mean dietary concentrations of FBs were
25 and 187 lg/kg feed, respectively, while at the 95th percentile the range was from 42 (LB) to 716
(UB) lg/kg feed. For horses, the calculated mean LB and UB diet concentrations of FBs were 22 and
203 lg/kg feed, respectively, while for the 95th percentile the range (LB–UB) was 22–223 lg/kg feed.
The calculated mean LB and UB exposures to FBs by pigs, derived from data for species-speciﬁc
compound feeds, ranged from 23 to 413 lg/kg feed, respectively, while the 95th percentile exposures
ranged from 568 (LB) to 943 (UB) lg/kg feed. For poultry, the calculated mean exposure ranged from
58 (LB) to 575 (UB) lg/kg feed, based on levels in individual feeds and their inclusion in diets. The
equivalent range for the 95th percentile estimates of exposure was 72 and 1,749 lg/kg feed,
respectively. For farmed salmonids and carp, the calculated mean LB and UB for dietary concentrations
ranged from 121 to 370 lg/kg feed, respectively. At the 95th percentile, LB and UB estimates dietary
concentrations ranged from 421 (LB) to 1,110 (UB) lg/kg feed. The calculated mean diet
concentration for farmed rabbits ranged from 7.0 (LB) to 233 (UB) lg/kg dry matter (DM), while the
equivalent range for the 95th percentile was from 20 to 296 lg/kg DM. The mean calculated diet
concentration for farmed mink ranged from 58 (LB) to 84 (UB) lg/kg DM, while the equivalent range
for the 95th percentile was 241 and 260 lg/kg DM. For companion animals (cats and dogs), the
calculated LB and UB mean diet concentrations of FBs were 365 and 465 lg/kg DM, respectively, while
at the 95th percentile the range was from 1,501 (LB) to 1,765 (UB) lg/kg DM.
Fumonisins hidden forms are assumed to be 60% of the dietary concentrations for FBs. The sum of
FBs plus the hidden forms may be calculated by multiplying the values given above (for FBs) by 1.6.
The risk of exposure to fumonisins was evaluated taking into consideration the comparison between
the exposure of the sum of FB1, FB2 and FB3, and the identiﬁed NOAELs/LOAELs for chronic adverse
effects. The risk characterisation of exposure to FBs and their hidden forms was evaluated based on
the comparison between the exposure of FBs and their hidden forms (exposure to FBs multiplied by a
factor of 1.6), and the identiﬁed NOAELs/LOAELs for chronic adverse effects of FBs. For dogs, cats and
mink, the health risk from the exposure to FBs and to FBs and their hidden forms could not be
assessed as no NOAEL or LOAEL have been identiﬁed. For cattle, the risk of an adverse health effects
from feed containing FBs was considered very low. It is expected that sheep and goat have similar
sensitivity to FBs as cattle and the risk was considered very low also for those species. For poultry,
horses, rabbits and ﬁsh, the risk of adverse health effects of feed containing FBs was considered low.
For pigs, the risk of adverse health effects of feed containing FBs was considered low for pigs exposed
to mean levels but of potential concern for animals exposed to levels at the 95th percentile. The same
conclusions apply to the sum of FBs and their hidden forms except for pigs for which the risk of
adverse health effects from feeds containing FBs was considered low for exposure at the mean levels
and of concern for animals exposed to levels at the 95th percentile.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
BACKGROUND
Following a request from the European Commission, the risks to human and animal health related
to modiﬁed forms of the Fusarium toxins zearalenone, nivalenol, T-2 and HT-2 toxins and fumonisins
were evaluated in the scientiﬁc opinion on the risks for human health related to the presence of
modiﬁed forms of certain mycotoxins in food and feed, adopted by the EFSA Panel on Contaminants in
the Food Chain (CONTAM) on 25 November 2014.
The CONTAM Panel indicated in the recommendations that the animal health effects of fumonisins
needed to be re-assessed in order to possibly set NOAELs/LOAELs for fumonisins in order to be able to
assess the risk for animal health related to the presence of fumonisins and their modiﬁed forms in
feed.
TERMS OF REFERENCE
In accordance with Art. 29 (I) (a) of Regulation (EC) No 178/2002, the Commission asks EFSA for a
scientiﬁc opinion on the risks for animal health related to the presence of fumonisins and their
modiﬁed forms in feed.
1.2. Interpretation of the Terms of Reference
The CONTAM Panel assumed that the previous EFSA risk assessment of fumonisins in feed (EFSA,
2005) comprehensively covered all relevant aspects of fumonisins and therefore used it together with
the recent opinion on modiﬁed mycotoxins (EFSA CONTAM Panel, 2014) and the opinion on
appropriateness to set a group health based guidance value for Fumonisins and modiﬁed forms (EFSA
CONTAM Panel, 2018) as a starting point for the present assessment.
The CONTAM Panel noted that, in addition to FB1 and FB2, FB3 and FB4 are among the most
common forms of fumonisins, and therefore decided to also consider these in the assessment. The
CONTAM Panel reviewed the new relevant data on FB1–4 (i.e. published after 2004) to evaluate
whether reference points for risk characterisation identiﬁed for FB1 in some animal species need to be
revised and to possibly set no-observed-adverse-effect levels (NOAELs)/lowest-observed-adverse-effect
levels (LOAELs) for fumonisins to assess the risk for animal health related to the presence of
fumonisins and their modiﬁed forms in feed.
The Panel decided to present the modiﬁed forms of FB1–3 identiﬁed to date and reviewed the
appropriateness of the methods currently available for their analysis as in the previous EFSA opinion
(EFSA CONTAM Panel, 2018). FB4 was not considered in this opinion as it occurs mainly in grapes,
which are not a major feedstuff. In addition, data on the occurrence, toxicity and toxicokinetics could
not be identiﬁed for FB4.
In this opinion, the CONTAM Panel have considered the parent compound, the modiﬁed forms and
‘physical entrapped’ or ‘hidden’ forms’ of fumonisins, as described in Section 1.3.1.
1.3. Additional information
1.3.1. Fumonisins, modiﬁed forms and hidden forms considered in this opinion
1.3.1.1. Fumonisins
Based on their different substituent groups, fumonisins are classiﬁed as A-, B-, C- and P-series
(EFSA CONTAM Panel, 2018). Those belonging to group B such as fumonisin B1 (FB1), B2 (FB2), B3
(FB3), B4 (FB4) occur mainly in feed commodities (Gelderblom et al., 1988; Cawood et al., 1991).
Other fumonisins belonging to group B, or those classiﬁed as A-, C- and P-series, usually account for
less than 5% of the total fumonisin (Rheeder et al., 2002).
In view of their occurrence in grains (see Section 3.2 Feed occurrence data), the CONTAM
Panel decided to include FB1, FB2 and FB3 as parent compounds, since these are the most abundant
forms of fumonisins of the B-type. However, the CONTAM Panel decided not to include other
fumonisins of the B-type, or fumonisins of the A, C and P series, since these usually represent less
than 5% of total fumonisins.
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– Modiﬁed forms
Fumonisins, as with other mycotoxins, may undergo modiﬁcation according to two different routes:
1) Biotransformation in the fungus, infested plant and animal organism. This includes phase I
metabolism through hydrolysis of the parent toxin, and phase II metabolism involving
conjugation with endogenous molecules.
2) Processing of food and feed by thermal or chemical treatment. This causes degradation
reactions during processing, as well as covalent binding to food and feed matrices.
However, few data about the occurrence of modiﬁed forms are available in the literature.
1.3.1.2. Hidden forms
Due to their chemical structure, fumonisins may form non-covalent binding products with food or
feed matrices as modiﬁed forms, although there is no change of the chemical structure involved. Such
non-covalent interactions may be mediated by hydrogen-bonding or ionic bonding and are therefore of
particular importance for fumonisins as they can seriously affect the analytical determination of the
parent fumonisins in food and feed, leading in some cases to underestimation of their content (see
Section 1.3.4 Methods of analysis). The complete disruption of such non-covalent interactions in the
gastrointestinal tract of animals may lead to the release of parent forms, thus contributing to the total
load of fumonisins. Therefore, the CONTAM Panel has decided to include hidden forms of fumonisins in
this exposure assessment.
1.3.2. Previous animal health risk assessments
The Scientiﬁc Opinion related to fumonisins as undesirable substances in animal feed (EFSA, 2005)
evaluated the toxicity of fumonisins in feed for different animal species. The CONTAM Panel concluded
that FB1 was the most prevalent and toxic derivative and derived NOAELs and LOAELs for a number of
livestock species and farmed animals based on FB1. Pigs and horses were identiﬁed as the most
sensitive species to FB1. LOAELs of 200 lg/kg body weight (bw) per day for FB1 were derived for pigs
and horses based on increased sphinganine/sphingosine (Sa/So) ratio levels detected at that dose in
serum of both species. In ruminants, a NOAEL of 600 lg/kg bw per day for FB1 was derived based on
liver changes and impaired lymphocyte blastogenesis. A LOAEL of 10 mg FB1/kg feed was identiﬁed for
ﬁsh (carp) based on pathological alterations in liver, pancreas, kidney, heart and brain. At the time of
the evaluation, experimental data available for catﬁsh and Nile tilapia suggested a NOAEL
corresponding to 20 mg FB1/kg feed. A LOAEL of 2,000 lg/kg bw per day for FB1 was identiﬁed for
poultry based on increased Sa and Sa/So ratios in liver (EFSA, 2005).
In 2014, the EFSA CONTAM Panel developed a Scientiﬁc Opinion on the risks for human and animal
health related to the presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM
Panel, 2014). The toxicity for animals and humans of metabolites and masked or bound forms of
mycotoxins, including fumonisins, was evaluated. The EFSA occurrence database contained no data on
modiﬁed fumonisins, and therefore occurrence was based on limited information reported in the literature.
An estimation of the human dietary exposure and animal feed exposure compared with the
exposure to the parent mycotoxins and assessments of the human and animal health risks was
performed. Based on occurrence data collected at the time of the evaluation (EFSA CONTAM Panel,
2014), modiﬁed forms1 of fumonisins, which included physically entrapped forms, occurred – together
with their precursor – occurred predominantly in corn and maize-based products. The exposure
assessment was performed, and included an additional 60% to account for modiﬁed mycotoxins to
the parent compound. Risk characterisation was done by comparing exposure scenarios with the
NOAELs/LOAELs for the parent compounds.
The CONTAM Panel identiﬁed several uncertainties and data gaps for ‘modiﬁed mycotoxins’1 and
recommended re-assessing the animal health effects of zearalenone and fumonisins in order to set
NOAELs/LOAELs for these compounds.
1 Fumonisins modiﬁed forms: In the EFSA CONTAM Panel (2014) opinion, modiﬁed forms included both covalently and non-
covalently (i.e. physically entrapped) bound forms (Covalent binding to food and feed matrix (hidden forms)).
In the CONTAM opinion on appropriateness to set a group health-based guidance value for fumonisins and modiﬁed forms
(EFSA CONTAM Panel, 2018) and in the present opinion, non-covalently bound forms (hidden forms) are not considered as
modiﬁed forms. Modiﬁed forms of FBs are phase I and phase II metabolites formed in fungi or infested plants or food or feed
products of animal origin as well as forms arising from food or feed processing including covalent adducts with matrix
constituents.
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Recently, the CONTAM Panel assessed the appropriateness to set a group health-based guidance
value (HBGV) for fumonisins and modiﬁed forms (EFSA CONTAM Panel, 2018). The CONTAM
Panel considered modiﬁed forms of fumonisins phase I and phase II metabolites formed in fungi or
infested plants or food or feed products of animal origin. In addition, the Panel considered forms
arising from food or feed processing, including covalent adducts with matrix constituents. The
CONTAM Panel established a tolerable daily intake (TDI) for FB1 of 1.0 lg/kg bw per day based on
increased incidences of megalocytic hepatocytes found in a chronic study with mice, and found it
appropriate to include FB2, FB3 and FB4 in a group TDI with FB1 and exclude the modiﬁed fumonisins
in the group TDI for FB1–4 (EFSA CONTAM Panel, 2018).
1.3.3. Chemistry
1.3.3.1. Fumonisins
The chemical structure of fumonisins, and their classiﬁcation into groups based on different
chemical features, has been described in the EFSA CONTAM Opinion on the appropriateness to set up
a group HBGV for fumonisins and their modiﬁed forms (EFSA CONTAM Panel, 2018), see Figure 1.
Brieﬂy, fumonisins are formed by a C20 (or C19) long-chain amino-polyol backbone carrying two
methyl groups. On the backbone, two propane-1,2,3-tricarboxylic acid (also named tricarballylic acid,
TCA) side chains are esteriﬁed to hydroxy groups at positions C14 and C15.
Structurally the B-type fumonisin backbone resembles the sphingoid bases sphinganine (Sa) and
sphingosine (So) especially with the amino and hydroxy functions in positions C2 and C3 (Figure 1).
According to IUPAC, FB1 is named (2R,20R)-2,20-((((5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-11,16,
18-trihydroxy-5,9-dimethyleicosane-6,7-diyl)bis(oxy))bis(2-oxoethane-2,1-diyl))disuccinic acid (CAS No.
116355-83-0, C34H59NO15, MW 721).
Fumonisins are highly polar compounds, soluble in water and in polar solvents, carrying various
reactive groups, i.e. four carboxylic groups, two esteriﬁed tricarballylic side chains, one primary amine
and several hydroxy groups. Therefore, they can react under thermal processing conditions giving rise
to a number of modiﬁed forms.
1.3.3.2. Modiﬁed forms of fumonisins
Based on the presence of several reactive groups on the fumonisin backbone, several modiﬁed
forms have been elucidated, especially generated by thermal processes applied during food or feed
production (Figure 2). However, phase I and phase II metabolites formed in plants, fungi, and animals
have also been described.
Tricarballylic acid 
(TCA)
R1 R2 Polar
surface
Log P
FB1 OH OH 288.51 -0.044
FB2 H OH 268.27 1.3169
FB3 OH H 268.27 1.3169
FB4 H H 248.04 2.5538
OH
OH
OHR1
R2 NH2
HO
HO
O
O
O
O
O
O
O
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Figure 1: Chemical structure of the main parent fumonisins FB1, FB2, FB3 and FB4
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Phase I modiﬁcation
Little is known about the phase I metabolism of fumonisins in living organisms. Due to their high
polarity, FB1–3 show a lower absorption, compared to other mycotoxins, and are often excreted as
parent forms. The hydrolysis of the tricarballylic moieties, leading to the release of HFB1–3, is the only
phase I modiﬁcation described in the literature. Hydrolysed and partially hydrolysed fumonisins may be
formed by microbial and animal metabolism (Hahn et al., 2015), while the low occurrence of these
forms in grains may be related to fungal/plant metabolisms as well as to chemical reactions occurring
at harvest. It must be underlined that the hydrolysed form of FB1 is often referred to as aminopentol
in animal studies. Hydrolysed fumonisins can be formed through use of enzyme-based feed additive
(EFSA FEEDAP Panel, 2014; EFSA FEEDAP Panel, 2016).
Phase II modiﬁcation
Minor modiﬁed forms of fumonisins are O-fatty acyl fumonisin B1 (EFB1). These compounds are
formed by the esteriﬁcation of a long-chain fatty acid on the fumonisin backbone (3-O-, 5-O- or 10-O-
acyl-fumonisins) (Figure 2) (Bartok et al., 2010a,b, 2013a; Falavigna et al., 2016). Besides O-fatty acyl-
fumonisins, the corresponding N-fatty acyl-fumonisins were also detectable in low amounts in Fusarium
(Bartok et al., 2013b). These phase II metabolites have been found in maize in the ﬁeld, but it is still
unclear if their formation is due to fungal or plant metabolism.
N-fatty acyl-fumonisins and N-fatty acyl-hydrolysed fumonisins with fatty acid chain length ranging
from C16:0 to C24:1 are also described as in vitro and in vivo metabolites of fumonisins (Seiferlein
et al., 2007; Harrer et al., 2013, 2015).
Process-derived forms
Fumonisins bear four carboxylic moieties, a primary amino group and several hydroxyl groups,
which are prone to react with other molecules under thermal processing conditions commonly applied
in food and feed production, leading to process-derived modiﬁed forms of fumonisins.
TCA side chains can be cleaved under alkaline conditions giving rise to hydrolysed fumonisins HFBx
(Humpf and Voss, 2004). When the hydrolysis is incomplete, partially hydrolysed fumonisins (pHFB1–3)
(a) formation of fatty acid esters of fumonisins (EFB1); (b) formation of N-acyl-fumonisin B1 and N-acyl-hydrolysed
fumonisin B1.
Figure 2: Formation of Phase I and Phase II metabolites of fumonisins
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are produced as isomeric forms from the cleavage of one of the two tricarballylic side chains on the
fumonisin backbone. Their structure has been described in the EFSA opinion on Fumonisins HBGVs
(EFSA CONTAM Panel, 2018 section on chemistry). pHFB1–3, (Figure 3) are formed by cleavage of only
one of the two TCA side chains. Hydrolysed fumonisin B1 (HFB1) occurs in nixtamalised corn products
and canned yellow corn, but usually at lower concentrations than FB1.
The primary amine group of fumonisins may easily react with reducing sugar upon heating,
originating from Maillard-type products. Among possible degradation products, only N-
(carboxymethyl)-fumonisin B1 (NCM-FB1) and N-(1-deoxy-D-fructos-1-yl)-fumonisin B1 (NDF-FB1) have
been detected in food and feed so far (Figure 3) (Humpf and Voss, 2004). These reactions have been
primarily shown for FB1 and HFB1 but all other fumonisins with a free primary amino group can react
in the same way. Recently, NDF derivatives of FB2 and FB3 have been identiﬁed in corn samples
(Matsuo et al., 2015).
Fumonisins can also covalently bind to macromolecules such as starch and proteins via their two
reactive TCA side chains. These matrix-bound forms of fumonisins were ﬁrst described and partially
characterised by Shier et al. (2000a,b) in model experiments with radiolabelled FB1 (Shier, 2000; Resch
and Shier, 2000; Shier et al., 2000a,b), and were further characterised by Seefelder et al. (2003).
Such covalent binding has been described so far only for FB1, which is the most abundant
fumonisin in crops. However, due to the chemical similarity of FB1 with other B-type fumonisins, the
formation of modiﬁed forms of FB2 and FB3 is very likely. Although these compounds have been
isolated and characterised in model systems, their direct determination in food as such is not possible,
as the covalently bound fumonisins have to be released ﬁrst by chemical hydrolysis. Therefore, these
matrix-bound forms of fumonisins can be determined indirectly by quantifying free FB1–3 and HFB1–3
before and after chemical hydrolysis or after digestion of the macromolecules (Dall’Asta et al., 2010).
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(a) Formation of matrix-bound forms; (b) formation of hydrolysed (HFB1) and partially hydrolysed fumonisins B1 (pHFB1); (c) N-alkylation with sugars (N-(carboxymethyl)-fumonisin B1
(NCM-FB1), N-(1-deoxy-D-fructos-1-yl) fumonisin B1 (NDF-FB1).
Figure 3: Process-derived modiﬁed fumonisins
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1.3.3.3. Hidden forms/Non-covalently bound fumonisins
While modiﬁed fumonisins have been isolated and structurally characterised, the presence of other
non-covalent forms of fumonisins have been assumed based on experimental observation, such as
poor recovery rates from different food matrices in interlaboratory studies (Dall’Asta et al., 2009b;
Bryła et al., 2015). These forms have been already discussed by EFSA CONTAM Panel (2018).
Due to their chemical structure, which is highly prone to form hydrogen bonds as well as apolar
interactions, fumonisins may undergo non-covalent binding with macromolecules occurring in food
(e.g. starch, proteins, lipids, etc.). This gives rise to the formation of non-extractable, non-covalent
forms, often described as ‘hidden’ or ‘physically entrapped’ fumonisins. In the same context, the
extractable fraction is commonly referred to as ‘free fumonisins’. Within this opinion, ‘hidden
fumonisins’ will be the term used for deﬁning such non-covalent forms.
Due to the non-covalent nature of these non-speciﬁc interactions and the structural diversity of
such complexation, which can range from quite weak to very strong, such forms cannot be isolated
and chemically characterised.
Although the physicochemical nature of such interaction has not been fully described, data collected
so far indicate that biopolymers – preferentially amylose and amylopectine, but also proteins – may form
inclusion complexes with fumonisins. These complexes are stable under the routine extraction conditions,
but can be easily destroyed under in vitro digestion conditions, when biopolymers are enzymatically
degraded (Dall’Asta et al., 2010).
Such interactions have been indicated as responsible for the difﬁculties in obtaining comparable and
reproducible results using different analytical methods. Complexation may be disrupted during the
extraction process as a consequence of different experimental parameters (i.e. pH, solvents,
temperature, etc.). This will lead to the release of parent forms, and thus to changes in the ﬁnal
recovery of analytes (Dall’Asta et al., 2009b). Moreover, it has been demonstrated that the instability of
fumonisins in stored analytical samples, and in particular spiked samples used in collaborative method
studies (Kim et al., 2002), may involve the formation of hidden fumonisins.
Unfortunately, current protocols for matrix macrocompounds disruption are based on alkaline
treatment, and cannot avoid the simultaneous hydrolysis of fumonisins. Therefore, as a result, hidden
fumonisins are determined indirectly as hydrolysed fumonisins, and not as parent compounds.
Data reported in the literature indicated that such forms can be related to the chemical composition
of maize hybrids, as well as to other environmental factors (Dall’Asta et al., 2012). In addition,
technological processes may affect the distribution ratio between extractable and non-extractable
fumonisins, mainly in consideration of starch-related phenomena (Bryła et al., 2015).
It has been demonstrated that matrix-fumonisin complexes can be destroyed by human digestive
enzymes in an artiﬁcial system, thus releasing the corresponding parent forms (Oomen et al., 2003;
Versantvoort et al., 2005; Dall’Asta et al., 2010). Indeed, enzymatic activity may induce the formation
of hidden forms which may signiﬁcantly contribute to the overall fumonisins exposure. Therefore,
these should be considered to avoid underestimation of the exposure in risk assessment.
1.3.4. Methods of analysis
1.3.4.1. Fumonisins
The methods of analysis for fumonisins have been largely described by the EFSA CONTAM Panel (2018).
Group B fumonisins are soluble in water and polar solvents, and therefore, they can be extracted from
raw and processed materials with water/methanol or water/acetonitrile mixtures. As for other
mycotoxins, sample clean-up strategies may involve the use of SPE cartridges, as well as immunoafﬁnity
columns (Hubner et al., 2012; Berthiller et al., 2014).
The analytical determination of fumonisins is usually carried out by reverse phase liquid
chromatography separation, using water/methanol or water/acetonitrile as elution solvents (M€oller and
Gustavsson, 2000; Bartok et al., 2010b). Due to the lack of UV-absorbing or ﬂuorescent chromophores,
measurement of fumonisins involves a derivatisation step with ﬂuorescent labels, such as o-
phthaldialdehyde (OPA) (Wilkes and Sutherland, 1998; Arranz et al., 2004). Such derivatisation is not
needed when liquid chromatography-mass spectrometry (LC–MS) methods are implemented.
These high-performance liquid chromatography coupled with ﬂuorescence detection (HPLC-FLD)
methods are still in use for routine purposes, but LC coupled to tandem mass spectrometry (LC–MS/MS)
has over the last decade become the method of choice for fumonisin determination. Common procedures
are based on electrospray ionisation (ESI) in positive mode. The sensitivity is often very good, reaching
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the limit of quantiﬁcation (LOQ) in the range 50–100 lg/kg for FB1 and FB2. However, the inclusion of
fumonisins in multitoxin methods is still difﬁcult, due to the different polarity and the increased matrix
effect, compared to other mycotoxins, i.e. trichothecenes. Therefore, such approaches often suffer from
poor recovery (≤ 60%) and lower accuracy for fumonisins, when compared to other analytes. Such
effects can be counteracted by using stable isotopic standards or matrix-matched calibration (Rychlik and
Asam, 2008; Varga et al., 2012).
Several tests, based on immunochemical detection, are available on the market for FB1–3
determination. The limit of detection (LOD) for enzyme-linked immunosorbent assay (ELISA) kits is
usually in the range 25–50 lg FBs/kg, with speciﬁcity of 100% for FB1 and FB3 and of 40% for FB2.
Lateral ﬂow devices have been developed for semiquantiﬁcation in maize and show a limit of detection
in the range 0.3–3.0 mg FBs/kg feed.
1.3.4.2. Modiﬁed forms of fumonisins
Methods for analysing modiﬁed fumonisins are commonly based on two different approaches, i.e.
direct analysis, or indirect analysis obtained by alkaline hydrolysis or enzymatic digestion of the
sample. According to the selected strategies, the monitored ﬁnal analyte may be different, and the
result may require a correction based on stoichiometric factors for the evaluation of the contamination
in terms of FBs. Since the calculation step may introduce an additional factor of uncertainty, this
should be considered in the exposure assessment procedure.
Direct methods
Phase I metabolites
Extraction and analysis methods for modiﬁed fumonisins are very similar to the parent compounds,
and therefore FB1–3, as well as HFB1–3 and other modiﬁed forms, are often determined within the same
chromatographic run. Historically, many protocols were based on HPLC-FLD with OPA derivatisation, as
already used for FBs. However, recent methods mainly involve mass spectrometry (MS) (De Girolamo
et al., 2014), and pHFB1–3 are less frequently measured because of their lower stability, although the
protocols in use are the same proposed for FB1–3 and HFB1–3.
Phase II metabolites
Phase II metabolites of fumonisins are often characterised by the conjugation with long-chain fatty
acids. These forms are, therefore, less polar than the parent compounds, and their co-extraction with
parent compounds can be challenging in terms of recovery and chromatographic separation. For this
reason, few studies are reported in the literature and the incidence of these forms compared to parent
compounds could be under- or over-estimated.
Fatty acid esters of FB1 have been recently reported in rice and maize (Bartok et al., 2010a;
Falavigna et al., 2013). These rather apolar compounds are commonly extracted from the matrix using
water: methanol (25/75, v/v), then the sample is directly analysed by LC–MS/MS. Similar conditions
have been applied to the determination of N-acyl forms of fumonisins (Bartok et al., 2013b).
Process-derived forms
Process derived forms of fumonisins are mainly Maillard-type compounds that can be easily
extracted from the matrix under the same conditions applied for parent compounds.
The main N-alkyl-conjugates of fumonisins, NDF-FB1 and NCM-FB1, are extracted with the same
methods used for FB1, mainly based on the use of water/methanol or water/acetonitrile mixture. The
clean-up step is usually avoided (Castelo et al., 2001; Seefelder et al., 2001, 2003; Voss et al., 2001).
Following the extraction, the analysis of modiﬁed fumonisins is almost exclusively based on LC–MS/
MS. The separation is obtained on a C18 column, using 0.1% aqueous formic acid or acetic acid and
methanol/water or acetonitrile/water as mobile phase, under positive ESI as an ionisation mode. As
with the parent compounds, modiﬁed fumonisins determination suffers from matrix effect. Therefore,
the use of matrix-matched calibration or of isotopic standards (when available), is strongly required.
Indirect methods
Starting from the 1990s, it has been observed that performing alkaline hydrolysis of contaminated
corn products often leads to a higher amount of released hydrolysed fumonisins than that
stoichiometrically derived by the conversion of the fumonisins detectable by routine analytical
methods. This additional amount of FBs may be due to both non-covalently and covalently bound
fumonisins, although it is not possible to distinguish between the two.
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Under alkaline conditions, FB1–3 lose their side chains (TCAs) and, if the reaction is complete, they
can be fully recovered as HFB1–3. As sugar, starch, peptide or protein conjugates are also attached to
the side chains, fumonisins can be liberated by this treatment and measured (Dall’Asta et al., 2009a,
2010; Bryła et al., 2014, 2015). However, although often used for total fumonisin determination, the
protocol may be easily affected by bias, especially when calculation is applied for obtaining free and
bound FB amounts (Dall’Asta et al., 2009b; Bryła et al., 2014, 2015).
The main drawback of this approach is the lack of information about the single modiﬁed forms
occurring in the samples, since all forms are detected as HFB1–3 and results are given as FB1–3
equivalents. Besides modiﬁed forms, under this approach non-covalently bound fumonisins are also
detected as HFB1–3, thus leading to additional difﬁculties in the estimation of exposure.
1.3.4.3. Hidden forms/non-covalently bound fumonisins
The term ‘hidden forms’ refers to the fraction of fumonisins associated with the matrix via strong
non-covalent interaction, and thus non-extractable. Such non-covalent interactions may be weakened
when matrix macrocompounds are disrupted, i.e. following protein denaturation, starch hydrolysis, etc.
Therefore, changes in extraction parameters such as pH, salts, temperature, particle size, etc., may
strongly affect the extractability of fumonisins.
To address this analytical issue, several approaches have been proposed, mainly based on the use of
strong chemical and/or enzymatic hydrolysis of the matrix. Alkaline hydrolysis, already discussed as an
indirect determination of modiﬁed forms, is actually the most widely used approach, in spite of possible
bias due to analytical difﬁculties (Dall’Asta et al., 2009b; Bryła et al., 2013, 2014, 2015). In addition, the
enzymatic digestion of the matrix has been proposed by several authors (Dall’Asta et al., 2010; Bertuzzi
et al., 2016).
1.3.5. Legislation
Directive 2002/32/EC on undesirable substances in animal feed stipulates that rules on feedingstuffs
are needed to ensure agricultural productivity and sustainability and to ensure public and animal health
and animal welfare. Annex I of this Directive contains maximum levels of a number of undesirable
substances (chemical contaminants) that may be tolerated in products intended for use as animal
feed. Fumonisins are not regulated under this Directive.
Guidance values for fumonisins (fumonisins B1 + B2) have been recommended under Commission
Recommendation 2016/1319/EC.2 The guidance values are shown in Table 1. Currently, modiﬁed forms
of fumonisins are not considered in the legislation.
Table 1: Guidance values for fumonisins B1 + B2 in products intended for animal feed in the EU
(Commission Recommendation 2016/1319/EC)
Products intended for animal feed
Guidance value in mg/kg relative to a
feedingstuff with a moisture content of 12%
Feed materials(a)
• Maize by-products(b) 60
Compound feed for
• pigs, horses (Equidae), rabbits and pet animals 5
• ﬁsh 10
• poultry, calves (< 4 months), lambs and kids 20
• adult ruminants (> 4 months) and mink 50
(a): Particular attention has to be paid to cereals and cereals products fed directly to the animals that their use in a daily ration
should not lead to the animal being exposed to a higher level of these mycotoxins than the corresponding levels of
exposure where only the complete feedingstuffs are used in a daily ration.
(b): The term ‘Maize and maize products’ includes not only the feed materials listed under heading 1 ‘Cereal grains and products
derived thereof’ of the list of feed materials referred to in part C of the Annex to Regulation (EU) No 68/2013 but also other
feed materials derived from maize in particular maize forages and roughages.
2 Commission Recommendation (EU) 2016/1319 of 29 July 2016 amending Recommendation 2006/576/EC as regards
deoxynivalenol, zearalenone and ochratoxin A in pet food. OJ L 208, 2.8.2016, p. 58–60.
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2. Data and methodologies
2.1. Data
2.1.1. Feed occurrence data
Following an European Commission mandate to EFSA, a call for an annual collection of chemical
contaminant occurrence data in food and feed, including fumonisins, was issued by the former EFSA
Dietary and Chemical Monitoring Unit (now DATA Unit)3 in December 2010 with a closing date of 1
October of each year. The data submissions to EFSA followed the requirements of the EFSA Guidance
on Standard Sample Description for Food and Feed (EFSA, 2010a); occurrence data were managed
following the EFSA standard operational procedures (SOPs) on ‘Data collection and validation’ and
‘Data analysis and reporting’. By the end of July 2017, a total of 18,273 analytical results from 8,057
samples on fumonisins in feed were available in the EFSA database. Data received after that date were
not included in the data set used to estimate dietary exposure. No data on the modiﬁed forms of
fumonisins were available in the EFSA Chemical Occurrence database.
Following the EFSA SOP on ‘Data analysis and reporting’ to guarantee an appropriate quality of the
data used in the exposure assessment, the initial data set was carefully evaluated applying several
data cleaning and validation steps. Special attention was paid to different parameters such as
‘Sampling strategy’, ‘Sampling year’, ‘Sampling country’, ‘Analytical methods’ and the ‘Reporting unit’.
Feeds were classiﬁed based on the catalogue of feed materials speciﬁed in the Commission Regulation
(EU) No 68/20134.
Analytical results were reported either on a whole weight basis or with a dry matter (DM) content
of 88%. Before estimating dietary exposure, all results were converted into 88% DM mg/kg. For those
samples expressed on whole weight basis, the moisture content was used to convert the analytical
result into 88% DM; when the moisture content was missing, whenever possible, the moisture content
was estimated from reported values (see Section 3.2.2).
In analysing the occurrence data of fumonisins, the left-censored data (results below LOD or below
LOQ5) were treated by the substitution method as recommended in the ‘Principles and Methods for the
Risk Assessment of Chemicals in Food’ (WHO/IPCS, 2009) and in the EFSA scientiﬁc report
‘Management of left-censored data in dietary exposure assessment of chemical substances’ (EFSA,
2010b). The guidance suggests that the lower bound (LB) and upper bound (UB) approach should be
used for naturally occurring contaminants, nutrients and mycotoxins. The LB is obtained by assigning a
value of zero (minimum possible value) to all samples reported as lower than the LOD (< LOD)/LOQ
(< LOQ). The UB is obtained by assigning the numerical value of LOD to values reported as < LOD and
LOQ to values reported as < LOQ (maximum possible value), depending on whether LOD or LOQ is
reported by the laboratory.
According to the previous studies reported in the literature, hidden fumonisins contribute to the
overall fumonisins occurrence for an additional amount ranging from 40% to 70% of the parent
compounds, and in a few cases may reach an additional 100% (See Appendix D). In maize, the
presence of hidden fumonisins is inﬂuenced by the growing season, the genotype, and on the
processing (Dall’Asta and Battilani, 2016). As a general observation, the ratio of modiﬁed fumonisins is
higher when the overall contamination is low, while it is lower in highly contaminated samples
(Dall’Asta and Battilani, 2016). Although this percentage can vary depending on the processing,
different factors cannot be derived for single products, due to the lack of sufﬁcient data from the
literature.
Therefore, the CONTAM Panel agreed that the exposure assessment would be performed assuming
an additional contribution of 60% with respect to the parent compound.
2.1.2. Feed consumption data
Fumonisins and their modiﬁed forms are predominantly found in cereal crops, cereal grains and by-
products of cereal processing and the highest levels are generally reported in maize grains and maize
3 From 1 January 2014 onwards, Evidence Management Unit (DATA).
4 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials.OJ L 29, 16.1.2013, p. 1–64.
5 The LOD can be deﬁned as the lowest concentration level that can be determined to be statistically different from a blank.
Similarly, the LOQ is the minimum concentration or mass of the analyte that can be quantiﬁed with acceptable accuracy and
precision (Keith et al., 1983. Principles of environmental analysis, Analytical Chemistry 55 (14), 2210–2218).
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by-products. Cereals and their by-products are widely used as feed for livestock, almost all of which
(> 95%) are grown or produced in the EU.6
Forages are also important constituents of livestock diets (principally for ruminants and horses),
and frequently are the sole feed. Since fumonisins and modiﬁed forms have been identiﬁed in certain
forages – and particularly maize silage – estimates of intake of forages are also required to assess
likely exposure.
In this opinion, two approaches have been adopted to estimate exposure to fumonisins and its
modiﬁed forms. For many livestock in the EU, part or all of the daily ration is provided in the form of
manufactured compound feeds, and where data on levels of fumonisins in species-speciﬁc compound
feeds7 are available these have been used to estimate exposure. Since compound feeds represent the
complete diet for many livestock, this is the preferred method of calculating exposure. However, for
some livestock categories, information on levels in compound feeds has not been given, or insufﬁcient
data have been provided to allow reliable estimates of exposure to be made, and for these, the
occurrence data on individual feed materials have been used, together with example diets
(Appendix C) to estimate exposure. It should be stressed that these do not represent ‘average’ diets,
nor are the feeding systems ‘typical’ for all of Europe. Instead, they are used to estimate levels of
exposure to fumonisins and their modiﬁed forms that might be indicative. They are based on published
guidelines on nutrition and feeding (AFRC, 1993; Carabano and Piquer, 1998; NRC, 2007a,b; Leeson
and Summers, 2008; McDonald et al., 2011; EFSA FEEDAP Panel, 2012; OECD, 2013) and expert
knowledge of production systems in Europe. Details of the rations used and live weights assumed are
given in Appendix C.
2.1.3. Toxicokinetic and toxicological data
Data were obtained from the scientiﬁc literature as described in 2.2.2.
2.2. Methodologies
2.2.1. Use of default value for Fumonisins, modiﬁed forms and hidden forms
included in the assessment
2.2.1.1. Modiﬁed forms
As described in Section 1.3.1 (Fumonisins, modiﬁed forms and hidden forms considered in this
opinion) FB1–3 as parent forms, modiﬁed forms of fumonisins and hidden forms of fumonisins have
been included in the assessment, according to the available occurrence data.
Due to the lack of information on their toxicity, the CONTAM Panel was unable to derive any
relative potency factor (RPF) for modiﬁed fumonisins (EFSA CONTAM Panel, 2018).
In consideration of the lack of occurrence data for modiﬁed forms of fumonisins in the EFSA
database, and since studies from the literature indicate a low occurrence (less than 10%) of these
forms compared to the parent compounds, modiﬁed forms of FB1–3 were not included in the exposure
assessment.
FB4 was not considered in this opinion since it occurs mainly in grapes, which is not a major
feedstuff. In addition, data on the occurrence, toxicity and toxicokinetics (TK) could not be identiﬁed
for FB4.
2.2.1.2. Hidden forms
As discussed in Section 1.3.3.3, hidden fumonisins may be available after digestion along with the
parent compounds, thus increasing the total fumonisin exposure.
Although the proportion of hidden fumonisins may vary depending on the food process, different
factors cannot be derived for different matrices due to the lack of appropriate information.
Based on the data from the literature and in agreement with the previous assessment (EFSA
CONTAM Panel, 2014), an additional factor of 60% was applied for hidden fumonisins to the
occurrence of parent compounds in feed. Therefore, two exposure scenarios were calculated, one for
the parent fumonisins (FB1 + FB2 + FB3) and one increased by a factor of 60% to take into account
the contribution of hidden fumonisins.
6 Source: FEFAC Feed and Food Statistical Yearbook 2014. Available online: www.fefac.eu
7 Complete and complementary feedingstuffs.
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2.2.2. Methodology for data collection and study appraisal
In 2015, the CONTAM Panel received from European Commission the mandate for an assessment
of the risk to animal health of fumonisins and their modiﬁed forms. In addition, a mandate was
received to assess whether it is appropriate and feasible to set a group HBGV for fumonisin B1 and B2
and their modiﬁed forms identiﬁed in the CONTAM opinion on the risks for human health related to the
presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM Panel, 2018), and
to consider, if relevant, the appropriateness to use the parent compounds as a marker for presence
and toxicity of fumonisin B1 and B2 and their modiﬁed forms.
A call for a literature search and review was launched in March 2016 within the Framework
Contract (FWC) No OC/EFSA/AMU/2014/01 Lot 2 Chemical/toxicological – FWC 6 with the aim of
identifying and collecting relevant literature related to fumonisins and their modiﬁed forms to support
preparatory work for the present opinion and that on HBGVs (EFSA CONTAM Panel, 2018). A ﬁnal
project report was delivered in November 2016 and published on 23 February 2018, together with the
opinion on HBGVs for fumonisins (EFSA CONTAM Panel, 2018; NFI-DTU, 2018). Brieﬂy, nine search
strings were designed to identify potentially relevant studies and after removal of duplicates and
applying inclusion/exclusion criteria (as described in NFI-DTU, 2018) potentially relevant references
were identiﬁed. Papers published in the period from 1/1/2000 (the year of publication of the SCF
opinion) until 21/7/2016 were considered (except for adverse effects in farm and companion animals
where the starting date was 1/1/1980). The total number of publications identiﬁed, and the number of
publications identiﬁed as potentially relevant for each of the scientiﬁc areas, were: Chemistry and
analysis (4,456/532), toxicokinetics (2,262/114), mode of action (1,649/273), in vivo toxicity (3,555/
87), in vitro toxicity (1,632/138), observations in humans (2,424/38), adverse effects in farm and
companion animals (5,087/270), occurrence in food (3,284/709) and occurrence in feed and animal
exposure (3,283/270). The report contains as an annex all abstracts screened together with an
evaluation of their relevance and the corner points of the individual publications.
The abstracts proposed as potentially relevant in the report were then screened by the working
group (WG) members and, by applying expert judgement, were used in the assessment if considered
relevant for animal risk assessment.
Since a series of previous assessments of either EFSA or other scientiﬁc bodies were available
(IARC, 1993, 2002; SCF, 2000, 2003; FAO/WHO 2001, 2012; EFSA, 2005; EFSA CONTAM Panel, 2014,
2018), these were also considered for the present assessment. Whenever necessary, original
publications referenced in these previous assessments were retrieved.
In addition to the systematic search and the use of previous evaluations for retrieval of relevant
literature, a ‘forward snowballing’ approach8 was applied by all WG members in order to obtain any
relevant information published up to 1 October 2017.
2.2.3. Methodologies for dietary exposure assessment in animals
Exposure to fumonisin by livestock is a function of its concentration in their diets and the amount of
the diet consumed. In the absence of a comprehensive database on the amounts or types of feed
consumed by livestock in the EU, estimates of feed consumed for each of the main categories of
farmed livestock and companion animals are based on published guidelines on nutrition (e.g. Carabano
and Piquer, 1998; NRC, 2007a,b; Leeson and Summers, 2008; McDonald et al., 2011; EFSA FEEDAP
Panel, 2012; OECD, 2013), together with expert knowledge of production systems in Europe.
For many farmed livestock and companion animals, their nutritional requirements are provided in
commercially manufactured complete (compound) feeds. Where sufﬁcient (reliable) data on the
concentrations of fumonisins in compound feeds have been provided, these have been used to
estimate exposure. However, where insufﬁcient compound feed data were available, the CONTAM
Panel identiﬁed example diets and feed inclusion rates, and used concentrations of fumonisin in
individual feed materials to estimate P95 and mean exposure both LB and UB. Details of the intakes
and composition of diets used in estimating animal exposure to fumonisins are given in Appendix C.
8 Identifying articles that have been cited in articles found in a search.
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2.2.4. Methodology applied for risk assessment
The CONTAM Panel applied the general principles of the risk assessment process for chemicals in
food as described by WHO/IPCS (2009), which include hazard identiﬁcation and characterisation,
exposure assessment and risk characterisation. The principles described by WHO/IPCS (2009) and
EFSA guidances pertaining to risk assessment have been applied for the present assessment. For
details on the speciﬁc EFSA guidances applied, see Appendix A.
3. Assessment
3.1. Hazard identiﬁcation and characterisation
3.1.1. Toxicokinetics
3.1.1.1. Fumonisins
The absorption, distribution, metabolism and excretion, (ADME) of fumonisins was reviewed by
EFSA in 2005 (EFSA, 2005) and, more recently in 2018 (EFSA CONTAM Panel, 2018), in an opinion
addressing the appropriateness to set an HBGV for fumonisins and their modiﬁed forms in humans.
Based on a limited data set in laboratory species, farm animals and humans, it was concluded that,
upon oral exposure, fumonisins display a limited bioavailability (3–6%) and exhibit peak plasma levels
a few hours after the exposure. The poor bioavailability is mainly due a very limited absorption rate, as
conﬁrmed by in vivo investigations with the labelled toxin and in vitro studies using differentiated
Caco-2 cells, an established model of human enteric absorption.
Once absorbed, fumonisins are rapidly cleared from the systemic circulation with half-lives of few
hours. Although relatively higher concentrations are usually detected in the liver and kidney, no speciﬁc
target tissues for fumonisins accumulation have been found.
Overall, fumonisins are known to be biotransformed to a limited extent in mammalian species. The
ﬁrst step entails the hydrolysis of the ester groups yielding two metabolites of pHFB1 (also referred to
as aminopolyols) and HFB1. The generation of HFB1 is of note due to the higher lipid solubility (and
hence potential bioavailability) of this metabolite compared to FB1 (Humpf et al., 1998). Accordingly,
an in vitro study performed with differentiated Caco-2 cells, HFB1, but not FB1, was able to cross the
epithelial cell barrier and its absorption appeared to be regulated by the drug transporter P-gp (De
Angelis et al., 2005).
Most of the hydrolytic reactions appear to be carried out by microorganisms occurring in the lower
enteric tract. Unlike studies with chyme suspensions, a number of in vitro experiments conducted with
primary cell cultures and/or tissue subfractions failed to detect any hydrolysed derivatives or other
metabolites following the incubation of the parent compounds. This notwithstanding, the incubation of
cloﬁbrate-induced9 pig liver microsomes with 2–100 lM FB1 has been reported to generate a type I
spectrum upon ultraviolet-visible (UV–vis) absorption spectroscopy, indicating that the toxin may be a
substrate of CYP4A with an afﬁnity of around 5 lM; a putative hydroxylated metabolite distinct from
the hydrolysed ones was tentatively identiﬁed (Marvasi et al., 2006).
Despite the scant information concerning the role of drug transporters and tissue biotransformation
enzymes in fumonisins kinetics, it has been reported that both may be modulated by fumonisins. The
modulation of biotransformation enzymes has been recently reviewed by Wang et al. (2016) and Wen
et al. (2016). For example, the intraperitoneal (i.p.) administration of FB1 (0.125, 0.25, 2.5 mg/kg bw
per day for 6 days) was documented to upregulate CYP1A and CYP4A in rat liver (Martinez-Larra~naga
et al., 1996). In addition, the oral administration of 0, 5, 15 and 45 mg FB1/day to ducks over 12 days
resulted in the increase in a number of hepatic CYP-mediated biotransformations (mainly CYP3A) even
at the lowest dose, while phase II enzymes were less affected (Raynal et al., 2001). More recently
(Antonissen et al., 2017), a trial was conducted on broiler chickens which were offered for 15 days a
diet containing FBs at levels approaching the EU guidance ones (20 mg/kg). Treated animals showed
an almost 25-fold increase in jejunum CYP1A4, an isoform which is orthologous to mammalian
CYP1A1; at the same time, a threefold increase in MDR1/ABCB1 (P-gp) expression was also noticed.
Interestingly, birds exposed to same dosages revealed minor but detectable changes in enroﬂoxacin
kinetic parameters following an oral bolus administration of the drug. Although the effects of FBs on
9 Cloﬁbrate is a typical CYP4A inducer and peroxisome proliferator in mammalian species; CYP4A metabolizes mainly fatty acids
at their omega carbon.
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biotransformation enzymes and drug transporters have not been thoroughly investigated, there is the
potential for the alteration of the kinetics of xenobiotics that are substrates of the affected enzymes/
drug transporters.
A further metabolic pathway, i.e. the N-acylation of the hydrolysed forms at the primary amino
group with fatty acids of various chain length, has been documented in cell lines and in rodents, but
not in livestock or companion species; the in vivo formation of N-acyl-FB1 has been also demonstrated
in rats. It is generally accepted that the N-acylation reactions are carried out by tissue ceramide
synthase. The main metabolic pathways of fumonisins are depicted in Figure 4.
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Figure 4: Metabolic pathways of fumonisins
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Biliary excretion of FBs has been documented in a number of species, followed by enterohepatic
circulation. Urinary excretion has been reported as a minor route, fumonisins being primarily excreted
via the faecal route.
No data on fumonisin biotransformations are available for avian species and no information on
fumonisin kinetics could be identiﬁed for companion animals, horses, rabbits, farmed mink and ﬁsh.
Appreciable interspecies differences in fumonisin TK have been reported (see Section 3.1.1.2).
However, due to a limited data set, a link between such differences, the various peculiar syndromes
occurring in farm animals and species sensitivity has not yet been established. Although contrasting
results have been reported in rats (reviewed in Wang et al., 2016), the majority of the available in vivo
studies carried out in laboratory species point to a lower toxicological signiﬁcance of FB metabolites
(mainly HFB1) vs the unmodiﬁed toxins. There is a limited knowledge concerning food producing
species. Based on plasma and liver Sa/So ratios, liver and enteric morphology, and cytokine
expression, a much lower effect of HFB1 compared to FB1 was documented in piglets fed a diet
contaminated compound feed at a concentration of approximately 37–44 mg/kg for 14 days (Grenier
et al., 2012). More recently, the toxic effects of FB1 or HFB1 were compared in turkeys and piglets
(Masching et al., 2016). Animals were offered a contaminated diet in the presence or absence of a
commercial carboxylesterase, which was intended to cleave FB1 into its hydrolysed metabolites. As
expected, marked reductions in FB1 content and a parallel rise in HFB1 concentration were detected in
the excreta of animals receiving the carboxylesterase fortiﬁed diet; this ﬁnding was matched by a
signiﬁcant reduction in the Sa/So ratio which was taken as a biomarker of FB1 toxicity. Although the
study was not performed with the puriﬁed metabolite, the results reinforce the view that FBs
hydrolysis should be considered as a detoxiﬁcation mechanism.
3.1.1.2. Species-related kinetics
Ruminants
Cattle
According to Smith and Thakur (1996) and Caloni et al. (2000), using an artiﬁcial model of a cow’s
rumen, a very limited decline (9–12%) in the amount of measurable fumonisins was observed after up
to 72 h incubation, and it was not possible to detect any hydrolysed metabolic derivative. A limited
degradation (8–10%) of FB1 was also reported by Gurung et al. (1999) following incubation of 50 or
100 mg FB1/kg in ruminal ﬂuid.
Cattle hepatic microsomes were incubated with FB1 (7, 14 or 28 lM) for up to 60 min in the presence
of an NADPH-generating system and the incubates were analysed for the presence of FB1, pHFB1 and
HFB1 by HPLC. Neither an appreciable decrease in the parent molecule concentration nor the
appearance of measurable amounts of the examined metabolites could be detected (Spotti et al., 2001).
To gain insight into the excretion of FB1 in milk, in vitro experiments were carried out with the
isolated and perfused udder (Spotti et al., 2001). For each udder (n = 3), 2 mg of FB1 were injected in
the perfusion blood of a pair of quarters to reach a concentration of 400 ng/mL, while the other two
were left untreated. The concentration of FB1 was measured in both serum and milk samples at 0, 30,
60, 120 and 150 min after dosing. At the end of the monitoring period, serum FB1 concentrations were
about the half of those measured after 30 min, with no appreciable binding to erythrocytes.
Measurable levels of FB1 (up to around 20 ng/mL) were found in milk samples. The authors concluded
that FB1 is able to cross the mammary barrier but did not provide evidence of the mycotoxin fate in
the udder tissue.
In a study speciﬁcally designed to set up analytical methods to measure FB1 and metabolites in
feeding stuffs and animal excreta (Rice and Ross, 1994), cattle (gender, breed and trial duration not
reported) were administered with a diet containing 200 or 400 mg FB1/kg (n = 5/dose). Faecal and
urine samples (sampling time not speciﬁed) were collected and analysed by HPLC for the presence of
FB1 and the sum of pHFB1 and HFB1 (the latter only in faeces). Faeces were found to contain FB1
(1–6 mg/kg) and a higher amount of pHFB1 + HFB1 (14 mg/kg), whereas a lower concentration of FB1
(0.1–0.7 mg/kg) was measured in urine. For comparison, the dietary exposure of rats to a higher FB1
concentration (1,000 mg/kg) resulted instead in a prevalent faecal excretion of the parent compound
with respect to pHFB1 + HFB1 (530 vs 282 mg/kg) and in urine FB1 concentrations of the same order
of magnitude as those reported for cattle. The study suggests that, upon oral exposure of cattle, FB1
is largely excreted via the faecal route and to a lesser extent via urine; faeces also contain a
measurable amounts of hydrolysed metabolites.
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Prelusky and collaborators (1995) investigated FB1 kinetics in four dairy cows (452–630 kg bw,
unspeciﬁed breed) following either i.v. dosing (50 or 200 lg/kg bw) or oral gavage (1 or 5 mg/kg bw).
Both FB1 (LOD = 4 ng/mL) and HFB1 (aminopentol) (LOD = 8 ng/mL) were assayed in plasma using
an HPLC technique with ﬂuorescence detection. Data from the i.v. administration best ﬁtted a two-
compartment model, with similar values irrespective of the dose. There was a very rapid distribution
phase (t½ a ~ 2 min) and a slower but still rapid elimination phase (t½ b 15–18 min) with the parent
compound and the metabolite being no longer detectable 120 min after dosing. Similar and relatively
low values also occurred for the volume of distribution (Vd ~ 0.25 L/kg) pointing to a prevalent
presence of the toxin in the extracellular compartments before being excreted. Whatever the dosage,
no measurable amounts of either compound were recovered in plasma from orally exposed animals.
The authors concluded that a low absorption and/or a very efﬁcient pre-systemic metabolism might
explain the observed results.
Sheep
The temporarily isolated rumen model is an experimental technique performed in living animals to
assess both the ruminal metabolism and the systemic absorption across ruminal walls of a given
molecule. Applying this technique to Texel wethers (N = 3, average weight 65 kg), no ruminal
degradation of FB1 (1 lg/mL) or systemic absorption could be demonstrated (Pantaya et al., 2014).
The only paper identiﬁed dealing with the in vivo TK of FB1 in sheep is the study of Rice and Ross
(1994). Sheep (gender, breed, sampling time and trial duration not reported) were exposed to a diet
containing 50 mg FB1/kg (n = 5/dose). The proportion of FB1/pHFB1 + HFB1 recovered in faeces
(6/10 lg/g) and the urinary levels (0.1–3.8 lg/g) were of the same orders of magnitude as those
reported for cattle.
Goats
Eight weanling female Angora goats (15  2.1 kg bw) were randomly allotted to a control group
(< 1 mg/g FB1) and a treated group receiving a contaminated diet (95 mg of FB1/kg diet) for
112 days, with four goats per diet (Gurung et al., 1998). Using an HPLC method with a low sensitivity
(LOD 1 mg/kg), an average daily consumption of 45  4 mg FB1 could be estimated for the whole
trial. Only 21  4 mg FB1 (47%) of the daily ingested toxin was excreted as such in faeces during the
last 7 days trial; in addition, no FB1 residues > LOD could be detected in the liver, kidneys or hearts of
the treated animals (metabolites not determined). Taken together, these results point to an extensive
biotransformation of the toxin, but no indication about FB1 bioavailability could be derived.
In conclusion, there is scant information on the kinetics of fumonisins in ruminants, and all what is
known refers to FB1. The available data indicate a very limited bioavailability of the toxin per se, along
with an extensive biotransformation to HFB1 and pHFB1. The in vitro data would exclude the
substantial involvement of either the ruminal microbiota or microsomal liver drug metabolising
enzymes in the generation of the hydrolysed derivatives. Both the parent compound and the
hydrolysed metabolites are mainly eliminated via the faeces, the urinary route representing only a
minor excretion pathway. Excretion in milk has been investigated and documented in cows only.
Pigs
To study the in vitro metabolism of FB1 in pigs, cecal chyme suspensions were incubated
anaerobically with 5 lM FB1 up to 72 h. Samples were collected at 12 h intervals and analysed for the
presence of FB1, pHFB1 and HFB1 with LC–MS. A very low amount of HFB1 was detected at each time
point, overall accounting for less than 1% conversion of the parent molecule. By contrast, a negative
correlation was found between FB1 and pHFB1 concentrations at the different sampling times; overall,
the conversion of FB1 into the measured metabolites amounted to about 50%. It was concluded that
under in vitro conditions, a signiﬁcant portion of FB1 is biotransformed into its hydrolysed derivatives
(Fodor et al., 2007).
A previous evaluation (EFSA, 2005) reported a study in which the kinetics of 14C-FB1 was
investigated in pigs after i.v. (0.40 mg/kg bw) or oral (intragastric, 0.50 mg/kg bw) single
administration. After i.v. dosing, a tri-exponential concentration–time proﬁle was observed, with
apparent plasma half-lives of 2.2 min (t½ a), 10.5 min (t½ b), and 192 min (t½ c), respectively. The
latter was assumed to reﬂect a signiﬁcant enterohepatic re-circulation. Biliary recovery was 70.8% of
the administered dose, while 3 days after treatment 21.2% and 58.3% of the administered FB1 were
found in urine and faeces, respectively. Based on plasma and excretion data, FB1 systemic
bioavailability in orally exposed pigs was estimated to be very limited (3–4%). No FB1 residues
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(LOD = 1 mg/kg) were found in milk from sows exposed to a diet containing 100 or 200 mg FB1/kg
for 14 days (Becker et al., 1995).
Meyer et al. (2003) investigated the tissue distribution of FB1 in 13 weaned castrated pigs
(12–14 kg bw, breed and age not mentioned) exposed to a diet contaminated by
Fusarium verticillioides fungal culture to ensure a daily intake of 100 mg FB1/head. Five individuals
died during the treatment. Six of the remaining animals were sacriﬁced after 5 days, while the two
remaining (living) animals were euthanised after 10 days of treatment. The amount of FB1 was
determined by a LC–MS analysis on plasma, bile and samples of lungs, liver, bile, kidney, brain, spleen,
pancreas, heart, eye, muscle (m. longissimus dorsi, m. biceps femoris and m. psoas major),
subcutaneous and abdominal fat. On average, FB1 content was highest in kidneys (1,530 lg/kg)
followed by spleen (1,020 lg/kg), liver (379 lg/kg) and lungs (204 lg/kg). Taken together, muscles
were found to contain 43 lg/kg and fat 6 lg/kg. Relatively high levels (384 lg/kg) were recovered in
the bile, likely indicating the occurrence of an important enterohepatic cycling.
Distribution and elimination of fumonisins in tissues was investigated in weaned barrows (breed not
speciﬁed, 12–14 kg bw) (Fodor et al., 2006). Piglets (N = 10) received a diet containing F. verticillioides
fungal culture to provide a daily intake of 50 mg FB1, 20 mg FB2, and 5 mg FB3 per animal for 22 days,
corresponding to 2.2, 0.88 and 0.22 mg FB1, FB2 or FB3/kg bw, respectively. Total collection of quantity
of faeces and urine was undertaken for 5 days, i.e. between days 13 and 17 of the treatment period. At
the end of the trial, animals were necropsied and samples of liver, lungs, kidney, brain, spleen, heart,
muscle longissimus dorsi and psoas, abdominal and subcutaneous fat, as well as bile, were collected. All
samples were analysed for FB1 and FB2 by a LC–MS method. Tissue levels of FB1 were in the order liver
(99  37 lg/kg) > kidney (31  10 lg/kg) > myocardium ~ spleen (7–9 lg/kg) > lung (about 3 lg/
kg). No appreciable levels were detected in brain and muscles or in fat. Measurable levels of FB2 could
only be found in livers, lungs and fat from some animals in very low concentrations, with an estimated
ratio of 1:19 with FB1. As regards excretion, only bile samples from 1 out of 10 individuals were found
to contain measurable FB1 levels. During the 5-day test collection, faecal excretion of FB1 largely
outweighed that in urine, being on average 28.2 mg vs 4.5 mg. In the same period, it could be
calculated that only 13% of the ingested FB1 was eliminated, faecal and urinary excretion amounting to
86% and 14%, respectively. By contrast, the extent of the excretion of FB2 appeared to be much less
pronounced since concentrations of 1/9 and 1/14 with respect to those of FB1 were measured in urine
and faces, respectively. Overall, due to the large discrepancy between the amount of the ingested toxin
and that recovered in the excreta, the results point to an extensive biotransformation of FB1 and FB2.
To address this issue, a further study was designed involving sixteen weaned barrows (Hungarian
Large White, 12–14 kg bw) (Fodor et al., 2008). For the assessment of FB1 absorption, as calculated
from the Cr-FB1 ratio in feed, piglets were offered a Cr2O3-fortiﬁed diet containing F. verticillioides
fungal culture to provide a concentration of 45 mg FB1/kg (36.6  6.5 mg/day), 8.6 mg FB2/kg and
4.6 mg FB3/animal for 10 days, respectively. Half of the experimental animals (ﬁve treated and three
controls) were sacriﬁced at the end of the trial, while the remaining were killed 10 days after
treatment cessation. A special T-cannula was implanted into the distal part of the ileum to allow for
the determination of FB1 absorption from the Cr-fortiﬁed feed. During the whole 10-day treatment
faeces and urines were quantitatively collected and samples of chymus and of the same tissues as
described in the previous paper (Fodor et al., 2006) were taken. The amounts of FB1, FB2 and the
hydrolysed metabolites pHFB1 and HFB1 were determined by a GC–MS method. On average, it could
be calculated that the amount of the absorbed FB1 over the treatment was of 4%. It could also be
estimated that in the colonic chymus the conversion rate of FB1 into pHFB1 and HFB1 amounted to
3.9% and 1%, respectively. At the end of the treatment, all examined organs contained measurable
amounts of FB1 and FB2, the latter being present at much lower concentrations in all tissues
but muscles, where FB2 levels were of the same order of magnitude. As regards FB1, liver
(17.4  1.7 lg/kg) and kidney (9.9  0.3 lg/kg) exhibited the highest values, but remarkable levels
could also be found in m. longissimus dorsi (11.2  1.2 lg/kg) and m. psoas major (4.75  1.5 lg/kg).
Besides FB1, both metabolites were consistently recorded, with HFB1 levels being similar or lower than
those of pHFB1 in most tissues but the kidney. Overall, taking into account the levels of FB1 and its
hydrolysed metabolites recovered in the examined organs after 10-day of exposure, 50% was made by
the parent compound while HFB1 and pHFB1 accounted for 30% and 20%, respectively. After comparing
these results with those from the colonic chymus, the authors concluded that the hydrolysed metabolites
are also likely to be generated in the proximal enteric tracts, where a signiﬁcant absorption may occur. Of
note, measurable levels (lg/kg) of both FB1 and HFB1 were still detected in most of the organs 10 days
after treatment.
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In the same study, during the 10-day feeding period, about 360 mg FB1 was calculated to be
ingested by piglets; of this, during the toxin exposure and the 10-day recovery period, 69% (247 mg)
appeared in the excreta as the sum of the parent compound and its hydrolysed metabolites. The faecal
route accounted for the majority of the eliminated toxins (98.5%), with 41% as FB1, 47% as pHFB1,
and 12% as HFB1. Conversely, only a very limited amount (1.5%) of the ingested toxins appeared in
urine during the entire trial, and in this case about one-third was represented by the parent compound,
the remaining being pHFB1 (~ 20%), and HFB1 (~ 15%). As regards FB2, 23% of the ingested toxin was
eliminated via the faeces and only 0.6% via the urine. On the whole, results from this study are
consistent with a low absorption and an extensive biotransformation of FB1 to pHFB1 and to a lesser
extent HFB1, both of which may be detected in tissues even after treatment cessation.
The kinetics of FB1 in blood and excreta was investigated with an HPLC method in four 8-week-old
weaned pigs (Landrace 9 Large White 9 Duroc, average weight 25 kg) exposed to a single oral dose
(gavage) of culture material of F. verticillioides containing 5 mg FB1/kg bw
10 (Dilkin et al., 2010).
Samples of blood were taken at 1 h interval up to 6 h and at 12 h intervals up to 60 h. Urine and
faeces were collected up to 72 and 96 h from dosing, respectively. Bile samples were not collected. The
toxin was rapidly absorbed, as reﬂected by the occurrence of measurable plasma levels as early as 1 h
post-dosing (average 125  1311 ng/mL). FB1 concentrations plateaued at 2 h (average 282  38 ng/mL)
and rapidly declined so that detectable levels could be measured in 2/4 animals and in 0/4 animals 36 and
48 h after treatment, respectively. A signiﬁcant amount of the toxin (average 551  117 lg12) was
excreted in urines within 8 h of FB1 administration, and a similar amount (average 561  102 lg) occurred
within 24 h. On the whole, a very limited amount of the administered toxin was detected in urine (0.93%)
while approximately 76.5% of FB1 was measured in faeces. According to the authors, the unaccounted
fraction in faeces could be due to a limited absorption rate, an intense enterohepatic circulation and
biotransformation to FB1 hydrolysed derivatives.
In summary, the studies published since the previous EFSA evaluations (EFSA CONTAM Panel,
2014) do not modify the earlier conclusions on FB1 kinetics in pigs, and indicate a very limited oral
bioavailability followed by a rapid tissue distribution and an extensive biotransformation into pHFB1 and
HFB1. Both metabolites are also detectable in tissues. This suggests that the generation of pHFB1 and
HFB1 could not only occur in the distal enteric tract but might also take place in the proximal tract,
where a higher absorption rate may be expected. Both the parent compound and its hydrolysed
metabolites tend to accumulate in liver and kidney, while conﬂicting results are reported for muscles.
Measurable levels of FB1 and HFB1 (lg/kg) may be detected several days after treatment cessation.
The faecal excretion largely outweighs the urinary one, while the extent of biliary excretion might vary
according to the dose and the duration of the exposure.
Very little is known about FB2 kinetics. No evidence has been identiﬁed of a higher bioavailability
compared to FB1. Both the urinary and faecal excretion, as well as tissue deposition, appears to be
much lower than that displayed by FB1, pointing to a high rate of biotransformation of FB2 into
hydrolysed and possibly other metabolites.
Poultry
The TK of FB1 in avian species has been recently reviewed by Guerre (2015).
Little is known concerning fumonisin ADME in chickens. In the only report found (Vudathala et al.,
1994), the kinetics of 14C-FB1 (2 mg/kg bw) was investigated in 30-week-old White Leghorn laying
hens (1.3–1.7 kg bw) following i.v. or oral administration. After 24 h, animals were sacriﬁced and in
the i.v. study, the kinetics was described as bi-exponential with a very rapid equilibrium (t1/2
a = 2.5 min) and a short t1/2 b (40–69 min), which is consistent with a very low Vd (0.063–0.125 L/kg)
and a rapid clearance of the toxin, which was present in the systemic circulation as largely unbound.
Following the oral exposure, Cmax was reached at 1.5–2.5 h in different birds with plasma levels in the
range 28–103 ng/FB1 equivalents; no radioactivity was detected in the 24 h plasma sample. The
estimated bioavailability was 0.71  0.5%, indicating a very limited systemic absorption. The largest
fraction of the administered dose (80%) appeared in the excreta collected between 2 and 6 h post-
dosing; excretion was virtually completed after 24 h from toxin administration. Besides crop and
intestine, liver and kidney were the only organs with measurable levels of radioactivity; no radioactivity
could be measured in eggs.
10 According to the authors, this dose corresponded to 83 mg FB1/kg feed.
11 Mean  SD.
12 As such in the paper.
Fumonisins in feed
www.efsa.europa.eu/efsajournal 26 EFSA Journal 2018;16(5):5242
It was concluded that, in laying hens exposed to a single oral dose, FB1 is poorly absorbed and
quickly eliminated, giving rise to negligible residues in edible tissues and eggs.
In a more recent paper (Antonissen et al., 2015a), six 24-day-old Ross broiler chickens were
administered 1.91 mg FB1/kg bw and 0.59 mg FB2/kg bw as a single intracrop administration. Blood
was collected at 10 min intervals up to 60 min and at 240 min and plasma FB1 levels were quantiﬁed
by a LC–MS/MS method. The dose was calculated according to the EU guidance levels for fumonisins
in poultry feed (20 mg/kg for the sum of FB1 + FB2) and a feed consumption of 125 g/kg bw.
Relatively low peak levels (about 35 lg/L) were reached after 20 min, indicating a rapid but limited
absorption rate. In addition, chicks exhibited elimination half-life (t1/2el 106 min) and mean residence
time (MRT 165 min) values consistent with a rapid elimination.
Turkeys
Very little is known about fumonisin TK in turkeys. In the only paper that could be identiﬁed, Tardieu
et al. (2008) investigated the comparative (i.v. vs oral) FB1 TK in 1-week-old BUT9 male turkeys. For
i.v. studies, eight individuals were dosed with 10 mg FB1/kg bw and blood samples were taken at
different intervals up to 2,000 min after treatment. For studies using the oral route, further eight
animals received a single dose of 100 mg FB1/kg bw and blood sampling was performed at 30–60 min
intervals up to 600 min after dosing. Plasma and tissue levels of FB1 were measured by an HPLC
method (ﬂuorescence detector, LOD 13 lg/kg). Data after i.v. dosing were best ﬁtted to a three-
compartment open model and were consistent with a rapid (t1/2 a 3.5 min) and notable distribution
within the body (Vd area around 1 L/kg) along with a rapid clearance (t1/2 b 85 min, MRT 52 min,
clearance around 8 mL/min per h). Following the oral administration, a Cmax of nearly 1,000 lg/mL was
reached after 180 min, while a bioavailability of 3.2% was estimated. A considerable Vd area (more than
2 L/kg) and both relatively long MRT (around 400 min) and t1/2 b (214 min) indicate the potential for
tissue accumulation of FB1 (and possibly its derivatives) in turkeys exposed to contaminated feed. To
test this hypothesis, the same animals used in the oral study were sacriﬁced 20 h after dosing (100 mg
FB1/kg bw); measurable values of FB1 were detected in serum (279  30 lg/L), liver (5,458  509 lg/kg),
kidney (5,785  1,002 lg/kg), and muscle (113  15 lg/kg).
The FB2 TK was examined by Benlashehr et al. (2011) in BUT9 turkeys (6- to 7-week-old, 2 kg bw)
using the puriﬁed toxin. In the i.v. study, ﬁve individuals were dosed with 1 mg FB2/mg bw and blood
samples were taken at different intervals up to 240 min after treatment. For the study by the oral
route, eight animals received a single dose of 1 mg FB2/mg bw; blood samples were collected up to
600 min after treatment. In i.v. dosed turkeys, the toxin was cleared very rapidly, with extremely short
values of both MRT (around 5 min) and t1/2 b (about 12 min) along with a very limited extent of tissue
distribution (Vd area around 0.15 L/kg). Accordingly, plasma levels declined very quickly, reaching values
below the LOQ (25 ng FB2/mL) already 60 min after toxin administration. As to the study involving the
oral route, measurable (> LOQ) FB2 plasma levels were found in only two out of eight animals and
data could not be ﬁtted to any TK model. Data are therefore consistent with a very limited oral
bioavailability of FB2 in turkeys.
Ducks
There is scant information about fumonisin ADME in ducks and only one report could be identiﬁed
in the open literature (Tardieu et al., 2009). Kinetic parameters were ﬁrst investigated in 42-day-old
ducks treated by either the i.v. or the oral route using the puriﬁed toxin (96%). For the i.v. study, six
animals received 10 mg FB1/kg bw in the jugular vein and blood samples were taken at different
intervals up to 1,200 min after dosing. The TK via the oral route was investigated in further six animals
which were administered a single dose of 100 mg FB1/kg bw and subjected to blood sampling up to
1,200 min after treatment. A second study (oral route only) was carried out on 96-day-old ducks after
a force feeding period of 12 days with an uncontaminated diet, using the same protocol as above.
After the last blood sampling, all animals were sacriﬁced and liver, kidney and muscle samples were
taken. Plasma and tissue levels of FB1 were measured by an HPLC method (ﬂuorescence detector, LOD
13 lg/kg).
A two-compartment open model was demonstrated in i.v. dosed animals, showing a very rapid
distribution phase (2.6  0.3 min) which was followed by a relatively slower elimination phase
(26  2 min); the Vd was about 800 mL/kg, while the MRT and the clearance were 24  1 min and
19  2 mL/min per kg, respectively. A three-compartment open model best described the kinetic data
in orally dosed ducks. The toxin was rapidly absorbed, with maximum serum levels of the toxin
(628 lg/mL) being reached 60 min after dosing, extensively distributed (Vd area = 1.7 L/kg bw) but
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also rapid cleared (MRT 200 min, t1/2 b around 70 min). A very limited bioavailability (2.3%) could be
calculated. Measurable levels of FB1 (see Section 3.1.1.5) could be detected only in liver.
The FB2 TK in ducks (male mule ducks, 10 weeks old, 2 kg bw) was examined in the study of
Benlashehr et al. (2011) cited above. In the i.v. study, ﬁve individuals received 1 mg FB2/kg bw and
blood samples were taken at different intervals up to 240 min after treatment. For the study by the
oral route, eight subjects were treated with a single dose of 1 mg FB2/kg bw; blood samples were
collected up 600 min after dosing. In i.v. dosed animals, there was a rapid decline in plasma levels and
values below the LOQ (25 ng FB2/mL) were reached already 120 min after toxin administration. A
rapid clearance of the toxin was observed, with very short values of both MRT (around 13 min) and
t1/2 b (about 32 min) along with a limited extent of tissue distribution (Vd area around 0.40 L/kg).
Measurable (> LOQ) FB2 plasma levels were not detected in any of the orally treated animals. Data
point to a negligible oral bioavailability of FB2 in ducks.
In conclusion, sparse information is available concerning FB1 kinetics in avian species.
Bioavailability is very low and in the order turkey>ducks>chickens. In general, the toxin is rapidly
absorbed and distributed, but also rapidly cleared. Kinetic parameters (MRT and t1/2el) suggest a lower
FB1 clearance in turkeys compared to ducks and chickens, with the potential for tissue accumulation in
turkeys (see Section 3.1.1.5). Currently, there is no information on FB1 metabolism in avian species.
Only one study could be identiﬁed on FB2 kinetics for turkeys and ducks, indicating that the oral
bioavailability of the toxin seems to be even lower than that of FB1. No data on chickens could be
retrieved.
No information on fumonisin kinetics could be identiﬁed for companion animals, horses, rabbits,
farmed mink, and ﬁsh.
The main TK parameters measured in cows, pigs, laying hens, boilers, turkeys and ducks are
reported in Table 2.
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Table 2: Parameters of toxicokinetics of fumonisins in various species
Species/category
Dose
(mg/kg bw)
(N)
Route of
admin.
Cmax
(ng/mL)
Tmax
(min)
t1/2 a
(min)
t1/2 b
(min)
t1/2 c
(min)
Vd L/kg
Bioavailability
(%)
Reference
Cows 0.050 (1) i.v. – – 1.7 15.1 0.251(a) – Prelusky et al. (1995)
0.200 (1) i.v. – – 1.7 18.7 0.278(a) –
1 Oral < LOD – – – – – –
5 Oral < LOD – – – – – –
Pigs 0.40(b) (5) i.v. – – 3(c) 10.5(c) 183(c) 2.4  0.6 – Prelusky et al. (1994)
0.50(b) (5) Oral – 70(d) – 96(d) – 4.1  1.1(d)
5 (4) Oral 282  38 120 – – – – – Dilkin et al. (2010)
Laying hen 2(b) (6) i.v. – 2.5  0.3 49  11 0.08  0.01 – Vudathala et al. (1994)
2(b) (6) Oral – 1303 – 86(c) – – 0.7  0.5
Broiler 2.5 (6) Oral 33  21 20  5 – 106  8 0.23  0.02 – Antonissen et al. (2015a,b)
Turkey 10 (8) i.v. – – 3.5  0.8 85  4 0.39  0.02 – Tardieu et al. (2008)
100 (8) Oral 991  61 180 29  3 214  36 2.3  0.4 3.2  0.2
Duck 10 (6) i.v. – – 2.6  0.3 26  2 0.79  0.11 – Tardieu et al. (2009)
100 (6) Oral 559  95 60 80  13 70  10 1.7  0.23 2.3  0.3
Cmax: maximum concentration achieved in the plasma following dose administration; tmax: time at maximum plasma/serum concentration, t1/2el: plasma/serum elimination half life; bw: body
weight; i.v.: intravenous; LOD: limit of detection.
(a): Based on area under the curve (AUC) method.
(b): 14C FB1.
(c): Average values.
(d): Average values of 4/5 individuals.
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3.1.1.3. Modiﬁed forms and hidden forms
Modiﬁed forms
No speciﬁc studies on the metabolic fate of modiﬁed forms of FBs in farm and companion animals
have been identiﬁed. As regards HFB1, only indirect evidence is available from studies in pigs and
turkeys. Lower intestinal and hepatic toxicity was recorded in pigs orally exposed to HFB1 (2 lM/kg bw
per day for 14 days) as compared to pigs receiving equimolar doses of the parent compound (Grenier
et al., 2012). Accordingly, the alteration of sphingolipid metabolism (serum Sa/So ratio) was much less
pronounced in pigs or turkeys receiving FB1 contaminated rations supplemented with carboxylesterase
(able to extensively hydrolyse FB1 to HFB1) in comparison with animals administered with the
unsupplemented diets (Masching et al., 2016). In keeping with the conclusions of a previous EFSA
opinion on the risks for animal and human health related to the presence of modiﬁed forms of certain
mycotoxins in food and feed (EFSA CONTAM Panel, 2014), the reduced toxicity of FB1 hydrolysed
derivatives might be due to poor absorption. However, based on studies performed in rats (Hahn
et al., 2015), other hypotheses (e.g. presystemic metabolism) cannot be ruled out.
A different behaviour has been shown by covalently bound FBs, such as NDF- and NCM-FB1
conjugates, which are rather stable in the in vitro model system and not further biotransformed
in vitro by a suspension culture of human gut microbiome (Falavigna et al., 2012; Cirlini et al., 2015).
Nothing is known so far about the stability in vitro of O- and N-acyl conjugates of fumonisins.
Hidden forms
Studies performed in vitro on the bio availability of modiﬁed FBs in maize showed that their release
is strongly affected by the nature of the feed matrix modiﬁcation. Non-covalent associations leading to
hidden FBs can be easily disrupted in vitro using a digestion assay that simulates human
gastrointestinal conditions (Dall’Asta et al., 2010; Falavigna et al., 2012). In these studies, the amount
of fumonisin detected in the sample before the digestive assay was lower than that found in the
chyme after the treatment. The release of hidden FBs from the matrix is likely due to the enzymatic
degradation of starch and proteins (Dall’Asta et al., 2010). After hydrolysis in the gut the fate would be
the same of parent FBs. However, speciﬁc studies on the TK of hidden forms have not been identiﬁed.
3.1.1.4. Conclusions on toxicokinetics
Little is known on fumonisin TK in food-producing animals and in companion species, and the
available information is almost entirely related to FB1 fate in ruminants, pigs and avian species. In
general, the toxin is poorly bioavailable (1–6%). The absorbed fraction is rapidly distributed, mainly to
the liver and kidneys, and rapidly excreted through the faeces, with the urinary route playing an
ancillary role. Biliary excretion has so far been documented only in the porcine species. Likely at the
enteric level, FB1 undergoes hydrolysis to both pHFB1 and HFB1, which may be detected in tissues and
excreta. However, data are lacking concerning the species-related extent, as well as the site of
generation and the further metabolism (e.g. formation of N-acyl derivatives) of both hydrolysed
derivatives. Based on a very limited data set, FB2 shows a metabolic fate similar to FB1 with poor
bioavailability. However, both the urinary and faecal excretion, as well as tissue deposition, appear to
be much lower than that displayed by FB1.
3.1.1.5. Contribution of products of animal origin to the presence of FBs and modiﬁed
forms in feed
The carry-over of FB1 in milk, eggs and edible tissues was addressed in a previous EFSA evaluation
(EFSA, 2005). Based on in vitro and in vivo studies, a limited to negligible carry over (namely
0.11–0.001%) of the toxin in cows’ milk and in sows milk, respectively, was identiﬁed. A low transfer
with levels in the ng/g range also occurred in eggs. Although the transfer rates were not mentioned,
different studies performed in pigs, with various dosages, duration and withdrawal times, showed that
livers and kidneys could be considered the target tissues of FB1 deposition, while much lower residual
levels were detected in muscles. No measurable amounts of FB1 (LOD 1 mg/kg) were found in the
liver or kidneys from goats exposed to a diet containing 95 mg FB1/kg (Gurung et al., 1998; see
Section 3.1.1.2). It was concluded that the low residue levels found in animal products from
experimentally exposed farm animals ‘do not contribute substantially to human exposure’. These
conclusions are in line with those drawn by the SCF (2000) and have been substantially conﬁrmed by
JECFA (2011, 2017). Interestingly, as mentioned in the opinion addressing the appropriateness to set
an HBGV for fumonisins and their modiﬁed forms (EFSA CONTAM Panel, 2018), a survey performed on
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a few dairy milk samples (N = 10) purchased in Italian retail shops revealed the presence of trace
levels of FB1 in eight samples (mean 0.33 lg/kg, range 0.26–0.43 lg/kg, LOQ 0.33 lg/kg) (Gazzotti
et al., 2009).
Since the 2005 EFSA evaluation, a limited number of reports have been published dealing with
tissue residues of FB1 and occasionally its metabolites, particularly in animals fed with fumonisin
concentrations corresponding or approaching those recommended in feedingstuffs by the EU
legislation.
In a preliminary study, Gazzotti et al. (2011) fed seven piglets (unspeciﬁed age and breed) with a
diet containing the EU recommended limits for fumonisins (5 mg/kg as the sum FB1 + FB2) for
7 weeks, providing an average daily intake of about 1.66 mg/head. At the end of the experiment, the
animals were sacriﬁced and liver samples were analysed for the presence of FB1, HFB1, FB2 and HFB2
by a LC–MS/MS method, with a LOD of 0.05 ng/g and a LOQ of 10 ng/g for each analyte. FB1 was
detected in 5/7 samples (range 15.8–42.5 lg/kg) and HFB1 in 1/7 (17.4 lg/kg), while traces of FB2
(between LOD and LOQ) were detected in 5/7 samples. No measurable amounts of HFB2 were found.
The authors concluded that detectable amounts of FB1 and its metabolites may be detected in liver of
piglets fed diets compliant with the EU recommended limits for fumonisins in feedingstuffs. Of note, in
a previously published review, Prelusky et al. (1996) concluded that, despite a poor bioavailability, pigs
are characterised by an extensive enterohepatic circulation resulting in a long elimination phase and a
rapid accumulation of FB1 in liver and kidney even in animals orally exposed to relatively low toxin
concentrations (2–3 mg/kg).
Twenty-four male Ross broiler chicks were fed a diet containing 10 mg FB1/kg from 21 to
42 days of age. At the end of trial, the average FB1 content of pooled liver samples amounted to
24 lg/kg (Del Bianchi et al., 2005).
A complementary study (Tardieu et al., 2008) on the tissue accumulation of FB1 was carried out in
1-week-old BUT9 turkeys which were offered a diet containing 0, 5, 10 or 20 mg FB1 + FB2/kg for
9 weeks. In accordance with the TK data, the highest levels were found in livers amounting to 33, 44
and 117 lg/kg in animals receiving 5, 10 or 20 mg FB1 + FB2/kg feed, respectively. Measurable kidney
levels (22 lg/kg) were observed only at the highest dietary concentration, while muscles did not
exhibit FB1 levels > LOD (13 lg/kg).
The same dosages (5, 10 or 20 mg FB1 + FB2/kg feed) were administered to 12-week-old ducks
for 12 days (Tardieu et al., 2009). Tissue levels > LOD (13 lg/kg) could be detected in livers from
animals exposed to 10 or 20 mg FB1 + FB2/kg feed only, while in all other cases liver, kidney and
muscle sample were free from measurable FB1 concentrations.
Conclusions
Overall, based on a limited data set, the experimental data on the transfer of FBs from
contaminated feedstuffs into animal tissues or products indicate that animal derived feedstuffs are
unlikely to contribute quantitatively to the exposure of animals to fumonisins and its modiﬁed forms
where foodstuffs of animal origin are included in their diets.
In evaluating the risk, target animal species fed with higher proportions of feedstuffs of animal
origin, such as dogs and cats, ﬁsh and farmed mink might need to be considered.
3.1.2. Mode of action
Recent evaluations, including FAO/WHO (2017) and EFSA CONTAM Panel (2018), have described in
detail the mode of action of fumonisins. Due to a structural resemblance with ceramide, fumonisins
competitively inhibit ceramide synthases (CerS), a group of key enzymes in the biosynthesis of
ceramide and more complex sphingolipids. Inhibition of these enzymes results in the disruption of the
de novo synthesis of ceramide as well as sphingolipid metabolism and, as a consequence, alterations
in other lipid pathways. Of note, six mammalian isoforms of CerS have been described which differ in
their tissue distribution as well as in their speciﬁcity of the fatty acid chain length used for N-acylation
(Loiseau et al., 2015).
Most of the data concern the mode of action of FB1; however, early studies indicated that FB1–3 are
inhibitors of CerS in rat liver slices at equimolar concentrations (Norred et al., 1997). As the inhibition
of CerS is the initial step of fumonisin toxicity, the previous opinion assumed that at the cellular level
FB1, FB2 and FB3 have the same mode of action (EFSA CONTAM Panel, 2018). Thus, even if toxicity
studies deal mainly with effects of FB1; the other forms, FB2 and FB3 are considered as having similar
toxicological proﬁles and potencies (EFSA CONTAM Panel, 2018).
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The inhibition of CerS by fumonisins leads to an increase of So in blood and tissues as well as a
greater increase of Sa. The change in Sa/So is observed upon exposure to fumonisin and considered
as a potential biomarker of FBs exposure in several animal species (Masching et al., 2016). However,
this biomarker varies according to the animal species, the dosage and the duration of the exposure
(Zomborszky-Kovacs et al., 2002a; Tran et al., 2006; Masching et al., 2016).
Sphingolipids are both highly bioactive compounds and important structural components in cell
membranes. The inhibition of CerS by fumonisins leads to broad impairment of cellular signalling
mechanisms (EFSA CONTAM Panel, 2018) with multiple cellular consequences such as apoptosis,
inhibition of cell proliferation, altered S1P receptor function, impairment of lipid raft formation, altered
cell–cell and cell matrix interaction. The disruption of the sphingolipid metabolism is closely related at
an early stage with fumonisin toxicity (EFSA CONTAM Panel, 2018); however, there is no evidence of
fumonisin-induced CerS inhibition in any human/animal disease, nor is there evidence that fumonisin -
induced CerS inhibition is in itself an adverse effect (FAO/WHO, 2017).
Of note the effect on FBs on sphingolipid metabolism has not yet been related to some of the
critical adverse effects observed in some target species such as impairment of the immune system in
cattle, brain alteration in and cardiovascular effects in horses, lung alterations in pigs and reduced
weight gain in most of the species.
The mode of action of modiﬁed form of fumonisins is well described (EFSA CONTAM Panel, 2018).
However it has been shown that N-acyl-FB1 derivatives are more cytotoxic in vitro compared with FB1
but no in vivo data are available. Similarly HFB1 has been shown repeatedly to be much less toxic
compared to FB1 in feeding studies (Grenier et al., 2012; Voss et al., 2013; Masching et al., 2016).
3.1.3. Adverse effects in livestock, ﬁsh, horses and companion animals
Toxicity studies deal mainly with effects of FB1, but FB2–3 are considered as having similar
toxicological proﬁles and potencies (EFSA CONTAM Panel, 2018).
In the previous EFSA evaluations (EFSA, 2005; EFSA CONTAM Panel, 2014), the increase in the Sa/So
ratio in serum and/or organs was taken as an endpoint for deriving reference points for certain species. A
critical reappraisal of the literature, however, revealed that in pigs the increase in serum Sa/So may occur
even in the absence of other biochemical changes or tissue lesions (Riley et al., 1993) and shows a clear
time- and dose dependence (Zomborszky-Kovacs et al., 2002a,b). In other species (e.g. ducks), the
increase in serum Sa/So seems to occur only in an early phase and could not be related to decrease in
body weight or tissue lesions (Tran et al., 2006). Therefore, the CONTAM Panel considers it necessary to
derive reference points for fumonisins based on endpoints other than the sole alteration of sphingolipid
ratio in serum or organs.
3.1.3.1. Fumonisins
Ruminants
Despite the limited number of suitable studies, ruminants are considered less sensitive to
fumonisins than other livestock species, notably pigs or horses (Mostrom and Jacobsen, 2011; Smith,
2012), In addition, ruminants tend to avoid mouldy feed (Voss et al., 2007).
No new studies on fumonisin adverse effects in ruminants could be retrieved since the last EFSA
evaluations.
For cattle, the previous EFSA evaluations (EFSA, 2005, EFSA CONTAM Panel, 2014) covered
several studies. The pivotal study used in the previous EFSA opinions (EFSA, 2005) is summarised in
Table 3.
Studies that could not be used for identifying NOAELs or LOAELs are summarised in the text below.
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Table 3: Adverse effects in ruminants
Study design breed, age,
gender, exposure period,
animal weight
Doses or feed
concentrations
Clinical signs/
biochemical
changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source and
nature of the toxin
Reference
N = 18 Crossbred
Limousine 9 Angus
Hereford steers
230 kg bw
3 groups
31 days
1) Control (N = 6)
2) Low FB
(26 mg/kg diet
FB1, 5 mg/kg
diet FB2,
< 5 mg/kg
diet FB3) ?
31 mg/kg diet
(N = 6)
3) High FB
(105 mg/kg
diet FB1,
32 mg/kg diet
FB2, 11 mg/kg
diet FB3) ?
148 mg/kg diet
(N = 6)
No effects on feed
consumption and
weight gain; in
the highest dosed
animals only:
↑↑ Serum AST,
GGT, LDH,
cholesterol
↓Mitogen-induced
lymphocyte
blastogenesis
Necropsy performed only on
two calves from High FB
group and control
Mild hydropic liver
degeneration and cloudy
swelling
NOAEL 31 mg/kg feed,
corresponding to
600 lg/kg bw (sum of
FB1FB2FB3)
Endpoint: serum enzymes
and cholesterol, suggesting
alteration of liver function,
and reduced immune
function
Pivotal study used in
EFSA (2005)
FB1 and FB2 naturally
contaminated corn;
levels of the most
common mycotoxins
below LOD
FB3 content not taken
into account
Osweiler
et al. (1993)
AST: aspartate aminotransferase; bw: body weight; FB: fumonisin B; GGT: gamma-glutamyl transferase; LDH: lactate dehydrogenase; LOD: limit of detection; N: number of animals;
NOAEL: no-observed-adverse-effect level.
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FB1–3 in cattle are endowed primarily with hepatic toxicity, as reﬂected by the increase in serum
enzymes and bilirubin, hepatocellular injury and biliary duct hyperplasia. Kidney involvement (increase
in BUN and in urinary GGT along with tubular nephrosis) has been demonstrated only in i.v. dosed
neonatal calves (Mathur et al., 2001).
In the study used by EFSA in 2005 to derive a reference point (Osweiler et al., 1993), 18 crossbred
feeder calves (around 230 kg bw) were allotted to one of the following experimental groups: control
(N = 6), low FB (26 mg/kg diet FB1, 5 mg/kg diet FB2, < 5 mg/kg diet FB3) amounting to 31 mg FBs/kg
diet (N = 6) and high FB (105 mg/kg diet FB1, 32 mg/kg diet FB2, 11 mg/kg diet FB3) amounting to
148 mg FBs/kg diet (N = 6) for 31 days. Weight gain and feed consumption were not affected by the
treatment. In contrast, animals exposed to the higher FB dosage exhibited an increase in AST, LDH and
GGT as well as in serum cholesterol and bilirubin suggesting an impairment of liver function. There was
also a decrease in the mitogen-induced lymphocyte blastogenesis. No such changes were noticed in low
FB1-dosed animals. According to the available data, a NOAEL of 31 mg/kg feed corresponding to 600 lg/kg
bw for the sum of FB1-FB2-FB3 could be calculated, based on the lack of the increase in serum enzymes,
cholesterol and bilirubin as well as the lack of decrease in lymphocyte blastogenesis observed in this group
compared to animals exposed to the high fumonisin dose (148 mg FB1-FB2-FB3/kg feed).
Scant information is available concerning the adverse effects of FB1–3 in sheep. Two sheep died
after the oral administration of 5 g of a F. verticillioides isolate (fumonisin content unknown)/head for
8 or 10 days, respectively; at necropsy, ‘acute nephrosis and hepatosis’ were recorded (Kriek et al.,
1981). The previous EFSA evaluation (EFSA, 2005) reported a study (Edrington et al., 1995) without
deriving a reference point. Fifteen crossbred whether lambs (average weight 32 kg) were allotted
to four experimental groups and dosed intraruminally with fumonisin-containing culture material at
doses of 0 (N = 3), 11.1 (N = 4), 22.2 (N = 4) or 45.5 (N = 4) mg total fumonisins (FB1 + FB2 + FB3)
for four consecutive days, respectively, equivalent to approximately 0, 0.35, 0.7 or 1.4 mg total
fumonisins/kg bw. In all treated animals, there was a statistically signiﬁcant decrease in feed intake
together with an increase in serum ALT, GGT AST, BUN, creatinine, cholesterol and triglycerides. All the
animals from the high dose level and one from the intermediate dose level died. All dosed animal
showed diarrhoea and lethargy as well kidney and liver degeneration. Due to the very short exposure
period in the only available study, the CONTAM Panel concluded that no NOAEL could be derived for
sheep.
Only one report (already examined in the EFSA previous opinion from 2005) addressed the adverse
effects in goats (Gurung et al., 1998, see Section 3.1.1.2). No overt signs of toxicity or effects on
weight gain were exhibited by weanling Angora goats (N = 4) receiving a FB1 contaminated diet
(95 mg FB1/kg) for 112 days. However, with respect to pretreatment values (T = 0), dosed lambs
exhibited a progressive, statistically signiﬁcant increase (p < 0.1) in serum cholesterol, triglycerides,
creatinine, LDH and GGT along with a tendency toward the increase in the Sa/So ratio in liver and
kidney. Due to the poor experimental design, no NOAEL could be derived from this study, in line with
the previous EFSA assessment.
In summary, there is scant information available concerning the adverse effects of FBs in
ruminants. The reported changes in organ macro- and microscopic appearance (cattle and sheep) as
well as in serum enzymes and biochemistry (cattle, sheep, and goats) are consistent with an
impairment of liver and possibly kidney function. Reference points (NOAEL) of 31 mg FB1–3/kg feed
could only be set for cattle based on the increase in serum enzymes, cholesterol and bilirubin as well
as the decrease in lymphocyte blastogenesis. However, a very limited data set indicate that sheep and
goats would not seem to be more susceptible to fumonisins than cattle.
Pigs
Pigs are considered one of the most sensitive farm animal species to FB1–3. For pigs a LOAEL of
200 lg/kg bw per day of fumonisins (based on FB1) was derived by EFSA in 2005 based on one study
of Riley et al. (1993) which reported accumulation in sphingoid bases in serum and tissue organs.
Since the publication of this opinion, several new studies, mainly on piglets around weaning, have
reported adverse effect produced by FBs exposure (see Table 4). The majority of these studies
indicated that changes in sphinganine: sphingosine ratio (Sa/So) is a sensitive biomarker in the
assessment of adverse effect exerted by FBs but other effects have been reported. These studies
conﬁrmed that FBs affect mainly the lungs and liver, producing a speciﬁc syndrome, pulmonary
oedema. Histological changes in the pancreas, intestines, spleen and lymph nodes were also observed
(Fodor et al., 2005; Piva et al., 2005; Stoev et al., 2012). Moreover, Gbore et al. (2010) described
alterations in brain neurochemistry: decrease in acetylcholinesterase (AChE) and speciﬁc
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acetylcholinesterase (SAChE) release and activity in different brain regions in pigs fed ≥ 5.0 mg FB1/kg
feed for 6 months.
Pulmonary oedema is observed in animals exposed to low (3–10 mg FB1/kg feed) and high
(20–100 mg FB1/kg feed) concentrations of fumonisins although with different degrees of severity.
Histological lesions were observed in the lungs from all piglets fed diets containing low concentrations
as for example 3, 6 and 9 mg FB1/kg feed (Grenier et al., 2013; Souto et al., 2015) for 35 and
28 days respectively, whereas the exposure to 12 mg FB1/kg feed of FB1 for 18 days produced slight
interstitial pneumonia and only one pig showed severe haemorrhagic congestion and some oedema
(Moreno Ramos et al., 2010). In two studies performed by Zomborszky-Kovacs et al. (2002a,b)
weaned pigs were exposed to 0, 1, 5 and 10 mg FB1/kg feed for 8 and 20 weeks. Slightly changes in
lung in one animal was observed at 1 mg FB1/kg feed while changes in lungs and in liver in more than
two animals was found at 5 and 10 mg of FB1/kg feed after 8 weeks of exposure. An increase in
permeability of blood vessels, which was responsible for perivascular and especially pericapillary
oedema in the lungs after three months oral administration of 10 mg FB1/kg feed was also observed
by Stoev et al. (2012). Increases in lung weight, irreversible ﬁbrosis and histopathological changes in
lungs and liver were also reported after prolonged exposure to FB1 (20 weeks). Administration of
higher doses (20–100 FB1/kg feed) of FB1 caused more severe alterations in lungs. Strong oedematous
changes, accumulation of seroﬁbrinous exudate or ﬁbrin in the interlobular and interalveolar tissue as
well as thickening of interalveolar septa due to epithelial hyperplasia were observed at 20 mg FB1/kg
FB (42 days) by Posa et al. (2013, 2016); distinct lesions, yellowish ﬂuid with clotting characteristics in
the lungs, pleural cavity and marked pulmonary oedema in all animals were reported at 30 mg FB1/kg
(42 days), 10–40 mg FB1/kg feed (28 days) and 45 mg FB1/kg feed (10 days) (Zomborszky-Kovacs
et al., 2002a; Piva et al., 2005; Fodor et al., 2008). Similar effects such as severe dyspnoea, the
presence of ﬂuid in thoracic cavity and pulmonary oedema were reported in all piglets, and lead to
death within 12–24 h at 50 and 100 mg FB1/kg with the difference that these effects occurred in a
much shorter time (5, 10 and 22 days) (Fodor et al., 2005) (Table 4).
As in the case of pulmonary oedema, hepatic injuries were observed, with various concentrations of
FB1 concentrations examined (Fodor et al., 2005). Hepatotoxicity was noticed in piglets exposed to
doses ranging from 1.5 to 100 mg FB1/kg feed. For instance, pigs fed diets containing 6 mg FB1/kg
feed (35 days) presented disorganisation of hepatic cords, cytoplasmatic and nuclear vacuolisation of
hepatocytes, and megalocytosis (Grenier et al., 2013). Pigs fed for 42 days with 30 mg FB1/kg feed,
and with 50 and 100 mg FB1/kg feed for 22, 5 and 10 days, respectively, had enlarged, friable, pale,
yellowish liver, visible discoloration (ﬁbrosis), vacuolation and necrosis (including occasional single cell
necrosis) of the liver (Fodor et al., 2005; Piva et al., 2005). Other studies showed increase in liver
weight at 1.5 and 30 mg FB1/kg feed (Piva et al., 2005; Lessard et al., 2009; Lalles et al., 2010),
polyploidy and fatty change in the liver at 12 mg FB1/kg feed (Moreno Ramos et al., 2010) but no
macroscopic or histological lesions in the liver and other organs (spleen, kidneys and heart) at 3.0, 6.0
or 9.0 mg FB1/kg diet and 28 days of exposure (Souto et al., 2015).
Liver alterations also led to changes in the level of serum biochemical analytes. Increases in
concentrations of albumin, total protein, cholesterol, triglycerides, creatinine and GGT were found in
pigs exposed for 28–42 days to 6, 8, 30 and 44 mg FB1/kg feed (Piva et al., 2005; Marin et al., 2006;
Grenier et al., 2012, 2013), while a lower level of hepatic enzymes (GGT, AST, ALT, LDH) was observed
by Marin et al. (2006) in the serum of male pigs receiving feed contaminated with F. verticillioides
culture material (8 mg FB1/kg feed) for 28 days.
Nephrotoxicity induced by FBs has been reported in several studies. Pigs fed with F. verticillioides
culture material showed slight to moderate degenerative histopathological changes in the kidneys
(Moreno Ramos et al., 2010; Stoev et al., 2012; Posa et al., 2016) in addition to increase in
permeability of vessels in the lungs, brain, cerebellum and kidney (Stoev et al., 2012). Alterations in
the brain were also reported by Gbore et al. (2010). This study demonstrated that feed contaminated
with FB1 ≥ 5 mg/kg feed for a 6-month period decreased in a dose dependent manner the release
AChE and SAChE activity from some brain regions (Gbore, 2010).
Several studies showed that ingestion of feed contaminated with fumonisins results in various
intestinal disorders. Thus, impaired morphology of the different segments of the small intestine, reduced
villi height and cell proliferation, reduced number of goblet cells and modiﬁed intestinal cytokine
expression were found by Grenier et al. (2012) and Bracarense et al. (2012) in pigs exposed by gavage
with 200 lg FB1/kg bw per day for 14 days or fed with 5.9 mg FB1-2/kg feed for 35 days. Intestinal
inﬂammation by the upregulation of proinﬂammatory cytokines, IL-1b, IL-6, TNF-a and IFN-c was
observed (Grenier et al., 2013). Also, consumption of 1.5 mg FB1/bw per day during 9 days increased
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eightfold alphaB crystallin and 12-fold COX-1 in the colon and various stress proteins along the GIT
(COX-1 and nNOS in the stomach, HSP 70 in the jejunum and HO-2 in the colon) (Lalles et al., 2010).
Changes in Sa/So ratio are considered as the most sensitive parameter in the assessment of
adverse effect exerted by fumonisins (EFSA, 2005). Increase in Sa/So ratio was found when pigs were
exposed from 2 mg FB/kg feed to 20 mg/kg FB1 (Posa et al., 2011, 2013; Grenier et al., 2013;
Masching et al., 2016). Sa/So alterations appear to be time dependent. Indeed, Masching et al. (2016)
reported a signiﬁcant increase in Sa/So ratio in serum of pig exposed to 2 mg FB/kg feed for 42 days
starting with day 28 of exposure in pigs fed 2 mg FB/kg feed for 42 days. Also, fumonisins at a level
of 11.8 mg FB1/kg feed were responsible for a statistically signiﬁcant increase in the Sa/So ratio in
serum, kidney and liver, 9 days after the beginning of toxin exposure of 63 days (Burel et al., 2013).
Several studies showed that FBs are reproductive toxicants in pigs. Indeed, the exposure of male
pigs to dietary FB1 ≥ 5 mg/kg feed produced delayed in sexual maturity by reducing testicular and
epididymal sperm reserves and daily sperm production (Gbore and Egbunike, 2008; Gbore, 2009), as
well as semen quality and motility (Gbore, 2009).
In pigs, FBs also impair both local and systemic immune responses. Ingestion of 8 mg FB1/kg feed
decreased in blood of pigs the gene expression of Th2 cytokines IL-4, IL-6 and IL-10 (Taranu et al., 2005;
Marin et al., 2006). These authors found also that short time exposure of piglets to 1.5 mg FB1/kg feed
altered the cytokine balance (IL-4 and IFN-c) in mesenteric lymph nodes and spleen. A reduced
expression of cytokines (IL-6, IL-1b, IL-12p40 and IL-8) in spleen was also reported by Grenier et al.
(2013). Following ingestion of 2.8 lM FB1/kg bw (37–44 mg FB1/kg feed), a decreased expression of
most of the cytokines was found in the different part of the intestine segments after 14 days of exposure
(Grenier et al., 2012).
An important number of studies investigated the situation when pigs given diet contaminated with
fumonisins were subjected to microbial or viral infection. Some studies analysed whether combined
treatment with fumonisin predisposed animals to lung inﬂammation by pathogenic bacteria like
Pasteurella multocida, Mycoplasma hyopneumoniae, Bordetella bronchiseptica, generating respiratory
disorders (Halloy et al., 2005; Posa et al., 2011, 2013). In all cases, the interaction between
fumonisins and pathogens aggravated the progression of infection, exacerbating the severity of lung
pathology. For instance, in a recent study, Posa et al. (2016) found that pigs fed with 20 mg FB1/kg
for 23 days and infected with M. hyopneumoniae presented a catarrhal bronchointerstitial pneumonia
with development of prominent peribronchial and peribronchiolar lymphocytes inﬁltration in the lungs
(due to M. hyopneumoniae infection); animals also showed accumulation of serous exudates in the
pleura and in the interstitium, mostly due to FB1 action (not characteristic for M. hyopneumoniae
infection) and in addition an increased permeability of vessels, responsible for the prominent
perivascular and especially pericapillary oedema mainly in the lungs. In another study of Halloy et al.
(2005), induced cough, and increased bronchoalveolar lavage ﬂuid (BALF) total cells, macrophages
and lymphocytes were also found in pigs exposed to 5–8 mg FB1/kg feed for 7 days and infected with
P. multocida. TNF-a, IFN-c and IL-18 mRNA expression was also increased in lung tissue for 7 days.
Similar results were obtained in the case of intestinal disorders caused by Escherichia coli or
Salmonella in pigs fed fumonisin contaminated diet. Using an infectious model with E. coli F4+,
Devriendt et al. (2009) showed that intoxication with a low dose of FB1 (1 mg/kg bw for 10 days) led
to a lower numbers of antigen-speciﬁc IgM antibody-secreting cells in the jejunal Peyer’s patches, a
signiﬁcantly reduced mucosal IgA immune response in FB1 exposed piglets and a prolonged shedding
of F4(+) enterotoxigenic E. coli (ETEC) following infection. Exposure to naturally contaminated feed
containing 11.8 mg fumonisins/kg over 63 days inhibited the ability of Salmonella–speciﬁc lymphocytes
to proliferate in the presence of a selective mitotic agent, result which remains to be conﬁrmed. Similar
concentration of FB1 (8 and 10 mg/kg) received by feed administration to piglets after weaning altered
the vaccinal antibody response by decreasing the antibody titre against Aujeszky’s disease at days 21
and 35 after vaccination (Stoev et al., 2012) and IgG-speciﬁc antibody against Mycoplasma agalactiae
at 28 days (Taranu et al., 2005). Consumption of fumonisins contaminated feed had no effect on pig
health but affected the microbiota proﬁles and this phenomena was ampliﬁed by the presence of
Salmonella (Burel et al., 2013). Little or no effect of fumonisins on pig performance has been reported
(Burel et al., 2013; Posa et al., 2013). However, some studies showed a decreased of average daily
gain at 8, 10, 15 and 100 mg FB1/kg feed (Marin et al., 2006; Gbore, 2009; Fodor et al., 2005). The
effects of FBs on feed intake and feed efﬁciency are also variable. No differences in feed intake was
observed by Piva et al. (2005), but Moreno Ramos et al. (2010) showed moderate anorexia and Gbore
(2009) and Fodor et al. (2005) reported a decreased in feed intake in pigs fed contaminated diet.
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In summary, in vivo pig experiments indicate that exposure to FBs disturb the Sa/So ratio in blood
and tissues, and induces speciﬁc syndromes for FB1–3 toxicity such as pulmonary oedema, lung and
hepatic lesions. Alteration of intestinal physiology, villous architecture and enzyme activities,
hypofunctions of brain regions with decrease of the activity and secretion of neurotransmitter (AChE)
were recently reported. A NOAEL of 1 mg FB1/kg feed (corresponding to 40 lg/kg bw per day) which
did not cause clinical signs and signiﬁcant performance impairment for short (8 weeks, Zomborszky-
Kovacs et al., 2002a) as well as for long (20 weeks, Zomborszky-Kovacs et al., 2002b) term exposure
could be considered for pig based on the studies of Zomborszky-Kovacs et al., 2002a,b). Also, a LOAEL
of 5 mg FB1/kg feed (corresponding to 200 lg/kg bw per day) could be identiﬁed for pigs based on
increased biochemical parameters in blood, serum Sa/So ratio as well as lungs and liver histological
changes (Zomborszky-Kovacs et al., 2002a,b). This LOAEL was supported recently by studies showing
alteration in brain neurochemistry by the decrease in AChE and SAChE activity and delayed sexual
maturity in pigs at this concentration (Gbore et al., 2010).
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Table 4: Adverse effects in pigs
Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 136 male SPF pigs
Average weight
13 kg bw
14 days of exposure
1) Control, 0 mg FB1–2/kg
feed (N = 5)
2) 5 mg FB1–2/kg feed
(N = 5)
3) 23 mg FB1–2/kg feed
(N = 5)
4) 39 mg FB1–2/kg feed
(N = 5)
5) 101 mg FB1–2/kg feed
(N = 5)
6) 175 ppm mg FB1–2/kg
feed (N = 5)
↑ Sa/So ratio in serum
starting at 5 mg FB1–2/
kg feed
↑ serum liver enzymes
at 101 mg FB1/kg feed
↑biochemical
parameters at 101 and
175 mg FB1–2/kg feed
↑sign of respiratory
distress
Pulmonary oedema at
175 mg FB1–2/kg feed
↑Sa/So ratio in liver
starting with 5 mg
FB1–2/kg feed
↑Sa/So ratio in liver,
lungs, kidney and
histological liver
damage at ≥ 23 mg/kg
LOAEL 200 lg/kg bw
per day corresponding
to 5 mg FB1–2/kg feed
Endpoint:
accumulation in
sphingoid bases in
serum and tissue
organs
Pivotal study used in
the EFSA (2005)
opinion to calculate
LOAEL based on Sa/So
ratio
Feed-containing corn
or corn screenings
naturally contaminated
with fumonisins
(166 mg FB1/kg feed
FB1 and 48 mg/kg FB2
feed)
Riley et al. (1993)
N = 20 pigs
Average weight
10 kg bw
8 weeks of exposure
1) Control, 0 mg FB1/kg
feed (N = 5)
2) 1 mg FB1/kg feed
(N = 5)
3) 5 mg FB1/kg feed
(N = 5)
4) 10 mg FB1/kg feed
(N = 5)
No effects on
productive parameters
↑ some serum
parameters (ALP, ALT
and AST activities) at
1, 5 and 10 mg FB1/kg
feed
Slightly changes in
lung in only one
animal at 1 mg FB1/kg
feed
5 and 10 mg FB1/kg
feed caused dose-
dependent increase in
the weight of the
lungs, pathological and
histopathological
chronic pulmonary
changes in the lungs
and liver
NOAEL 1 mg FB1/kg
feed
LOAEL 5 mg FB1/kg
feed
Endpoint: increase in
the weight of the
lungs, pathological and
histopathological
chronic pulmonary
changes in the lung
and liver
Study mentioned in
the EFSA (2005)
opinion
LOAEL based on lung
lesions
Feed contaminated
with fungal (Fusarium
moniliforme) culture
Zomborszky-Kovacs
et al. (2002a)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 20 pigs
Average weight
10 kg bw
4 weeks of exposure
1st experiment
8 weeks of exposure
2nd experiment
20 weeks of exposure
3rd experiment
4 weeks:
1) control, 0 mg FB1/kg feed
(N = 5)
2) 10 mg FB1/kg feed
(N = 5)
3) 20 mg FB1/kg feed
(N = 5)
4) 40 mg FB1/kg feed
(N = 5)
8 weeks and 20 weeks:
1) control, 0 mg FB1/kg feed
(N = 5)
2) 1 mg FB1/kg feed
(N = 5)
3) 5 mg FB1/kg feed
(N = 5)
4) 10 mg FB1/kg feed
(N = 5)
No effects on
productive parameters
↑ some serum
parameters (AKLP, ALT
and AST activities) at
1, 5 and 10 mg FB1/kg
feed
↑ time- and dose-
dependent increase in
the AST activities at 20
and 40 mg FB1/kg
feed
↑ Sa/So ratio at
10–40 mg FB1/kg feed
10–40 mg FB1/kg feed
caused mild or severe
pulmonary oedema
since the 2nd weeks
In chronic toxicosis
(2–20 weeks, the
pathological changes
like pulmonary
oedema turned to
irreversible ﬁbrosis at
lower doses (10 mg
FB1/kg feed)
NOAEL 1 mg FB1/kg
feed
Endpoint: no clinical
signs and no effect on
feed consumption,
body weight gain and
feed conversion; no
increase in serum
Sa/So ratio
LOAEL 5 mg FB1/kg
feed
Endpoint: increase in
serum Sa/So ratio;
macroscopic alteration
in lung
Study mentioned in
the EFSA (2005)
opinion
LOAEL based on lung
lesions
Feed contaminated
with fungal
(F. moniliforme)
culture
Zomborszky-Kovacs
et al. (2002b)
N = 15 conventional
piglets
Average weight
9.6 kg bw
7 days of exposure
1) Control, 0 mg FB1/bw per
day (N = 5)
2) 0.5 mg FB1/kg bw per
day (5–8 mg FB1/kg
feed) (N = 5)
Administrated by gavage
No clinical sign ↑ expression of IL-8,
IL-18 and IFN-c mRNA
in the lung tissue
minimal enlargement
of the alveolar septa
LOAEL 500 lg/kg bw
per day corresponding
to 5–8 mg/kg feed
Endpoint:
Immunological
(increased expression
of cytokines IL-8, IL-18
and IFN-c) and
histological effects
(lung lesions and
minimal enlargement
of the alveolar septa
due to an increase in
the macrophage and
lymphocyte number)
Soluble crude extract
of fungal
F. verticillioides, 54%
FB1, 8% FB2 and 9%
FB3)
Halloy et al.
(2005)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 28 castrated male
weanling piglets
(Landrace 9 Large
White)
Average weight
6.9 kg bw
42 days of exposure
1) Control, < 2 mg FB1/kg
feed (N = 16)
2) 30 mg FB1/kg feed as fed
basis (N = 12)
No clinical signs (e.g.
difﬁculty in breathing)
↑ concentrations of
cholesterol, GGT, GOT,
free sphinganine,
sphingosine-1-
phosphate and
sphinganine 1-
phosphate
↓ performance Marked
pulmonary oedema;
Lesions in the lungs,
heart and liver of pigs
changes in the
pancreas, intestines,
spleen and lymph
nodes
LOAEL 2,250 lg/bw
per day corresponding
to 30 mg/kg feed
Endpoint: increase in
sphingolipid proﬁle
biochemical changes,
organ lesions and
pulmonary oedema
Feed contaminated
with fungal
(F. proliferatum)
culture corn
Addition of activated
carbon
Control feed
contaminated with
< 2 mg FB1/kg
Only one dose
Piva et al. (2005)
N = 12 male and
female weaned piglets
Average weight
7.3 kg bw
7 days of exposure
1) Control, 0 mg FB1/kg bw
(N = 6)
2) 1.5 mg FB1/kg bw per
day (N = 6)
– Altered the cytokine
balance (↓ IL-4 and
↑ IFN-c) in mesenteric
lymph nodes and
spleen
LOEL 1,500 lg
FB1/kg bw per day
Endpoint: alteration of
Th1/Th2 cytokines
production
Puriﬁed FB1
Only one dose
Gavage administration
Taranu et al.
(2005)
N = 20 male and
female weaned piglets
Average weight
12.3 kg bw
28 days of exposure
1) Control, 0 mg FB1/kg bw
(N = 10)
2) 8 mg FB1/kg feed
(N = 10)
– ↓ IL-4 mRNA
expression by porcine
WBC
LOEL 500 lg FB1/kg
bw per day
corresponding to 8 mg
FB1/kg feed
Endpoint: decrease in
cytokine production
(IL-4, IFN-c)
Feed contaminated
with fungal
(F. verticillioides)
puriﬁed culture
material
Only one dose
Taranu et al.
(2005)
N = 12 castrated pigs,
same genotype
Average weight
13.0 kg bw
22 days of exposure
1) Control, 0 mg FB1/animal
per day (N = 4)
2) 50 mg FB1/animal per
day (2.5 mg FB1/kg bw
per day) (N = 8)
No clinical signs Pulmonary oedema
developed
LOEL 2,500 lg FB1/bw
per day corresponding
to 50 mg FB1/kg feed
Endpoint: pulmonary
oedema
Feed supplemented
with fungal
(F. verticillioides)
culture material
Only one dose
Fodor et al.
(2005)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 12 castrated pigs,
same genotype
Average weight
13.0 kg bw
5 days of exposure
1) Control, 0 mg FB1/animal
per day (N = 4)
2) 100 mg FB1/animal per
day (6.6 mg FB1/kg bw
per day) (N = 8)
Lost appetite, ↓ feed
intake on the 5th–6th
day
Pulmonary oedema;
High signiﬁcant FB1
concentration in the
liver, kidney, lung and
spleen
LOAEL 6,600 lg
FB1/kg bw per day
corresponding to
100 mg FB1/kg feed
Endpoint: pulmonary
oedema and increased
FB1 content in organs,
lower feed intake
Feed supplemented
with fungal
(F. verticillioides)
culture material
Only one dose
Fodor et al.
(2005)
N = 12 castrated pigs,
same genotype
Average weight
13.0 kg bw
10 days of exposure
1) Control, 0 mg FB1/animal
per day (N = 4)
2) 100 mg FB1/animal per
day (N = 8)
Lost appetite, ↓ feed
intake on the 5th–6th
day
Pulmonary oedema
developed ↑FB1
content in organs
LOAEL 6,600 lg
FB1/kg bw per day
corresponding to
10 mg FB1/kg feed
Endpoint: pulmonary
oedema and increased
FB1 content in organs,
lower feed intake
Feed supplemented
with fungal
(F. verticillioides)
culture material
Only one dose
Fodor et al.
(2005)
N = 20, 4 weeks old
males and females
weaned pigs
Average weight,
12.3 kg bw
28 days of exposure
1) Control, 0 mg FB1/kg
feed (N = 10)
2) 8 mg FB1/kg feed (0.99
and 1.49 mg/bw per day)
(N = 10)
↓ weight gain (males
only)
↑ creatinine level in
serum
↓ sex-dependent
decrease in the
expression of Th2
cytokines; ↓ IL-4, IL-6,
IL-10 mRNA
expression in male
LOEL 500 lg/kg bw
per day corresponding
to 8 mg/kg feed
Endpoint: decrease in
cytokine production,
serum biochemistry
(creatinine)
Feed contaminated
with F. verticillioides
puriﬁed crude extract
Only one dose
Marin et al. (2006)
N = 16, weaned
barrows, 8 weeks of
age
Average weight,
12–14 kg bw
10 days of exposure
1) Control, 0 mg FB1/kg
feed (N = 8)
2) 45 mg FB1, 8.6 mg FB2,
4.6 mg FB3/kg feed
(N = 8)
No clinical signs Pulmonary oedema in
all animals
↓ decrease the
reduced glutathione
content in blood
plasma and R
haemolysate,
pathological change in
organs
LOAEL 3,500 lg
FB1/kg bw per day
corresponding to
58 mg FB/kg feed
Endpoint: pulmonary
oedema and reduction
in the second line of
the antioxidant system
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material containing
FB1, FB2, FB3
FB2, FB3 content not
taken into account
Only one dose
Fodor et al.
(2008)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 24, Large White
male weanling piglets,
8–9 weeks old
Average weight,
6.94 kg bw
6 months of exposure
(3 physiological phases:
weaning, prepubertal
and pubertal)
1) Control, 0.2 mg FB1/kg
feed (N = 6)
2) 5.0 mg FB1/kg feed
(N = 6)
3) 10.0 mg FB1/kg feed
(N = 6)
4) 15.0 mg FB1/kg feed
(N = 6)
– Reduced testicular and
epididymal sperm
reserves and daily
sperm production
LOAEL 300 lg FB1/kg
bw corresponding to
≥ 10.0 mg FB1/kg feed
Endpoint: reduction of
daily sperm production
and reproductive
performance
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture maize
grains
Control feed
contaminated with
0.2 mg FB1/kg
Gbore and
Egbunike (2008)
N = 24, Large White
male weanling piglets,
8–9 weeks old
Average weight,
6.94 kg bw
24 weeks of exposure
(measurements in
pubertal phase at 36
weeks old)
1) Control, 0.2 mg FB1/kg
feed (N = 6)
2) 5.0 mg FB1/kg feed
(N = 6)
3) 10.0 mg FB1/kg feed
(N = 6)
4) 15.0 mg FB1/kg feed
(N = 6)
No effect on
performance
No effect on relative
weights of the testis
(and volume) and
epididymides, reduced
sperm concentration,
total sperm and motile
sperm per ejaculate
LOAEL 300 lg
FB1/kg bw
corresponding to
≥ 10.0 mg FB1/kg feed
Endpoint: reduced
semen quality, motility
and concentration
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture maize
grains
Control feed
contaminated with
0.2 mg FB1/kg
Gbore (2009)
N = 24, Large White
male weanling piglets,
8–9 weeks old
Average weight,
6.94 kg bw
24 weeks of exposure
1) Control, 0.2 (N = 6)
2) 5.0 mg/kg feed
(N = 6)
3) 10.0 mg/kg feed
(N = 6)
4) 15.0 mg FB1/kg feed
(N = 6)
↓ feed intake during
0–4 months and a FB1
concentration-
dependent decrease in
body weight and
DWGs at 10 and 15
mg FB1/kg feed in
pubertal phase
Delayed sexual
maturity
LOAEL 200 lg
FB1/kg bw,
corresponding to
≥ 5.0 mg FB1/kg feed
Endpoint: reduced
semen quality and
capacity of fertility,
lower performance in
growing pigs
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture maize
grains
Control feed
contaminated with
0.2 mg FB1/kg
Gbore (2009)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 36 [Pietrain X
(Landrace X Large-
White)] castrated male
weaned pigs (intralitter
paired), 35 days of age
Average weight, 10.87
kg bw (control) and
10.94 kg bw (FB1
group)
9 days of exposure
1) Control, 0 mg FB1/kg bw
(N = 18)
2) 1.5 mg FB1/kg bw per
day (25–30 mg FB1/kg
feed) (N = 18)
↓ the gain: feed ratio ↑ liver weight
Alteration of intestinal
physiology, villous
architecture, and
enzyme activities
LOAEL 1,500 lg
FB1/kg bw per day
corresponding to
25–30 mg FB1/kg feed
Endpoint: modulation
of intestinal structure
and physiology,
reduced performance
Puriﬁed extract
(2.3 g/L FB1, 0.34 g/L
FB2, 0.38 g/L FB3)
Only one dose
Lessard et al.
(2009)
N = 14, 16-day-old
weaned piglets
42 days of exposure
1) Control, 0 mg FB1/kg
feed (N = 7)
2) 20 mg FB1/kg feed
(N = 7)
No clinical signs No signiﬁcant
differences in body
weight gain and no
macroscopic and CT
lung lesions
NOAEL 1,000 lg
FB1/kg bw per day
corresponding to 20
mg FB1/kg feed
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Posa et al. (2009)
N = 10, weaned piglets,
34 days of age, both
sexes
Average weight, 5.8 kg
bw
18 days of exposure
1) Control, 0 mg FB1/kg/
feed (N = 5)
2) 12 mg FB1/kg feed
(N = 5)
Moderate anorexia,
depression, prostration
and ﬂuid stools
Pathologic and
histopathologic
changes in the lungs,
liver and kidney
LOAEL 800 lg
FB1/kg bw per day
Endpoint: lesions in
lungs, liver and kidney
Feed contaminated
with FB1 standard pure
toxin
Only one dose
Moreno Ramos
et al. (2010)
N = 36 [Pietrain X
(Landrace X Large-
White)] castrated male
weaned pigs (intralitter
paired), 35 days of age
Average weight, 10.87
kg bw (control) and
10.94 kg bw (FB1
group)
9 days of exposure
1) Control, 0 mg FB1/kg bw
(N = 18)
2) 1.5 mg FB1/kg bw per
day (N = 18)
Little effects on
growth rate
↑ liver weight
↑ increased alphaB
crystallin, COX-1 and
HO-2 in the colon,
nNOS in the stomach,
HSP70 in the jejunum
LOAEL 1,500 lg
FB1/kg bw per day
corresponding 25–30
mg FB1/kg feed
Endpoint: induces
stress protein
responses along the
GIT, especially in the
colon
Puriﬁed FB1 extract
(2.3 g/L FB1, 0.34 g/L
FB2, 0.38 g/L FB3)
Only one dose
Lalles et al. (2010)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 24, Large White
male weanling piglets,
8–9 weeks old
Average weight, 6.94
kg bw
6 months of exposure
(3 physiological phases:
weaning, prepubertal
and pubertal)
1) Control, 0.2 (N = 6)
2) 5.0 mg/kg feed
(N = 6)
3) 10.0 mg/kg feed
(N = 6)
4) 15.0 mg FB1/kg feed
(N = 6)
– Altered brain
neurochemistry;
Signiﬁcant inﬂuence of
dietary FB1 on regional
brain and
↓ dose-dependent
release of AChE
(corresponding to
2.0 mg FB1/kg bw per
day) from some brain
regions
↓ acetylcholinesterase
(AChE) activities
LOAEL 200 lg
FB1/kg bw
corresponding ≥ 5.0
mg FB1/kg feed
Endpoint:
hypofunctions of brain
regions, ↓ of AChE
activities and secretion
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture maize
grains
Control feed
contaminated with
0.2 mg FB1/kg
Gbore et al.
(2010)
N = 14 female piglets,
16 days old
Average weight, 3.0 kg
bw
23 days of exposure
1) Control 0 mg FB1/kg feed
(N = 7)
2) 10 mg FB1/kg feed
(N = 7)
No clinical signs, only
a pronounced
heterogeneity of body
weight on day 39
↑ Sa/So ratio in blood
at 39 days
No lung lesions LOAEL 800 lg
FB1/kg bw per day
corresponding to
10 mg FB1/kg feed
Endpoint: increase in
serum Sa/So ratio
Receiving diets
included fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Posa et al. (2011)
N = 24 castrated male
piglets, 5 weeks old
Average weight,
9.54 kg bw (control)
and 9.52 (FB group)
35 days of exposure
1) Control, 0 mg FB1-2/kg
feed (N = 12)
2) 5.9 mg FB1-2/kg feed
(4.1 mg FB1 + 1.8 mg
FB2) (N = 12)
No clinical signs Atrophy and fusion of
villi
↓ villi height and cell
proliferation in the
jejunum; reduced
number of goblet cells
and lymphocytes
↑ TNF-a, IL-1b, IFN-c,
IL-6 and IL-10 in the
ileum or the jejunum
↓ expression of E-
cadherin and occluding
in the intestine
LOAEL 400 lg FB/kg
bw per day
corresponding to
5.9 mg FB/kg feed
Endpoint: intestinal
and immunological
changes
Feed artiﬁcially
contaminated with
fungal culture material
Only one dose
Bracarense et al.
(2012)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 12, Pietrain/Duroc/
Large-White, female
piglets
Average weight
10.98 kg bw (control)
and 10.92 kg bw (FB1)
14 days of exposure
1) Control, 0 mg FB1/kg
bw per day (N = 6)
2) 2.8 lmol
FB1/kg bw per day;
corresponding to 2.0 mg
FB1/kg bw per day
(N = 6)
↑ biochemical analytes FB1 induced
hepatotoxicity,
impaired morphology
of the different
segments of the small
intestine, ↓villi height
and modiﬁed intestinal
cytokine expression
LOAEL 2,000 lg
FB/kg bw per day
corresponding to
37–44 mg FB1/kg
Endpoint: increase in
biochemical analytes,
morphological and
immunological effect in
intestine
Fumonisins extract
containing 530.85 mg/
L FB1, 133.30 mg/L
FB2, and 35.60 mg/L
FB3
Only one dose gavage
administration
Grenier et al.
(2012)
N = 6 (3 males and 3
females) piglets
Average weight 12–14
kg bw
3 months of exposure
1) Control, 0 mg FB1/kg
fed (N = 6)
2) 10 mg FB1/kg feed
(N = 6)
Scarce clinical signs:
transient cases of
diarrhoea
↑ of serum creatinine,
urea and enzyme
activity of AST/ALT
↓ of serum cholesterol,
total protein, albumin
and glucose
↑ in permeability of
vessels mainly in lung,
brain, cerebellum or
kidneys; slight to
moderate degenerative
changes in kidneys
LOAEL 500 lg
FB1/kg bw per day
corresponding to
10 mg FB1/kg feed
Endpoint: increase in
biochemical
parameters, changes
in organs
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Stoev et al. (2012)
N = 12 castrated males
Pietrain/Duroc/Large-
White piglets
4 weeks old
35 days of exposure
1) Control 0 mg FB1-2/kg
feed (N = 6)
2) 5.9 mg/kg feed
FB1-2 (N = 6)
↑ Sa/So ratio in plasma
↑ creatinine
concentration
↑ lesions in lung, liver
and intestine
↓ lymphocytes
proliferation
↑ inﬂammatory
cytokines in spleen
and jejunum
↓ anti-OVA IgG
antibodies
LOAEL 400 lg
FB1/kg bw per day
corresponding to 5.9
mg FB1/kg feed
Endpoint: increase in
plasma parameters
(Sa/So ratio,
creatinine), histological
and immunological
effects
Feed contaminated
with fungal
(F. verticillioides) not
puriﬁed culture
material
Only one dose
Grenier et al.
(2013)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 24 Large-White,
SPF growing pigs (1/3
females and 2/3
males), 4 weeks old
Average weight
41.6 kg bw
63 days of exposure
1) Control, 0 mg FB/kg feed
(N = 12)
2) 11.8 mg FB1-2/kg (8.6 mg
FB1 + 3.2 mg FB2)
(N = 12)
No effect on
performance, mortality
or disease
↑ Sa/So ratio in serum
Imbalance in digestive
microbiota, with
Salmonella exposure
amplifying this
phenomenon
LOAEL 500 lg
FB1/kg bw per day
corresponding to
11.8 mg FB1/kg feed
Endpoint: imbalance in
digestive microbiota
Feed contaminated
with maize naturally
contaminated with FB
Only one dose
Burel et al. (2013)
N = 14 weaned piglets,
16 days old
Average weight,
3.0 kg bw
42 days of exposure
1) Control, 0 mg FB1/kg
feed (N = 7)
2) 20 mg FB1 (+3.5 mg/FB2
and 1.9 mg FB3)/kg feed
(N = 7)
No signiﬁcant
differences in the body
weights
↑ Sa/So ratio
Lesions extending to
the cranial and middle
or in the cranial third
of the caudal lobe of
the lungs; pulmonary
oedema; aggravated
progression of
catarrhal
bronchointerstitial
pneumonia
LOAEL 1,000 lg
FB1/kg bw per day
corresponding to
20 mg FB1/kg feed
Endpoint: increase
serum Sa/So ratio and
pulmonary lesions
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Posa et al. (2013)
N = 24 castrated males
pigs, 4 weeks old
Average weight,
10.8 kg bw
28 days of exposure
1) Control, 0 mg FB1/kg
feed (N = 6)
2) 3.0 mg FB1/kg feed
(N = 6)
3) 6.0 mg FB1/kg feed
(N = 6)
4) 9.0 mg FB1/kg feed
(N = 6)
No clinical signs No signiﬁcant
differences in the body
weights of the pigs; no
macroscopic or
histological lesions in
the spleen, liver,
kidneys and heart
Histological lesions in
lungs but not
quantiﬁed
LOAEL 400 lg
FB1/kg bw per day
corresponding to
6–9 mg FB1/kg feed
Endpoint: Histological
lesions in lungs
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Souto et al.
(2015)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 70 PIC 337 male
and female 28 days old,
weaned piglets
42 days of exposure
1) Control, 0 mg FB/kg feed
(N = 35)
2) 2 mg FB1-2/kg feed
(N = 35)
↑ Sa/So ratio starting
with day 28
No other pathological
ﬁndings
LOEL 100 lg
FB/kg bw per day
corresponding to 2 mg
FB/kg feed
Endpoint: increase
serum Sa/So ratio
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Masching et al.
(2016)
N = 14 female piglets,
16 day old
Average weight,
3.0 kg bw
42 days of exposure
1) Control, 0 mg FB1/kg
(N = 7)
2) 20 mg FB1/kg feed
(N = 7)
No clinical signs
throughout the
experiment
No signiﬁcant
differences in the body
weights
Strong oedema in the
lung and slight
oedema in the other
internal organs and
mild degenerative
changes in the kidneys
LOAEL 1,000 lg
FB1/kg bw per day
corresponding to 20
mg FB1/kg feed
Endpoint: pulmonary
alterations
Feed contaminated
with fungal
(F. verticillioides) no
puriﬁed culture
material
Only one dose
Posa et al. (2016)
AChE: acetylcholinesterase; AKLP or ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; bw: body weight; DWG: daily weight gain; FB: fumonisin B; GGT:
gamma-glutamyl transferase; GIT: gastrointestinal tract; GOT: glutamic-oxaloacetic transaminase; LDH: lactate dehydrogenase; IFN: interferon; IL: interleukin; LOAEL: lowest-observed-adverse-
effect level; LOEL: lowest-observed-effect level; LOD: limit of detection; mRNA: Messenger Ribonucleic Acid; N: number of animals; NOAEL: no-observed-adverse-effect level; Sa/So: sphinganine-
to-sphingosine ratio; TNF: tumour necrosis factor; WBC: white blood cells.
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Poultry
EFSA derived a LOAEL of 2 mg/kg bw per day for poultry (EFSA, 2005). This was based on a
21-day feeding study where broiler chickens were given 0, 20, 40 or 80 mg pure FB1/kg feed for
21 days from day 1 (Henry et al., 2000). FB1 did not affect body weight or growth in this study. FB1
induced a dose-dependent increase in liver sphinganine and Sa/So ratio in all groups. In serum, the
ratio was only increased at the highest dose. Total liver lipids were decreased in chickens given 40 or
80 mg FB1/kg feed. These birds also had an increased serum GOT/ASP ratio. Cholesterol, ALP and LDH
were not affected by any treatment. EFSA calculated that a LOAEL of 20 mg/kg feed would correspond
to 2 mg/kg bw per day. EFSA also concluded that the LOAELs for other poultry species were higher,
5 mg/kg bw per day for Mallard ducks, 17 mg/kg bw per day for Peking ducklings, and 9 mg/kg bw
per day for turkeys (EFSA, 2005). The more recent papers identiﬁed are summarised below.
Chickens
Ninety-six-day-old chicks (breed not speciﬁed) were given 0 (control), 5, 10 or 15 mg FB1/kg feed
for 21 days in two experiments Cheng et al., 2006). FB1 was prepared by inoculation of grains with
F. moniliforme. The cultured material was analysed with HPLC and contained deoxynivalenol (DON)
(0.5 mg/kg, zearalenone (< 1.0 lg/kg) aﬂatoxins (3.3 lg/kg) and FB1 (5,250 mg/kg feed). The
mycotoxin concentrations were diluted to approximately 1/1,000 of this in the lowest dose group. The
relative weight of the bursa was reduced in chicks given 10 or 15 mg FB1/kg feed. Increased serum
AST was observed in chicks exposed to FB1 levels from 5 mg/kg feed and serum albumin and
cholesterol in chicks given 15 mg FB1/kg feed. In the ﬁrst experiments, chickens were vaccinated
against Newcastle disease at 4 days of age with a booster injection 10 days later. Chickens from the
groups given 10 or 15 mg FB1/kg feed had signiﬁcantly lower antibody titres against Newcastle disease
than controls. Finally, peritoneal macrophages were collected, counted and the macrophages
phagocytic activity towards Candida albicans was tested ex vivo. A dose-dependent decrease in
number of macrophages and % of phagocytic macrophages was observed with the high dose group
being statistically signiﬁcant lower than controls. The number of Candida per phagocytic macrophage
was signiﬁcantly lower in treated chickens compared to controls. In addition, decreased gene
transcription of proinﬂammatory cytokines in spleen after challenge with LPS was observed in all
treated birds. There were some unclarities in the reporting of the studies related to performance
parameters and the CONTAM panel could not derive a reference point based on the study.
Ross broiler chickens (6 replicate cages, 6 chickens/cage) were fed 0 (control), 5.6, 11.3, 17.5, 47.8
or 104.8 mg of sum of FB1 and FB2 from fungal cultures mixed into the diet for 20 days from day 1 of
age (Grenier et al., 2015). FBs in the diet had no effect on body weight or feed intake. The levels of
Sa and the Sa/So ratio was increased ratio in liver, kidney, jejunum, ileum and caecum from chickens
given from 11.3 mg FB1 + FB2 in the diet, but not in chickens given 5.6 mg FB1 + FB2 in the diet.
Furthermore, FB increased the gene expression of proinﬂammatory regulatory genes in the small
intestines. The upregulation was not dose-dependent and the largest increase was found in chickens
given 11.3 mg FB1 + FB2 in the feed. The effects observed in this study are not considered as adverse.
A decrease in liver lipids was observed in chickens given from 40 mg FB/kg feed in the studies by
Henry et al. (2000). Taking the known liver toxicity observed in most tested species into consideration,
the WG considered the decreased liver lipids as an adverse effect and identiﬁed a NOAEL of 20 mg/kg
feed, at. At this level, only the Sa/So ratio was altered and this is not considered as an adverse effect.
A NOAEL of 20 mg/kg feed (corresponding to 2 mg/kg bw per day) could be identiﬁed based on the
studies by Henry et al. (2000).
Laying hens
Only one feeding study with laying hens was available in which Hisex Brown layer hens (37 weeks
of age) were fed either a control diet or a diet containing 25 mg FB1 + FB2/kg feed for 56 days (two
cycles of 28 days). There were six replicates, with four birds/replicate for each treatment group. The
feed was prepared by mixing cultures of F. verticillioides into the feed. Laying hens given FB1 + FB2 in
the feed had shorter small intestines (1.37 vs 1.57 m) compared to controls. The treatment did not
have any effect on performance, blood lipids or plasma cholesterol (Siloto et al., 2013). Only one dose
of FBs was used in the study and no NOAEL could be derived. The feed concentration used in the trial
corresponded to 1.6 mg/kg bw per day.
Fumonisins in feed
www.efsa.europa.eu/efsajournal 48 EFSA Journal 2018;16(5):5242
Ducks
EFSA concluded in 2005 that there was no evidence that ducks or ducklings were more sensitive
than chickens. The statement was based on two published feeding experiments where LOAELs of
5 mg/kg bw per day for Mallard ducks and 17 mg/kg bw per day for Pecking ducklings were reported.
These were, however, the lowest doses tested in the studies. The more recent papers are summarised
below.
Benlashehr et al. (2011) gave mule ducks (25/diet) a diet where culture material of F. verticillioides
was mixed into the diet. The ﬁnal diet contained 10 mg FB1 + FB2/kg feed while aﬂatoxin B1,
ochratoxin A, zearalenone, DON and T2 toxin were all below their respective limit of detection. Five
birds from each group were examined on days 0, 3, 7, 14 and 21. The ducks given FB1 + FB2 in the
feed had a decreased feed consumption and body weight gain compared to the control. Furthermore,
the Sa and Sa/So ratio was increased compared to the control group. The relative organ weighs were
not statistically different in exposed birds compared to controls, but the serum concentrations of
cholesterol, LDH, ALT and AST were elevated in ducks given FB1 + FB2 in the feed.
Growing Mallard ducks (age and start weight not speciﬁed) were force-fed a diet containing 0, 10
or 20 mg FB1 from naturally contaminated maize in the feed for 12 days (25 ducks/treated group, 30
controls). The feed contained traces of FB2 and FB3 while aﬂatoxins B1, ochratoxin A, zearalenone,
trichothecenes, fusarine C, fusaric acid and moniliformine could not be detected. The mortality
increased in the high dose group (8% vs 0%). A dose-related increase in levels of Sa and the Sa/So
ratio was observed in treated ducks. The liver of the high dose birds were slightly discoloured and
microscopic examinations of the livers indicated steatosis in all exposed ducks (Tardieu et al., 2004).
Mule ducks from 1 week of age received daily oral doses corresponding to dietary concentrations of
0, 2, 8, 32 or 128 mg FB1/kg feed from a puriﬁed culture material of F. verticillioides for 77 days (Tran
et al., 2006). The puriﬁed extract contained 54% FB1, 8% FB2, 9% FB3 and 29% maize pigments. The
concentrations of aﬂatoxin B1, ochratoxin A, zearalenone and T-2 were below their respective LODs.
The treatments had no effect on feed intake or body weight gain and did not give any macroscopic
lesions. Serum Sa and Sa/So ratio were increased in ducks receiving more than 2 mg FB1/kg feed. The
increase in serum Sa and Sa/So ratio was highest during days 1–21 and decreased thereafter. No
visible signs of toxicity or effects on body weight gain and feed intake was observed even at the
highest dose, even though the Sa and Sa/So ratio was increased. Tardieu et al. (2006) examined the
effects of FB1 on Sa and Sa/So ratio in liver and kidneys and the serum biochemistry of the same
birds. The Sa and Sa/So ratio were increased in liver and kidney from all ducks from 2 mg/kg feed,
with the maximum concentrations reached on days 3–21. FB1 also increased serum protein,
cholesterol, ALP, LDH, ALT, AST in birds given doses corresponding to 32 mg/kg feed. Like for
sphinganine, the increase was highest after 7–21 days for most parameters and decreased thereafter.
In addition, a microglandular structure in both periportal and centrolobular areas was observed in the
livers of exposed animals on treatment days 7, 14, 21 and 28 but not on treatment day 77. The
structure was not characterised. Based on the high Sa concentrations found in birds without any visible
toxic effects in this study, the authors suggested that ducks may be relatively resistant to increased Sa
concentrations compared to other species. In this study, 8 mg FB1/kg feed could be considered a
NOAEL for effects other than increased Sa and Sa/So ratio. Using the EFSA conversion tables, a feed
concentration of 8 mg FB1/kg feed would correspond to 0.4 mg FB1/kg bw per day.
As an overall evaluation of feeding studies with ducks, a NOAEL of 8 mg FB1/g feed could be
identiﬁed for ducks. This NOAEL was based on alterations of liver enzymes indicating liver damages of
birds given 32 mg FB1/kg feed, but not in birds given 8 mg/kg feed (Tardieu et al., 2006). In addition,
the Sa and Sa/So ratio was increased in birds given from 2 mg/kg feed.
Turkeys
EFSA concluded in 2005 that there was no evidence that turkeys are more sensitive than chickens.
The statement was based on two published feeding experiments where high feed concentrations were
used and effects had been observed at the lowest doses used.
Since then, a few feeding studies have been published. Increased Sa and Sa/So ratio were
observed in two feeding studies using 10 or 15 mg FB1 + FB2 in the diet (Benlasher et al., 2012;
Masching et al., 2016). No other effects were reported from these studies.
Male turkey chicks of the BUT-9 strain (n = 36/group) were given fumonisins B1 and B2 in the diet
for 9 weeks (Tardieu et al., 2007). The diet was prepared by replacing some of the non-infected maize
in the feed with naturally infected maize. The ﬁnal feed contained 0, 5, 10 or 20 mg sum of FB1 and
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FB2 in the feed. Aﬂatoxin B1, ochratoxin A, zearalenone, DON and T-2 toxin were not detected in the
ﬁnal feed. No macroscopic lesions were detected in any tissues and histopathological examinations of
liver and kidneys did not reveal any alterations. There were no effects on body weight gain, relative
organ weights or feed conversion but a slight but statistically signiﬁcant increase in feed consumption
(177.7 vs 189.3 g/day) was reported from chicks given 20 mg/kg feed. Furthermore, there were no
signiﬁcant changes in serum levels of total protein, cholesterol or enzymatic activities of LDH, AAT and
AST. The Sa concentrations and Sa/So ratios were increased in liver and kidneys but not in plasma
from turkeys receiving from 10 mg FB1 + FB2 in the feed during the experiment. No adverse effect
was observed in turkeys even at the highest dose used.
In conclusion, the information available for oral feeding studies with dose–response relationships
from relevant feed concentrations in turkeys is scarce, but no adverse effects have been reported from
turkeys given up to 20 mg FB1/kg feed, corresponding to 0.67 mg/kg bw per day, and this could be
considered as a NOAEL.
Japanese quail
EFSA did not evaluate the toxicity of fumonisins in quails in 2005. Several studies with one high
concentration of fumonisins in the feed have been published since then, demonstrating that fumonisins
potentially may have toxic effects in quails. Increased mortality, rufﬂed feathers, reduced feed intake
and body weight gain and increased pathological alterations after infection with Salmonella Gallinarum
and effects on spleen and lymphoid cell depletion in tissues have been reported from feeding studies
where quails were a given single dietary feed concentration from 150 mg FB1/kg feed (see Table 5,
Asrani et al., 2006; Deshmukh et al., 2005a,b, 2007; Sharma et al., 2008). Reduced feed consumption
and bw gain and reduced egg weight were also reported from laying quails given a feed containing
10 mg FB1/kg feed from F. verticillioides culture material for 140 days (5 egg laying circles of 28 days)
(Ogido et al., 2004), but even in this study only one feed concentration was used and no reference
points could be identiﬁed.
Young laying Japanese quails (4 replicate pens with 8 birds/treatment) were given 0 (control), 10,
50 or 250 mg FB1/kg feed for 28 days (Butkeraitis et al., 2004). FB1 was added as a fungal culture
material of F. verticillioides containing 6,500 mg FB1/kg, 2,100 mg FB2/kg and 680 mg FB3/kg.
Aﬂatoxins, ochratoxin A. DON and zearalenone were not detected in the basal feed. Feed intake and
body weight gain were lower in birds receiving 50 or 250 mg FB1/kg feed compared to controls while
no effects were found in birds given 10 mg FB1/kg feed.
Feed conversion was reduced in quails receiving 250 mg FB1/kg feed. Histopathological
examinations did not reveal any changes in liver, kidney or heart from any group. The egg production
was only reduced in quails given 250 mg FB1/kg feed, but egg weight and the thickness of the egg
shells were reduced in eggs from quails receiving from 50 mg/kg feed. No effects were reported from
the group fed 10 mg FB1/kg diet. This could be considered as a NOAEL.
Japanese quail were fed F. verticillioides culture material mixed into the feed to produce feed
containing 10 mg FB1/kg feed for 140 days, which constitutes ﬁve egg laying cycles of 28 days (Ogido
et al., 2004). The treatment resulted in decreased feed intake in cycles 4 and 5, but not in the ﬁrst 3
cycles. The body weight was reduced only in cycle 5. In addition, the egg weight was lower in eggs
from the exposed birds compared to the controls.
In summary, only one feeding study with several doses of fumonisin in the feed to Japanese quails
was available (Butkeraitis et al., 2004). In this study, 10 mg could be considered as a NOAEL.
However, there are indications of adverse effects in Japanese quail given 10 mg/kg feed in a study
where this was the only dose used (Ogido et al., 2004).
In summary, even though low feed concentrations have been shown to alter the Sa levels and
Sa/So ratios in both tissues and serum of poultry, in chickens, adverse effects were observed at feed
concentrations exceeding 20 mg/kg feed. For ducks, a NOAEL of 8 mg FB1/kg feed and a LOAEL of
32 mg FB1/kg feed were identiﬁed and for turkeys, no adverse effects have been reported from birds
given up to 20 mg FB1/kg feed, corresponding to 0.67 mg FB1/kg bw per day. The overall LOAEL for
Japanese quail was 10 mg FB1/kg feed used (Ogido et al., 2004).
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Table 5: Adverse effects in poultry
Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Broiler chickens from
day 1
21 days
1) 0 mg FB1/kg feed
(n = 5 9 6)
2) 20 mg FB1/kg feed
(n = 5 9 6)
3) 40 mg FB1/kg feed
(n = 5 9 6)
4) 80 mg FB1/kg feed
(n = 5 9 6)
↑ SA and Sa/So ratios (from
20 mg/kg feed)
Increased liver lipids (from
40 mg/kg)
Increased ratio GOT:ASP
(from 80 mg/kg)
No effect on body weight
gain, serum cholesterol, ALP
and LDH
– NOAEL 20 mg/kg feed
Corresponding to
2,000 lg/kg bw per
day
Endpoint: increased
liver lipids
Pivotal study used in
EFSA (2005)
Pure Fumonisin B1
added to the feed
Henry et al.
(2000)
Day-old broilers (breed
not speciﬁed) given
contaminated feed for
21 days
Grains inoculated with
F. moniliforme mixed
into the feed (culture
material also contained
0.5 mg DON/kg, < 1.0
mg ZEN/kg, aﬂatoxins
3.3 lg/kg and
fumonisins (B1)
5250 mg/kg
20 days
1) 0 mg FB1/kg feed
(n = 24)
2) 5 mg FB1/kg feed
(n = 24)
3) 10 mg FB1/kg feed
(n = 24)
4) 15 mg FB1/kg feed
(n = 24)
No effect on bw gain
Increased serum albumin
and cholesterol (from
10 mg/kg
Increased AST (from 5
mg/kg)
Decreased antibody titre
response towards
vaccination (from 15 mg/kg
feed)
Altered macrophage function
(from 15 mg/kg feed)
Decreased gene expression
of proinﬂammatory cytokines
(from 5 mg/kg feed)
Decreased relative weight
of bursa (from 10 mg/kg)
No reference points
could be identiﬁed due
to unclarities in the
reporting
Contaminated feed
used in the study.
Other mycotoxins
present in low
concentrations
Breed not speciﬁed
Limited time (3 weeks)
Limitations with data
provided in Table 3
Cheng et al.
(2006)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
1-day old male broilers
(Ross) Toxins from
F. verticillioides
cultures. Feed
contained DON (0.236–
0.344 mg/kg) and ZEN
(0.015–0.029 mg/kg)
21 days
1) 0 (control),
(n = 6 9 6)
2) 5.6 mg FB1 +
FB2/kg
(n = 6 9 6)
3) 11.3 mg FB1 +
FB2/kg
(n = 6 9 6)
4) 17.5 mg FB1 +
FB2/kg
(n = 6 9 6)
5) 47.8 mg FB1 +
FB2/kg
(n = 6 9 6)
6) 104.8 mg FB1 +
FB2/kg
(n = 6 9 6)
No effect on performance
Increased Sa/So ratio in
liver, kidney, jejunum,
ileum and caecum (from
11.3 mg/kg feed)
– Upregulation of
proinﬂammatory
cytokine gene
transcription in all
groups. Response not
dose-dependent
NOAEL > 105 mg/kg
feed
No adverse effects
reported
Culture material used
in the study
Short-term study (21
days)
Grenier et al.
(2015)
Ross 308 broiler
chickens, 3 9 34
animals/treatment
culture material (F.
verticillioides) in the
feed 15 (6/dose) or
21–23 days
1) 0 (control)
2) (16.2 mg/kg feed
for days 1–8, 27.6
days 9–16, 18.0
from day 17. fed a
mixture of B1, B2
and B3
Average B1 10.4
mg/kg feed, average
total FB1-3:
20.6 mg/kg feed
Increased plasma Sa and
Sa/So ratio
No effect on body weight
gain
Reduced small intestine
length villus height and
crypt depth
Increased relative liver
weight
Altered microbiota
composition in ileum, but
not in duodenum
Increased susceptibility to
Clostridium perfringens-
induced necrotic enteritis
LOAEL 16.2 mg/kg
feed
Endpoint: Altered gut
morphology, increased
susceptibility to
C. perfringens-induced
necrotic enteritis
Culture material used
Only one dose
Short-term
Antonissen et al.
(2015a)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Ross 308 broiler
chickens
Puriﬁed from culture
material
15 days
1) 0 (control)
2) Average level of
FB1, FB2, and FB3
in the two batches
were 8.4, 7.0 and
1.7 mg/kg
Increased plasma Sa and
Sa/So ratio
No effect on weight gain,
feed conversion
– Altered mucus layer
composition in
duodenum
– Altered ileal gene
expression of genes
involved in
antioxidative responses
LOAEL 17.1 mg/kg
feed
(dose could not be
estimated as bw not
given)
Endpoint: altered
mucus
Culture material used
Only one dose
Short-term
Antonissen et al.
(2015b)
Broiler chickens (Ross)
Pure FB1
21 days (21–42 days of
age)
1) 0 (control)
(n = 4 9 6)
2) 10 mg/kg feed
(n = 4 9 6)
Bile duct hyperplasia with
ﬁbrosis
NOAEL of 10 mg/kg
feed
No adverse effect
Only one dose
Short-term
No details given of the
pathological alterations
Del Bianchi
et al., 2005
Male broiler chicks
F. proliferatum culture
extracts mixed into the
feed (trial 1–3) or pure
FB1 (Trial 4)
7–28 days in four
different trials
(trial 1: 1–28 days of
age, trial 2: 8–28 days
of age; trial 3: 21–28
days of age; Trial 4:
1–14 days of age)
Trial 1:
1) 0 (control)
(n = 30)
2) 75, (n = 30) 3,
231 (n = 30)
3) 644 mg
FB1 + FB2/kg feed
(n = 30)
Trial 2:
1) 0 (control,
n = 6)
2) 75 (n = 6) 3, 231
(n = 6)
3) 644 mg
FB1 + FB2/kg feed
(n = 6)
Gross and
histopathological lesions
in all investigated organs
(liver, lungs, kidneys,
heart, intestine, gizzard,
bursa, brain, pancreas
pericardium, peritoneal
cavity)
LOAEL 75 mg
FB1 + FB2/kg feed
Endpoint: Pathological
lesions in several
organs
Only high doses used
in the experiments
Culture material used
in most trials
High concentrations of
moniliformin present in
the contaminated feed
(66–367 mg/kg feed)
Several short-term
trials
Javed et al.
(2005)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Trial 3:
1) 0 (control,
n = 6)
2) 75 (n = 6) 3, 231
(n = 6)
3) 644 mg
FB1 + FB2/kg feed
(n = 6)
Trial 4:
1) 125 mg FB1/kg
feed (n = 10)
2) 274 mg FB1/kg
feed (n = 10)
One-day-old chicks
(Cobb 500)
F. verticillioides culture
material was mixed into
the feed
21 days
1) 0 (control,
n = 12)
2) 100 mg FB1/kg
feed (n = 12)
Increased Sa/So ratio Increased liver weight,
relative liver weight, feed
conversion ratio
Increased lipid
peroxidation and ascorbic
acid and CAT activity in
the liver
LOAEL 100 mg/kg feed
Feed conversion ratio,
indications of oxidative
damages
Only one dose
Culture material
High dose
Indication of oxidative
stress in the livers
Poersch et al.
(2014)
One-day-old chicks
(Cobb 500) given
culture material from
F. verticillioides in the
diet
28 days (days 1–28)
1) 0 (control),
(n = 6 9 11)
2) 100 mg FB1/kg
feed (n = 6 9 11)
3) 200 mg FB1/kg
feed (n = 6 9 11)
The diet also contained
0, 20 or 40 mg FB2/kg
in addition to FB1
– No mortality
– Reduced feed intake
and bw gain
– Increased feed
conversion rate
– Increased Sa/So ratio
– Increased plasma
protein and albumin
– Increased serum Ca
– Decreased serum uric
acid
– Alterations in serum
ALT, AST, GGT, Chol, Tri
Increased rel. liver weight LOAEL 100 mg/kg feed
Endpoint: Reduced
reed intake and bw
gain and increased
feed conversion ratio,
alteration in serum
biochemistry
Only high doses used
Culture material
Rauber et al.
(2013)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
One-day-old chicks
(Vencobb) (n = 25/
treatment)
Culture material of F.
moniliforme was mixed
into the feed
8 weeks
1) 0 (control,
n = 25)
2) 50 (n = 25)
3) 100 (n = 25)
4) 200 (n = 25)
5) 400 mg FB1/kg
(n = 25)
Histopathological
alterations reported from
liver, kidney, bursa of
Fabricius, proventriculus
heart and intestines
LOAEL 50 mg/kg feed
Endpoint:
Histopathological
alterations in several
organs
Culture material
Only high doses
Lack of details on
ﬁndings from each
treatment
No statistics
Satheesh et al.
(2005)
Male broiler chicks
commercial Hybro-PG).
Fumonisins prepared
from cultures extracts
of F verticillioides
34 days (from 8 to 41
days of age)
1) 2.23 mg FB1/kg
feed (control,
n = 12)
2) 50 mg FB1/kg feed
(n = 12)
3) 200 mg FB1/kg
feed (n = 12)
Also contained FB2 and
FB3
No visible clinical effects
Reduced body weight gain
(from 50 mg/kg feed)
Increased rel. weight of
heart (from 50 mg/kg), liver
and bursa (from 200 mg/kg
feed). No effect on rel.
weight of spleen
Vacuolar degeneration in
liver
Cell proliferation in bile
ducts near
The liver portal space or
between the hepatocytes
(from 50 mg/kg feed)
Reduced antibody titres
against Newcastle disease
(from 50 mg/kg feed)
LOAEL 50 mg/kg feed
Endpoint: Reduced bw
gain, pathological
alterations in liver and
reduced antibody titres
Culture material used
Only high doses
No pure control
Tessari et al.
(2006)
Male broiler chicks
commercial Hybro-PG).
Fumonisins prepared
from cultures extracts
of F verticillioides
34 days (from 8 to 41
days of age)
1) 2.23, mg FB1/kg
feed (control,
n = 12)
2) 50 mg FB1/kg feed
(n = 12)
3) 200 mg FB1/kg
feed (n = 12)
Also contained FB2 and
FB3
Increased plasma AST (from
200 mg/kg feed)
No effects on plasma total
protein
No reference points
could be identiﬁed
Culture material used
Only high doses
No pure control
Tessari et al.
(2010)
Laying hens
(Hisex Brown layer
hens), 37 weeks of
age, 56 days exposure
1) 0 (control)
2) 25 mg FB/kg feed
No effect on performance
No effect on blood lipids or
plasma cholesterol
– No effect on feed
intake, bw gain or
relative organ weights
– Reduced small
intestine length
– Increased abdominal
fat
LOAEL 25 mg/kg bw
per day
Endpoint: Reduced
small intestinal length
and increased
abdominal fat
Only one dose Siloto et al.
(2013)
Fumonisins in feed
www.efsa.europa.eu/efsajournal 55 EFSA Journal 2018;16(5):5242
Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Male mule ducks 22
days old
Force-fed
Culture extracts
containing B1 and B2,
from 22 days of age
21 days
1) 0 (control)
2) oral administration
of 10 mg FB1 +
FB2/kg bw per day
Other mycotoxins were
not detected
Decreased body weight gain
and feed consumption
Increased Sa and Sa/So ratio
in serum, liver and kidney
Increased serum cholesterol,
LDH, ALT, AST
No lesions, increased rel.
liver weight
LOAEL 10 mg/kg bw
per day
Endpoint: Decreased
bw gain and feed
consumption, altered
serum biochemistry
Only one dose tested
Force feeding
Benlasher et al.
(2012)
Mallard ducks (n = 25/
group) were given a
feed where naturally
contaminated maize
was used in the feed
12 days
1) 0 (control)
2) 10 mg FB1/kg feed
3) 20 mg FB1/kg feed
Other mycotoxins were
not detected
Increased mortality in the
high-dose group
Increased ratio Sa/So in
plasma
No effect on standard
plasma biochemical
parameters
NOAEL 10 mg/kg feed
(corresponding to 0.5
mg/kg bw per day)
Endpoint: Increased
mortality
Force feeding Tardieu et al.
(2004)
Mule ducks from 1
week of age
Culture material from
F verticillioides was
mixed in the feed
traces of FB2 and
FB3, AFB1, ochratoxin
A, zearalenone,
trichothecenes, fusarine
C, fusaric acid and
moniliformine could not
be detected
77 days
1) 0 (control) (n =
30)
2) 2 mg FB/kg feed
(n = 25)
3) 8 mg FB/kg feed
(n = 25)
4) 32 mg FB/kg feed
(n = 25)
5) 128 mg FB/kg
feed (n = 25)
No effect on feed intake or
bw gain
Increased serum protein,
cholesterol, ALP, LDH, ALT,
AST (from 32 mg/kg feed).
Increase highest after 7–21
days for most parameters
Increased serum Sa and
Sa/So ratio (from 2 mg/kg
feed).
– NOAEL 8 mg/kg feed
Endpoint: Altered
serum biochemistry
By gavage
Culture material
Tran et al.
(2006)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Mule ducks from 1
week of age
Culture material from F
verticillioides was mixed
in the feed
Traces of FB2 and FB3,
AFB1, ochratoxin A,
zearalenone,
trichothecenes, fusarine
C, fusaric acid and
moniliformine could not
be detected
77 days
1) 0 (control)
(n = 30)
2) 2 mg FB/kg feed
(n = 25)
3) 8 mg FB/kg feed
(n = 25)
4) 32 mg FB/kg feed
(n = 25)
5) 128 mg FB/kg
feed (n = 25)
No effect on feed intake or
body weight gain
Increased Sa/So ratio in liver
and kidney (from 2 mg/kg
feed)
No macroscopic lesion
Alteration in the
centrilobular areas of the
fumonisin-fed animals on
days 7, 14, 21 and 28,
but not on day 77
NOAEL 32 mg/kg feed
No adverse effect
reported
Tardieu et al.
(2006)
One-week-old male
turkey chicks (BUT-9)
(n = 36/dose)
Naturally contaminated
maize was mixed into
the feed.
Other mycotoxins
(AFB1, ochratoxin A,
ZEN, DON, T-2 toxin
below their respective
LOD
63 days (on days 7–70)
1) 0 (control)
2) 5 mg FB1 +
FB2/kg feed
3) 10 mg FB1 +
FB2/kg feed
4) 20 mg FB1 +
FB2/kg feed
Increased feed consumption
(20 mg FB1/kg feed)
No effect on body weight
gain
No effect on markers of liver
damage
Increased Sa/So ratio in liver
and kidney from 10 mg/kg.
No effects on Sa/So in
serum
No changes in organ
weights
No pathological
alterations
NOAEL 20 mg/kg feed
No adverse effect
reported
Naturally contaminated
material
Tardieu et al.
(2007)
Male turkeys (BUT 9
strain)
Culture extracts
containing B1 and B2,
from 22 days of age
Force-fed an oral dose
of 10 mg FB1 + FB2/kg
bw for 21 days
No effects on body weight
gain, no mortality
Increased Sa and Sa/So ratio
in serum, liver and kidney.
No lesions, or organ
weight alterations
Oral force feeding Benlasher et al.
(2012)
Female turkeys 11
weeks old at start of
the experiment Culture
material of
F. verticillioides
15 mg FB (B1 + B2) on
the feed for 14 days
⇑sphinganine/sphingosine in
serum
NOAEL 15 mg/kg feed
No adverse effect
observed
Only one dose Masching et al.
(2016)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Japanese quail
50 control, 100
exposed, from 1 day
old
FB1 given as:
verticillioides culture
material mixed into
feed
1) 0 (control)
(n = 50)
2) 300 mg FB1/kg
feed (n = 100)
– 59% mortality
– Signs of neurotoxicity
– Rufﬂed feathers
– Reduced feed intake
and body weight gain
– Diarrhoea
– Altered clinical
chemistry
LOAEL 300 mg/kg feed
Endpoint: Reduced
feed intake and body
weight gain, diarrhoea,
clinical chemistry
Only one high dose
Culture material used
Asrani et al.
(2006)
Young laying Japanese
quail days old).
Culture material from
F. verticillioides in the
diet. In addition the
material contained FB2
(approximately 33% of
FB1) and FB3 (approx.
10% of FB1)
28 days
1) 0 (control)
2) 10 mg FB1/kg feed
3) 50 mg FB1/kg feed
4) 250 mg FB1/kg
feed
– Reduced feed intake
and body weight gain
(from 50 mg/kg feed,
reduced feed
conversion (from 250
mg/kg feed, reduced
egg production (from
250 mg/kg feed),
reduced egg weight
(from 50 mg/kg feed,
thinner egg shells
(from 50 mg/kg feed)
No histopathological
changes in liver, kidney or
heart from any treatment
group
NOAEL 10 mg/kg feed
LOAEL 50 mg/kg feed
Endpoint: Feed intake
and body weight gain
Butkeraitis et al.
(2004)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Japanese quail from 5
days old. 75/group
F. moniliforme culture
material was mixed into
the feed. Birds were
infected with
S. Gallinarum at 21
days of age (exposed
for 16 days)
37 days (16 days
before infection with
S. Gallinarum and 21
days after infection
1) 0 (control)
2) 150 mg FB1/kg
feed
– 3 dead birds in FB1 fed
vs none in controls
– Reduced feed and
water intake
– Reduced body weight
gain
– Increased erythrocyte
count
– leucocytosis
– Diarrhoea, clinical
neurological symptoms
– More severe and earlier
onset of symptoms
after infection
– Reduced lymphocyte
response to infection
– Increased mortality
after infection
LOAEL 150 mg/kg feed
Endpoint: Reduced
feed intake and bw
gain, haematology and
immunology,
neurological
symptoms, diarrhoea,
mortality
Culture material used
Only one high dose
Deshmukh et al.
(2005a)
Japanese quail from 5
days old. 75/group
F. moniliforme culture
material was mixed into
the feed. Birds were
infected with
S. Gallinarum at 21
days of age (exposed
for 16 days)
37 days (16 days
before infection with
S. Gallinarum and
21 days after infection
1) 0 (control)
2) 150 mg FB1/kg
feed
Mild to moderate
hepatomegaly and pale
discoloration of liver
Increased pathological
alterations in liver after
infection with S.
Gallinarum
LOAEL 150 mg/kg feed
Endpoint: Pathological
changes in liver after
and without infection.
Culture material used
Only one high dose
Deshmukh et al.
(2005b)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Japanese quail from 5
days old. 75/group
F. moniliforme culture
material was mixed into
the feed. Birds were
infected with S.
Gallinarum at 21 days
of age (exposed for 16
days)
37 days (16 days
before infection with S.
Gallinarum and 21 days
after infection
1) 0 (control)
2) 150 mg FB1/kg
feed
– Reduced spleen size -
depletion of white pulp
thinning of
cardiomyocytes,
lymphoid cell depletion
from bursal follicles
renal tubular nephrosis
lower response in
agglutination test to
S. Gallinarum
LOAEL 150 mg/kg feed
Endpoint: Pathological
alterations in several
organs, lower immune
response towards
infection
Culture material used
Only one high dose
Deshmukh et al.
(2007)
Japanese quail from 8
weeks of ageCulture
material of F.
verticillioides mixed into
the feed140 days (5
egg laying cycles of 28
days)
1) 0 (control)
(n = 48)
2) 10 mg B1/kg feed
(n = 48)
 Reduced feed
consumption in cycles
4 and 5, but not 1–3.
 Reduced body weight
on cycle 5, not 1–4
 No effect on feed
efﬁciency (g feed/g
egg)
 Reduced egg weight
LOAEL 10 mg B1/kg
feed
Endpoint: reduced
feed consumption,
reduced body weight,
reduced egg weight
Culture material
Only one dose
Ogido et al.
(2004)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
Japanese quail from
day 1
Culture material of
F. verticillioides mixed
into the feed 35 days
1) 0 (control)
2) 200 mg/kg FB1
 Rufﬂed feathers and
reduced body weight
gain
 Increased serum
protein, albumin,
cholesterol, AST, LDH,
creatinine kinase
 Reduced mononuclear
immunity response
 Increased skin
thickness
LOAEL 200 mg/kg feed
Endpoint: Reduced bw
gain, neurological
symptoms, altered
serum biochemistry,
reduced immunological
response
Culture material
Only one dose
Short-term
Sharma et al.
(2008)
AFB: aﬂatoxin B; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; bw: body weight; Chol: total cholesterol; DON: deoxynivalenol; FB: fumonisin B; GGT:
gamma-glutamyl transferase; GOT: glutamic-oxaloacetic transaminase; LDH: lactate dehydrogenase; LOAEL: lowest-observed-adverse-effect level; n: number of animals; NOAEL: no-observed-
adverse-effect level; Sa/So: sphinganine-to-sphingosine ratio; Tri: triglycerides; ZEN: zearalenone.
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Horses
Fumonisins were ﬁrst isolated and described from cultures of Fusarium verticillioides isolated from
maize associated with equine leucoencephalomalacia (ELEM) (Marasas, 2001). Clinical signs of ELEM
include apathy, drowsiness, pharyngeal paralysis, blindness, circling, staggering, hyperexcitability, and
seizures. In some cases, sudden death occurs without any prior signs. A typical ﬁnding at necroscopy
is necrosis of the white matter in the brain. Fumonisins also damage the cardiovascular system in
horses, causing decreased heart rates, lower cardiac output, and ventricular contractility (EFSA, 2005)
and these effects are probably linked to the neurological effects.
In the previous opinion, EFSA concluded that horses, together with pigs, were the most sensitive
farm animal species (EFSA, 2005). Evaluations of ﬁeld outbreaks of ELEM in the USA showed that
consumption of feed containing more than 10 mg FB1/kg feed was associated with increased risk of
ELEM, while no increased risk was found for feed containing less than 6 mg/kg feed (Ross et al., 1991).
No oral dose–response studies with fumonisins including low doses are available. EFSA based its
previous evaluation on a study using iv injection. Horses (3 or 4/group) were given daily injections of 0
(control), 0.01, 0.05, 0.1 or 0.2 mg pure FB1/kg bw for up to 28 days. Horses considered as unsafe
for themselves or the surroundings were euthanised prior to 28 days (Constable et al., 2000; Foreman
et al., 2004). The horses were subject to neurologic and cardiovascular examinations. In addition,
serum biochemical analysis of liver enzymes creatinine and cholesterol were performed and samples of
cerebrospinal ﬂuid were investigated in the euthanised horses. Neurological symptoms such as
hindlimb ataxia, delayed forelimb placing reactions, decreased tongue movement, depression,
hyperaesthesia and dementia were reported. Two horses died unexpectedly few hours after detection
of mild neurological symptoms (at the highest dose 0.2 mg pure FB1/kg bw). Cardiovascular effects
like decreased heart rate, cardiac contractility arterial pulse pressure, venous blood pH and increased
systemic vascular resistance were reported from horses with neurological symptoms. The symptoms
were more severe and occurred more rapidly with increasing doses. No neurological or cardiovascular
effects were reported from horses given 0.01 mg/kg bw per day. Increased serum creatinine, AST, ALP
and GGT activity and increased bile acids, total bilirubin and cholesterol concentrations were found in
all treated horses. Based on these ﬁndings, the authors concluded that 0.01 mg/kg bw was a LOAEL
for horses, which was also used by EFSA in 2005. Both the authors and EFSA assumed an oral
bioavailability of 5% and estimated that 0.01 mg/kg bw corresponds to an oral dose of 0.2 mg/kg bw
per day or 8 mg/kg feed (Foreman et al., 2004; EFSA, 2005).
No later oral feeding studies with horses were identiﬁed.
In more recent ﬁeld reports of ELEM in horses, the syndrome has been associated with feed for
horses containing 6.6 mg FB1/kg feed in Brazil (dos Santos et al., 2013) and 12.5 mg/kg in feed in
Argentina (Giannitti et al., 2011). In Serbia, 21 out of 100 horses in a stable were diagnosed with
ELEM based on clinical observations. Pathological examinations performed on one of the horses
revealed ﬁndings consistent with fumonisin intoxications. One sample of each of the feed ingredients
were collected. The samples of milled maize collected at the time of diagnosis contained 6.0 mg
FB1/kg and 2.4 mg FB2/kg, while the maize bran contained 6.05 mg/kg FB1 and 1.68 mg/kg FB2
(Jovanovic et al., 2015), but there are no description of the sampling procedure or any information of
levels in the previous feed batch. These ﬁeld reports do not contain details such as feed consumption.
It is therefore not possible to establish safe limits based on these reports.
The EFSA evaluation from 2005 was based on a preliminary report from UDSA (Constable et al.,
2000). Parts of the ﬁndings have been published in other papers (Smith et al., 2002; Foreman et al.,
2004), but the effects on serum biochemistry have not been published in peer-reviewed journals.
Furthermore, the preliminary report provided is uncomplete and the actual data are lacking. The
CONTAM Panel could therefore not derive a reference point based on the effects on serum biochemical
parameters. EFSA therefore consider an i.v dose of 0.01 mg FB1/kg bw per day for a NOAEL based on
neurological and cardiovascular effects (Smith et al., 2002; Foreman et al., 2004). Assuming a 5%
bioavailability, this would correspond to 0.2 mg/kg bw per day.
Using the consumption value in Appendix C.1, this corresponds to feed contaminated at 8.8 mg/kg
feed.
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Table 6: Adverse effects in horses
Study design breed, age,
gender, exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source and
nature of the toxin
Reference
Healthy horses between
6 months and 6 years of age
(252–524 kg, breed and
gender not speciﬁed) were
given pure (purity not
speciﬁed) FB1 for 28 days
I.v. injection of 0
(control), 0.01, 0.05,
0.1 or 0.2 mg/kg bw
Hindlimb ataxia, delayed
forelimb placing
reactions, decreased
tongue movement,
depression,
hyperaesthesia and
dementia, decreased
heart rate, cardiac
contractility arterial pulse
pressure, venous blood
pH and increased
systemic vascular
resistance
NOAEL of 200 lg/kg
bw per day
(neurological effects)
Corresponding to
8.8 mg/kg feed
Pivotal study used in
EFSA (2005), FAO/WHO
(2001)
I.v. injection
Limited number of
horses
Smith et al. (2002),
Foreman et al. (2004)
bw: body weight; i.v.: intravenous; FB: fumonisin B; NOAEL: no-observed-adverse-effect level.
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Rabbits
No LOAEL or NOAEL was identiﬁed for rabbits in the previous EFSA opinion (EFSA, 2005). New
studies were reported since and data from the study of Ewuola (2009) indicates a LOAEL of 5 mg
FB1/kg diet (130 lg FB1/kg bw) based on decreased performance, biochemical alterations in serum
(total protein, liver enzymes) and blood composition. These results are supported by the ﬁndings of
Ewuola and Egbunike (2008) showing moderate to severe alterations in liver at the same concentration
(5 mg FB1/kg feed).
In the present opinion, the studies without a control group were excluded.
Based on studies published after the last EFSA opinion, it appears that the effect of Fumonisin on
rabbit performance was time and dose-dependent. For example, Szabo et al. (2014) reported that
10 mg FB/kg diet had no effect on feed intake and body weight gain of male rabbits exposed to the
toxins for 4 weeks while a decrease of feed intake was observed in rabbits fed diets contaminated with
higher doses (12.3 and, respectively, 24.5 mg FB/kg diet) for 5 weeks (Ewuola et al., 2008); in
addition, a single dose of 630 mg FB1/kg feed (31.5 mg/bw) decreased body weight in male rabbits
(Orsi et al., 2009).
Serum biochemical analyses revealed that FB1 decreased serum total protein, albumin, urea and
creatinine levels in serum of male rabbits exposed to 5 mg FB1/kg diet (Ewuola and Egbunike, 2008)
or to 1.5 mg FB1/kg bw per day (Orsi et al., 2007). A decrease in serum total protein concentrations
was also observed in pregnant female rabbits fed a diet contaminated with 5 or 10 mg FB1/kg diet
(Gbore and Akele, 2010). By contrast, a dose of 31.5 mg FB1/kg body weight signiﬁcantly increased
the total protein, urea and creatinine in male rabbits and increased the urinary protein concentrations
(Orsi et al., 2009).
Contradictory data were also observed for the albumin/globulin ratio. Concentrations of 7.5 and
10 mg FB1/kg diet increase the ratio (Ewuola et al., 2008) while 12.3 mg FB/kg diet induce a decrease
of the albumin/globulin ratio (Ewuola and Egbunike, 2008).
The majority of the studies have shown that FB increases the activity of hepatic enzymes (ALT, AST,
ALP, GGT) (Orsi et al., 2007, 2009; Ewuola and Egbunike, 2008; Gbore and Akele, 2010). Only one
study showed no effect of FB on serum biochemical and enzyme parameters (Ewuola et al., 2008).
The exposure of New Zealand rabbits to 1.5 mg FB1/kg bw per day for 21 days increased the Sa level
and the Sa/So ratio in urine, serum and liver of rabbits (Orsi et al., 2007). In some of these studies,
the feed for control group was contaminated with low doses of FB1 (Ewuola and Egbunike, 2008,
2010a,b; Ewuola et al., 2008).
Some studies showed that concentrations of 5–10 mg FB1/kg diet (12 weeks of exposure)
decreased the packed cell volume, haemoglobin concentration and erythrocytes number in rabbits
(Ewuola and Egbunike, 2008; Gbore and Akele, 2010). These alterations were accompanied by the
increase of white blood cells count and of the lymphocyte number (Ewuola and Egbunike, 2008; Gbore
and Akele, 2010). However, other studies using higher concentration of FB1 (12.3 and, respectively,
24.56 mg FB1/kg diet) during 5 weeks of exposure showed no effect of FB on the mean values of all
the haematological variables (PCV, RBC, WBC, Hb, MCH, MCV, MCHC) (Ewuola et al., 2008).
FB decrease the relative weight of visceral organs (liver, spleen, kidney, testes) (Orsi et al., 2007,
2009; Ewuola, 2009). Histopathological analyses showed liver congestion after 21 days of exposure to
1.5 mg FB1/kg bw per day with different degree of liver lesions with moderate vacuolar degeneration
(Orsi et al., 2007). Liver necrosis was observed after an exposure to 5 mg/kg feed for 196 days
(Ewuola, 2009). Renal congestion associated with hypo pigmented areas were also associated with the
exposure to 1.5 mg FB1/kg bw per day (Orsi et al., 2007). The stomach and small intestine present
erosion of the tunica mucosa in rabbits exposed to 7.5 and 10 mg FB1/kg bw (Ewuola, 2009). Gross
pathological proﬁle of kidney of intoxicated rabbits is characterised by renal congestion associated with
hypopigmented areas (Orsi et al., 2007).
Mild-to-moderate lesions and Sertoli cell degeneration were observed in testis of rabbits exposed to
0.13, 5 and 7.5 mg FB1/kg diet (Ewuola, 2009) for 196 days. FB1 impaired spermatogenesis and
decrease the sperm reserves in testis, caput, corpus and caudal epididymis (Ogunlade et al., 2006;
Ewuola and Egbunike, 2010a). FB1 delay the onset of puberty (Ewuola and Egbunike, 2010b).
In summary, data available from the study of Gbore and Akele (2010), Ewuola (2009) and Ewuola
and Egbunike (2010a) indicates a LOAEL of 5 mg FB1/kg feed (0.2 mg FB1/kg bw) based on mild
moderate to severe alterations in liver and impairment of reproductive capacity. However, it is to be
mentioned that the feed of control group was contaminated with a low dose of toxin (0.13 mg FB1/kg
diet) in this study.
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Table 7: Adverse effects in rabbits
Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
No pivotal study to derive
NOAELs/LOAELs
EFSA CONTAM
Panel (2014)
N = 30, adult male
rabbits, 25 weeks
of age)
Average weight
1.88 kg bw
5 weeks of exposure
1) Control 0.35 mg
FB/kg diet
(N = 10)
2) 12.3 mg FB/kg diet
(N = 10)
3) 24.6 mg FB/kg diet
(N = 10)
Impaired
spermatogenesis
↓gonadal sperm
reserves of matured
rabbits
LOAEL 24.6 mg FB/kg
diet
Endpoint: ↓ caput and
caudal epididymides
weight
Feed contaminated
with no puriﬁed
(F. verticillioides)
cultured maize grains
No data on feed intake
–no correspondence in
lg/kg bw for LOAEL
Control group
contaminated with low
dose of fumonisin
Ogunlade et al.
(2006)
N = 16, New Zealand
rabbits
Average weight 1.7 kg
21 days of exposure
1) Control, 0 mg FB1/kg
bw per day
(N = 8)
2) 1.5 mg FB1/kg bw
per day
(N = 8)
No effect on body weight
↓ total protein, albumin,
urea and creatinine levels
and an increase in AP,
AST, ALT and GGT
↑ Sa level and the Sa/So
ratio in urine, serum
↓ liver weight
Gross pathological
proﬁle characterised
by hepatic
Renal congestion
associated with
hypopigmented areas
Moderate vacuolar
degeneration of the
liver
↑ Sa level and the
Sa/So ratio in liver
LOAEL 1.5 mg FB1/kg
bw per day
Endpoint: ↑ Sa level and
the Sa/So ratio in urine,
serum and liver
↓ in biochemical
parameters
Histological effects, liver
degeneration
Feed contaminated
with puriﬁed FB1
Only one dose
No data about feed
intake
No correspondence in
lg/kg bw for LOAEL
Orsi et al.
(2007)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 48, 49-day-old New
Zealand White 9
Chinchilla male
rabbits
Average weight
757.50 g;
12 weeks of exposure
1) Control, 0.1 mg
FB1/kg diet
(N = 12)
2) 5.0, mg FB1/kg diet
(N = 12)
3) 7.5 mg FB1/kg diet
(N = 12)
4) 10 mg FB1/kg diet
(N = 12)
7.5 and 10 mg FB1/kg
diet ↓the packed cell
volume, haemoglobin
concentration and RBC
number
↑ WBC count and the
lymphocyte number
↓ total serum protein,
albumin, albumin-globulin
ratio 7.5 and 10 mg FB1/
kg diet ↑ ALT, AST and
ALP
– LOAEL 5 mg FB1/kg diet
Endpoint: Decrease in
biochemical parameters
Modulation of
haematological
parameters
Feed contaminated
with not puriﬁed fungal
(F. verticillioides)
culture material
No data on feed intake
– no correspondence in
lg/kg bw for LOAEL
Control group
contaminated with low
dose of fumonisin
Ewuola and
Egbunike (2008)
N = 30, 22–24 week of
age, matured crossbred
male rabbits
Average weight 1.36 kg
5 weeks of exposure
1) Control, 0.35 mg FB/
kg diet (low dose)
(N = 10)
2) 12.30 mg FB/kg diet
(medium dose)
(N = 10)
3) 24.56 mg FB/kg diet
(high dose)
(N = 10)
↓the dry matter intake
no effect on the mean
values of all the
haematological variables
(PCV, RBC, WBC, Hb,
MCH, MCV, MCHC) or on
the serum biochemical
and enzyme parameter
Medium dose of FB1↑the
albumin/globulin ratio
LOAEL 12.30 mg FB/kg
diet
Endpoint: decrease in
feed intake
Feed contaminated
with not puriﬁed F.
verticillioides cultured
maize grains
No data on feed
intake; no LOAEL
calculated in lg/kg bw
Control group
contaminated with low
dose of fumonisin
Ewuola et al.
(2008)
N = 18, white
New Zealand male
rabbits, 50-day-old
Average weight 1.7 kg
A single dose of
puriﬁed FB1
1) Control 0 mg FB1/kg
bw
(N = 6)
2) 31.5 mg FB1/kg bw,
corresponding to
about 630 mg FB1/kg
diet
(N = 12)
↓ body and liver weight.
↑total protein, AP, AST,
ALT, GGT, urea and
creatinine
↑ urinary protein
concentrations
– LOAEL 31.5 mg FB1/kg
Endpoint: alteration of
reproductive system
Decrease in performance
and increase in
biochemical parameters
Puriﬁed toxin
Only one dose
Oral administration
(Gavage)
Orsi et al.
(2009)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 48, 49-day old New
Zealand white 9
Chinchilla male
rabbits
Average weight
757.50 g
196 day of exposure
1) Control, 0.13 mg FB1/
kg diet
(N = 12)
2) 5.0 mg FB1/kg diet
(N = 12)
3) 7.5 mg FB1/kg diet
(N = 12)
4) 10.0 mg FB1/kg diet
(N = 12)
↓ the relative weight of
visceral organs (liver,
spleen, kidney, testes)
FB1 > 5 mg/kg diet
induces mild moderate
to severe liver
necrosis/lesions
FB1 concentrations
higher than 7.5 mg/kg
diet induces mild–
moderate lesions and
sertoli cell
degeneration in testis
FB1 > 7.5 mg/kg diet
induces tunica mucosa
erosion in the stomach
and small intestine
LOAEL 199 lg FB1/kg bw
corresponding to 5 mg
FB1/kg diet
LOAEL reported in the
study
Endpoint: mild moderate
to severe liver necrosis/
lesions
Feed contaminated
with no puriﬁed fungal
(F. verticillioides)
culture material
Control group
contaminated with low
dose of fumonisin
Ewuola (2009)
N = 48, 7- week-old
New Zealand White 9
Chinchilla
Male rabbits
Average weight
757.50 g
28 weeks of exposure
1) Control, 0.13 mg FB1/
kg diet
(N = 12)
2) 5.0 mg FB1/kg diet
(N = 12)
3) 7.5 mg FB1/kg diet
(N = 12)
4) 10.0 mg FB1/kg diet
(N = 12)
FB1 decrease the daily
sperm production
↑ the epididymal weight
↓the sperm reserves in
testis, caput, corpus and
caudal epididymis
↓ the sperm reserves
in testis, caput, corpus
and caudal epididymis
LOAEL 5 mg FB1/kg diet
Endpoint: changes in
reproductive system
Feed contaminated
with no puriﬁed fungal
(F. verticillioides)
culture material
No data on feed intake
– no correspondence
in lg/kg bw for LOAEL
Control group
contaminated with
Low dose of fumonisin
Ewuola and
Egbunike
(2010a)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 24, normal
matured crossbred
female rabbits
Average weight
1.82 kg bw
Six weeks of exposure
1) Control, 0 mg FB/kg
diet
(N = 8)
2) 5 mg FB/kg diet
(N = 8)
3) 10 mg FB/kg diet
(N = 8)
↓ daily dry matter intake
and ﬁnal live weight
↓ serum total protein
concentrations in
pregnant female rabbits
↑ the serum enzymes ALT,
AST (low and high dose)
ALP (high dose)
↓ the haemoglobin values
and ↑the leukocyte values
of the pregnant female
rabbits
↓ the RBC counts and
packed cell volume only
at 10 mg of FB1
– LOAEL 130 lg FB/kg bw,
corresponding to 5 mg
FB/kg diet
Endpoint: modulation of
serum biochemical
parameters
Feed contaminated
with no puriﬁed fungal
(F. verticillioides)
cultured maize grains
Gbore and Akele
(2010)
N = 40
Male New Zealand
White 9 Chinchilla male
rabbits, 49 day old
Average weight
757.50 g
175 days of exposure
1) Control 0.13 mg
FB1/kg diet
(N = 10)
2) 5.0 mg FB1/kg diet
(N = 10)
3) 7.5 mg FB1/kg diet
(N = 10)
4) 10.0 mg FB1/kg diet
(N = 10)
7.5 and 10.0 mg FB1/kg
diet delay the onset of
puberty
– LOAEL 7.5 mg FB1/kg diet
Endpoint: delay the onset
of puberty
Feed contaminated
with no puriﬁed fungal
(F. verticillioides)
cultured maize grains
No puriﬁed culture
material
No data about feed
intake- no
correspondence in lg/
kg bw for LOAEL
Control group
contaminated with low
dose of fumonisin
Ewuola and
Egbunike
(2010b)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed
concentration
Clinical signs/
biochemical changes
Pathological
ﬁndings
NOAEL/LOAEL and
endpoint
Remarks source
and nature of the
toxin
Reference
N = 20 male rabbits
35 day old
Average weight 949.8 g
(control)
998.8 g (FB1)
4 weeks of exposure
1) Control, 0 mg FB1/kg
diet
(N = 10)
2) 10 mg FB1/kg diet
(N = 10)
No signiﬁcant bw
differences
FB1 signiﬁcantly increased
the RBC Na+/K+ ATPase
activity
Minor alterations on the
RBC membrane fatty acid
(FA) composition
No effect on the
haematological proﬁle
No effect on organ
(heart, liver, kidney,
spleen) weight
LOAEL 10 mg FB1/kg diet
Endpoint: increase
ATPase activity in RBC
Feed contaminated
with not puriﬁed
fungal (F. verticillioides
strain MRC 826)
culture material
Only one dose
Szabo et al.
(2014)
AP: alkaline phosphatase; AFB: aﬂatoxin B; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; bw: body weight; Chol: total cholesterol; DON:
deoxynivalenol; FA: fatty acid; FB: fumonisin B; GGT: gamma-glutamyl transferase; GOT: glutamic-oxaloacetic transaminase; Hb: haemoglobin concentration; LDH: lactate dehydrogenase; LOAEL:
lowest-observed-adverse-effect level; MCH: mean cell haemoglobin; MCHC: mean cell haemoglobin concentration; MCV: mean cell volume; N: number of animals; NOAEL: no-observed-adverse-
effect level; PCV: packed cell variable; RBC: red blood cell; Sa/So: sphinganine-to-sphingosine ratio; Tri: triglycerides; WBC: white blood cell; ZEN: zearalenone.
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Fish
The available database from feeding studies giving fumonisins to ﬁsh is limited as only two feeding
experiments with carp and one with each of channel catﬁsh, African catﬁsh and Nile tilapia have been
identiﬁed. Fumonisins reduced the body weight gain of all species.
EFSA (2005) concluded that the available data at that time indicated a LOAEL of 10 mg FB/kg feed
for carp, based on a study where 1-year-old carps (mean weight 127 g) were given feed containing 10
or 100 mg FB1/kg feed for 42 days (Petrinec et al., 2004). The diet was prepared by mixing Fusarium
culture material into the feed. Pathological alterations in liver, endocrine and exocrine pancreas, kidney,
heart and brain were reported from ﬁsh receiving the low dose feed.
In another feeding study, 1-year old carp (120–140 g) were given FB1 puriﬁed from Fusarium culture
material mixed into the feed and given feed corresponding to 0.5 or 50 mg/kg bw per day (feed
concentration not given). The exposure resulted in a loss of body weight gain and alterations of
haematological and biochemical parameters, indicating liver and kidney damage (Pepeljnak et al., 2003).
One additional study from the same group has been published since the EFSA opinion. One-year
old carps were given 10 or 100 mg FB1/kg feed using the same experimental design as in the studies
above (Kovacic et al., 2009). Histopatholgical examinations revealed reduced weight gain, and
vacuolated, degenerated or necrotic neural cells around damaged brain capillaries in both dose groups.
A LOAEL of 10 mg FB1/kg feed, corresponding to 0.5 mg/kg bw per day, could be derived for carp
based on the available studies.
EFSA concluded in 2005 that available data indicated a NOAEL of 20 mg/kg feed for catﬁsh, based
on a study by Lumlertdacha et al. (1995). In this study, catﬁsh were fed diets containing Fusarium
culture material with ﬁnal FB1 concentrations of 20, 80, 320 or 720 mg/kg feed for 10 weeks to
1-month-old ﬁsh (n = 50/group) or for 14 weeks to 1-year-old ﬁsh (n = 30/group). The mortality
increased from 320 mg/kg feed in both age groups. In the 1-month-olds, the weight gain was
decreased in ﬁsh given from 20 mg FB1/kg feed, while in the 1-year-old ﬁsh, the body weight gain
decreased from 80 mg/kg feed. Haematocrit, erythrocyte and leucocyte counts were reduced in
1-month-old ﬁsh given from 80 mg FB1/kg feed and from 320 mg FB1/kg feed in 1-year-old ﬁsh.
Microscopic examinations revealed liver lesions in ﬁsh given from 20 mg FB1/kg feed or more in both
age groups.
There are no new feeding studies with channel catﬁsh available since then and the LOAEL for Nile
tilapia is 10 mg FB1/kg feed.
EFSA also concluded that the data at that time indicated a NOEL of 20 mg FB1/kg feed for catﬁsh
and Nile tilapia (EFSA, 2005). This was based on a study where groups of Nile tilapia (n = 20/group)
(Oreochromis niloticus) had been given feed containing 0, 10, 40, 70 or 150 mg FB1/kg feed prepared
by mixing culture material into the feed (Tuan et al., 2003). The body weight gain was reduced in ﬁsh
receiving from 40 mg/kg feed. The Sa/So ratio in liver increased dose dependently and no
histopathological lesions were found. No new studies with Nile tilapia has been found and 10 mg/kg
feed, corresponding to 0.4 mg/kg bw per day, is still considered as a NOAEL for Nile tilapia.
African catﬁsh (Clarias gariepinus, 17.35  1.26 g size) were fed a diet where maize culture
material of F. verticillioides, were mixed into the feed in different rations to give feed concentrations of
0 (control), 5.0 mg, 10.0 or 15.0 mg B1/kg feed for 6 weeks. There were 16 tanks with 20 ﬁsh in each
treatment (Gbore et al., 2010). Feed intake and weight gain was reduced in all groups exposed to
fumonisins compared to the control. Due to limitations in experimental design and reporting from the
studies, the study could not be used to establish a safe limit for catﬁsh.
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Table 8: Adverse effects in ﬁsh
Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL
and endpoint
Remarks source
and nature of the
toxin
Reference
Carp (Cyprinus carpio
L), 1 year old, mean
weight 127 g, n = 8/
group, (gender not
speciﬁed), Puriﬁed
fumonisin (purity not
speciﬁed) 42 days
1) Control (n = 8)
2) 10 mg FB1/kg feed (n = 8)
3) 100 mg FB1/kg feed
(n = 8)
No mortality. Reduced
body weight gain in
treated groups, but no
difference between
dose groups,
erythrodermatitis
cyprini lesions
Pathological and
histopathological
alterations in several
organs including liver,
pancreas, head and
trunk kidneys, gall
bladder, pericardium
LOAEL 10 mg/kg
feed
Endpoint:
bw gain,
pathological
alterations
– Pivotal study in EFSA
2005 for carp
– kept in separate
cages immersed in
one pond
– fed once daily, (FB1
may partly dissolve
in water but pelleted
feed) Only 1 cage/
treatment
Petrinec et al. (2004)
Carp (Cyprinus carpio
L), 1 year old, mean
weight 127 g (gender
not speciﬁed)
Puriﬁed fumonisin
(purity not speciﬁed) 42
days
1) Control (n = 8)
2) 10 mg FB1/kg feed (n = 8)
3) 100 mg FB1/kg feed
(n = 8)
– Vacuolated,
degenerated or
necrotic neural cells,
around damaged brain
blood capillaries and
the periventricular
area
LOAEL 10 mg/kg
feed
Endpoint:
Reduced weight
gain, neuronal
apoptosis in
brain
– Kept in separate
cages immersed in
one pond
– fed once daily, (FB1
may partly dissolve
in water but pelleted
feed) Only 1 cage/
treatment
Kovacic et al. (2009)
Channel catﬁsh
(Ictalurus punctatus)
one year old (1.2 g) or
2 year old (31 g)
F. moniliforme culture
material 10 or 14
weeks
1) 0.3 mg FB1/kg feed
(control) (n = 50 9 4 for 1
year old, 30 9 4 for 2 year
old)
2) 20 mg FB1/kg feed
(n = 50 9 4 for 1 year old,
30 9 4 for 2 year old)
3) 80 mg FB1/kg feed
(n = 50 9 4 for 1 year old,
30 9 4 for 2 year old)
4) 320 mg FB1/kg feed
(n = 50 9 4 for 1 year old,
30 9 4 for 2 year old)
5) 720 mg FB1/kg feed
(n = 50 9 4 for 1 year old,
30 9 4 for 2 year old)
Increased mortality
(from 320 mg/kg feed)
Decreased body
weight gain (from 20
mg/kg feed
Decreased
haematocrit, red blood
cell counts and white
blood cell (from 80
mg/kg feed
Liver lesions (from 20
mg/kg feed
LOAEL 20 mg/kg
feed
Endpoint: bw
gain, liver
pathology
Pivotal study from
channel catﬁsh in
EFSA (2005)
Culture material also
contains FB2
Lumlertdacha et al.
(1995)
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Study design breed,
age, gender,
exposure period,
animal weight
Doses or feed concentration
Clinical signs/
biochemical
changes
Pathological
ﬁndings
NOAEL/LOAEL
and endpoint
Remarks source
and nature of the
toxin
Reference
African catﬁsh (Clarias
gariepinus), 17.351.26
g size. Maize cultured
with F. verticillioides
For 6 weeks
1) control (n = 4 9 20)
2) 5.0 mg B1/kg feed
(n = 4 9 20)
3) 10.0 mg B1/kg feed
(n = 4 9 20)
4) 4)15.0 mg B1/kg feed
(n = 4 9 20)
All doses had reduced
feed intake and weight
gain compared to
Decreased
haematocrit,
erythrocytes,
haemoglobin, MCV and
MCH.
Increased leucocyte
counts.
Reduced serum
protein levels
LOAEL 5 mg/kg
feed
Endpoint:
Reduced weight
gain and
reduced levels of
haematological
parameters
Fungal culture material
used
Surplus feed removed
only once/day
Method for measuring
feed consumption not
given
Increased levels of
ammonia in water
Decreased DO2
Gbore et al. (2010)
Nile tilapia
(Oreochromis niloticus)
2.7 g F. moniliforme
culture material 8
weeks
1) 0 (n = 3 9 40)
2) 10 (n = 3 9 40)
3) 40 (n = 3 9 40)
4) 70 (n = 3 9 40)
5) 150 (n = 3 9 40)
Reduced body weight
gain (from 40 mg/kg
feed)
Increased FCR (from
40 mg/kg feed)
Reduced haematocrit
(from 150 mg/kg feed)
Increased Sa/So ratio
(from 150 mg/kg feed
No histological
abnormalities found in
internal organs
NOAEL of 10
mg/kg feed (0.4
mg/kg bw per
day)
Stated in EFSA as
NOAEL of 20 mg/kg
feed in Nile tilapia
Fungal culture material
used
Tuan et al. (2003)
bw: body weight; FB: fumonisin; FCR: feed conversion ratio; LOAEL: lowest-observed-adverse-effect level; MCH: mean cell haemoglobin; MCHC: mean cell haemoglobin concentration; MCV: mean
cell volume; n: number of animals; NOAEL: no-observed-adverse-effect level; PCV: packed cell variable; RBC: red blood cell; Sa/So: sphinganine-to-sphingosine ratio.
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Cats
No information could be retrieved on the adverse effects of fumonisins and modiﬁed forms in cats.
Dogs
No information could be retrieved on the adverse effects of fumonisins and modiﬁed forms in dogs.
Farmed mink
Only one study on the effect of fumonisins on farmed mink was published since the last EFSA
evaluation. In this study conducted by Bursian et al. (2004), male adult mink were exposed for
14 days to a basal diet contaminated with fungal (F. verticillioides) culture material resulting in 200 mg
FB1 + 34 mg FB2/kg feed concentration. FB1 had no effect on feed consumption and body weight.
Only the sphinganine concentration in urine was signiﬁcantly higher, but sphingosine concentration as
well as the urinary Sa/So ratio were unaffected by the FB exposure. The addition of a mycotoxin
adsorbent did not reduce the increased urinary sphinganine concentration. Because cereal grains are
important components of mink diets more information is needed on the effect of fumonisins on mink
to derive reference points for this species. For the sum of fumonisin B1 and B2, guidance value is 50
mg/kg for mink (EFSA CONTAM Panel, 2014, Commission Recommendation 2016/1319/EC)2,13.
3.1.3.2. Modiﬁed forms of Fumonisins
Only one study has investigated the effect of modiﬁed forms of Fumonisin in farm and companion
animals. This study compared the toxicity of HFB₁ to the one of FB1 in piglets (Grenier et al., 2012).
Animals were exposed by gavage for 2 weeks to 2.8 lmol FB1 or HFB1/kg body weight per day
(corresponding to 2.0 mg FB1/kg bw per day and equimolar concentration of HFB1). In contrast to FB1,
HFB1 did not trigger hepatotoxicity as indicated by lesion score, level of several biochemical analytes
and expression of inﬂammatory cytokines. Similarly HFB1 did not alter the morphology and villus height
of the different segments of the small intestine and slightly modiﬁed the mRNA level in the intestine
and the mesenteric lymph nodes (increased 12p40 mRNA expression in the mid- and distal small
intestine, increased IFN-c in the distal small intestine, decreased TNF-a· and IL-6 in the mesenteric
lymph nodes). This low toxicity of HFB₁ correlated with a weaker increased of the sphinganine/
sphingosine ratio in the liver and in the plasma, when compared to FB1.
This low toxicity of HFB1 is supported by several feeding trial performed in pigs and in poultry, in
which the feed was supplemented with enzyme hydrolysing FB1 to HFB1 (Grenier et al., 2013;
Masching et al., 2016).
3.1.3.3. Conclusions – Adverse effects
There are rather limited data available on oral toxicity in livestock species, horses, ﬁsh and dogs,
especially studies using puriﬁed toxins. Only a few of these are suitable for the derivation of NOAELs
and LOAELs. Table 9 summarises the adverse effects observed in cattle, pigs, poultry, horse, rabbit,
and ﬁsh. Sheep and goats would not seem to be more susceptible to fumonisins than cattle. Except
for horses, the NOAEL and/or LOAEL value were obtained from studies using feed contaminated with
ﬁxed levels of toxins and calculation were made to convert the reference value in lg/kg bw per day.
No suitable data were available to derive NOAEL or LOAEL for dog, cats and fur animals.
The adverse effects observed in the different animal species upon exposure to FBs are summarised
in Table 9. The main targets organs are the liver (cattle, pig, chickens, ducks, rabbits, channel catﬁsh)
the lung (pig) and the brain (horse, carp). The immune and cardiovascular systems were also a target
for cattle and horses, respectively.
Pigs was the most sensitive species to FBs as evidenced by a low NOAEL (1 mg FB1/kg feed
corresponding to 40 lg/kg bw per day) and LOAEL (5 mg FB1/kg feed corresponding to 40 lg/kg bw
per day).
Rabbits and horses were quite sensitive to FBs. For rabbits, a LOAEL of 5 mg FB1/kg feed
(corresponding to 130 lg FB1/kg bw per day) was derived. For horses the NOAEL was 8.8 mg FB1/kg
feed (derived from i.v dosing and calculated into 0.2 mg FB1/kg bw per day).
Poultry were more resistant to FBs; however, large variation was observed between duck and
chicken or turkey. The NOAELs were 8 mg FBs/kg feed for ducks and 20 mg FBs/kg feed for chickens
13 Commission Recommendation 2006/576/EC of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin A,
T-2 and HT-2 and fumonisins in products intended for animal feeding. OJ L 229, 23.8.2006, p. 7–9.
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and turkeys. A similar variation was observed among ﬁsh species with LOAEL ranging from 10 mg
FBs/kg feed for carp; 20 mg FBs/kg feed for channel cat ﬁsh and 40 mg FBs/kg feed for Nile tilapia.
Ruminants appear quite resistant to FBs; however, it was only possible to derive a reference point
for cattle. The NOAEL for cattle was 31 mg FBs/kg feed corresponding to 600 lg FBs/kg bw per day.
Table 9: Relevant fumonisin toxicity studies with ruminants, pigs, poultry, horse, rabbit and ﬁsh to
possibly set NOAELs/LOAELs for fumonisins
Species
No observed
adverse effect
levels (NOAEL)
Lowest
observed
adverse effect
level (LOAEL)
Adverse effects
observed
(type of study)
References Comments
Cattle 31 mg FBs
(FB1 + FB2)/kg
feed
(corresponding
to 600 lg FBs/
kg bw per day)
N/A Biochemical alterations of
serum enzymes and
cholesterol, suggesting
alteration of liver function,
lymphocyte blastogenesis
Osweiler et al.
(1993)
From EFSA
(2005)
Pig 1 mg FB1/kg
feed
(corresponding
to 40 lg/kg bw
per day)
5 mg FB1/kg
feed
Corresponding
to 200 lg/kg bw
per day
Mild pulmonary lesions in 1
animal at 1 mg FB1/kg
feed (NOAEL)
5 mg FB1/kg feed increase
in the weight of the lungs,
pathological and
histopathological chronic
pulmonary changes in the
lung and liver (LOAEL)
Zomborszky-
Kovacs et al.
(2002a)
Mentioned in
EFSA (2005)
Chicken 20 mg FB1/kg
feed
(corresponding
to 2.6 mg/kg bw
per day)
40 mg FB1/kg
feed (4.7 mg/kg
bw per day)
Decreased liver lipids (from
40 mg/kg)
Increased ratio GOT:AST
(from 80 mg/kg)
No effect on body weight
gain, serum cholesterol,
ALP and LDH
Henry et al.
(2000)
From EFSA
(2005)
Turkeys 20 mg FBs
(FB1 + FB2)/kg
feed
(corresponding
to 0.9 mg FBs/
kg bw per day)
No macroscopic lesions
were detected in any
tissues and
histopathological
examinations of liver and
kidneys did not reveal any
alterations
No effects on body weight
gain, relative organ
weights or feed conversion
but a slight but statistically
signiﬁcant increase in feed
consumption reported at
20 mg/kg feed
Tardieu et al.
(2007)
Ducks 8 mg FB1/kg
feed
32 mg FB1/kg
feed
Serum biochemistry,
indicative of liver damage
Tardieu et al.
(2006)
Horses 0.2 mg FB1/kg
bw per day
(8.8 mg/kg
feed)
1 mg FB1/kg bw
per day (44 mg
kg/feed)
Neurological abnormalities
Cardiovascular effects
From EFSA
(2005)
Rabbits 5 mg FB1/kg
feed
(corresponding
to 130 lg FB1/
kg bw per day)
Decreased performance
and biochemical alteration
(Serum protein, enzymes)
Altered blood formula
Gbore and Akele
(2010)
Supported by
other studies,
i.e. Ewuola
(2009)
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3.2. Feed occurrence data
3.2.1. Previously reported feed occurrence data in the open literature
Data reported in the literature about occurrence of fumonisins in raw materials and feed are mainly
based on the determination of FB1 and FB2 by HPLC or ELISA methods, while only in the more recent
years LC-MS/MS analysis enables the collection of occurrence data for FB3. Consistently, data are
commonly reported as the sum of FB1 and FB2, also in agreement with current regulation. Data on the
occurrence of FB4 in feed were not identiﬁed in the literature.
Surveys are generally addressed to raw materials, while small scale studies may cover speciﬁc
animal feed categories.
The main global survey for mycotoxin contamination in feed was reported by Schatzmayr and Streit
(2013), and further analysed with a focus on European countries by Streit et al. (2013).
The survey covered 19,757 samples collected worldwide, among them 11,439 considered for
fumonisin occurrence. Overall, 54% of the samples were found positive for fumonisins (as the sum of
FB1, FB2 and FB3), with a mean of 1,674 lg/kg. More in details, 70% of samples from South Europe
and 33% from Eastern Europe were found to be positive, while no positive sample was identiﬁed in
Northern Europe.
Similar results were described by Griessler et al. (2010), who analysed compound feeds and
ingredients collected in EU between 2005 and 2009. Samples were grouped on the base of the analytical
method used. Overall, fumonisins (sum of FB1 and FB2) were found in 33 out of 43 samples analysed by
HPLC, with a mean concentration of 1,411 lg/kg (range: 25–7,714 lg/kg), and in 26 out of 46 samples
analysed by ELISA, with a mean concentration of 6,260 lg/kg (range: 373–36,390 lg/kg). The highest
contamination levels were associated with samples from Italy, Portugal and Spain.
These ﬁndings are consistent with data reported over years for fumonisin occurrence in maize from
Italy (Berardo et al., 2011; Pietri et al., 2012), underlying a strong frequency of positive samples at high
concentration levels. Camardo Leggieri et al. (2015) reported on the strong occurrence of FB1 and FB2 in
maize from Italy in 2012 (mean concentration: 3,040 lg/kg; max concentration: 10,604 lg/kg; n = 46),
in 2010 (mean concentration: 3,781 lg/kg; max concentration: 12,637 lg/kg; n = 48) and in 2011 (mean
concentration: 2181 lg/kg; max concentration: 21,007 lg/kg; n = 46). The authors underlined the
signiﬁcant correlation between climate factors and fumonisin incidence in maize.
Surveys performed in Poland showed a signiﬁcant inﬂuence of the environmental condition on the
contamination levels. Kosicki et al. (2016) reported on the occurrence of fumonisin B1 and B2 in maize
harvested in 2011–2014 in Poland, with mean concentration levels in the range 53–324 lg/kg feed,
and 33–1,063 lg/kg for ﬁnished feed. A similar study was performed on animal feed from Poland by
Grajewski et al. (2012), showing concentrations in the range 28–1,030 lg/kg for corn grains and
Species
No observed
adverse effect
levels (NOAEL)
Lowest
observed
adverse effect
level (LOAEL)
Adverse effects
observed
(type of study)
References Comments
Fish
(Carp)
10 mg FB1/kg
feed
(corresponding
to 0.5 mg/kg bw
per day)
Reduced weight gain,
neuronal apoptosis in brain
Kovacic et al.
(2009), Petrinec
et al. (2004)
Same values as
EFSA (2005)
Other ﬁsh:
Channel
catﬁsh
20 mg FB1/kg
feed
Reduced weight gain, liver
lesions
Lumlertdacha
et al. (1995)
From EFSA
(2005)
Other
ﬁsh: Nile
tilapia
10 mg FB1/kg
feed
(corresponding
to 0.4 mg FB1/
kg bw per day)
40 mg FB1/kg
feed
Reduced weight gain Tuan et al.
(2003)
From EFSA
(2005)
ALP: alkaline phosphatase; AST: aspartate aminotransferase; bw: body weight; FB: fumonisin B; GGT: gamma-glutamyl
transferase; GOT: glutamic-oxaloacetic transaminase; LDH: lactate dehydrogenase; LOAEL: lowest-observed-adverse-effect level;
N/A: not applicable; NOAEL: no-observed-adverse-effect level; Sa/So: sphinganine-to-sphingosine ratio.
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15–2,260 lg/kg for silages. Czembor et al. (2015) reported an incidence of 100% in samples collected
from Poland in 2011–2012, with a mean FB1 concentration of 373 lg/kg.
Data on fumonisin occurrence in wheat from Europe have not been identiﬁed, with the only
exception of a study from Western Romania (Alexa et al., 2013). The authors reported for FB1 a 15%
of frequency in wheat, with a contamination range of 960–1,180 lg/kg. Similar data have been
obtained for Argentinian wheat, demonstrating the possible occurrence of FB1 and FB2 at lower
concentration levels than those commonly reported in maize (Cendoya et al., 2014).
Considering other feed ingredients, Batatinha et al. (2007) investigated the presence of FB1 in spent
brewers’ grains from barley as dairy cattle feed, and found a mean contamination of 44–500 lg/kg.
Almeida et al. (2011) described the incidence of FB1 and FB2 in feed for sows, with a frequency of
8.7% and a concentration range of 50–200 lg/kg.
A number of studies have been recently performed on companion animal’s feed. Bohm et al. (2010)
investigated the occurrence of FB1 and FB2 in dry dog feed. Overall, 42% of the samples (n = 76) were
found positive at low levels, with the mean and maximum concentration 178 lg/kg and 568 lg/kg,
respectively. Extruded dog feed was considered by Gazzotti et al. (2015), indicating a 85% of positive
samples (n = 48) with a mean and maximum concentration of 67 lg/kg and 350 lg/kg, respectively. In
contrast, dry dog feed from the market was analysed by Pagliuca et al. (2011), showing higher
contamination levels. In particular, premium complete (n =16) and standard complete (n = 16) feed were
found in the range 150–3,050 lg/kg and 20–5,190 lg/kg, respectively. In addition, complementary feed
(n = 9) was found in the range 230–8,800 lg/kg.
Liesener et al. (2010) described the possible occurrence of FB1 and FB2 in commercial horse feed
(n = 62). Overall, 94% of the samples were found contaminated, in a range of 2–2,200 lg/kg.
Results for swine feed were reported by Martins et al. (2012), who performed a survey over the
years 2007–2010 (n = 278) with an incidence of contamination < 10% in the concentration range
53–3,815 lg/kg.
Nacher-Mestre et al. (2015) described the possible occurrence of FB1, FB2 and FB3 in feed for
Atlantic salmon and gilthead sea bream. A very low contamination was found in wheat gluten (mean
13.2 lg/kg), while higher levels were reported for corn gluten (range: 11–4,901 lg/kg).
Hidden fumonisins are commonly determined after alkaline hydrolysis of the sample. Dall’Asta et al.
(2012) investigated the occurrence of hidden fumonisins in maize harvested in 2009 and 2010 in Italy.
The total fumonisins detected after hydrolysis and expressed as FB1–3 equivalents, were found to exceed
the free FB1–3 of about 60% in both years. Similar results were conﬁrmed by Giorni et al. (2015).
More comprehensive studies on the accumulation and distribution of hidden fumonisins in maize
and its milling fractions, were reported by Bryła et al. (2014, 2015, 2016, 2017). The authors
conﬁrmed the signiﬁcant occurrence of hidden fumonisins in maize, and pointed out that the both
particle size and starch amount may affect the distribution of hidden fumonisins. Also in these studies,
the hidden fraction was in the range 30–100% compared to the parent compounds, although the
average additional factor was about 59%.
The occurrence of hidden fumonisins was investigated in ensiled maize by Latorre et al. (2015),
indicating that hidden FB1 accounted in average for an additional 64%. The same average additional
factor was reported by Oliveira et al. (2015) by analysing 72 maize samples from Brazil for fumonisins
(the sum of FB1 and FB2) by alkaline hydrolysis.
Oliveira et al. (2015) reported higher concentration values for hidden fumonisins. Overall, after
hydrolysis the total fumonisin content in raw maize (n = 72) was up to 3.8 times higher than before
hydrolysis. Concerning modiﬁed forms of fumonisins, the Panel identiﬁed no occurrence data in feed in
the open literature.
3.2.2. Feed Occurrence data submitted to EFSA
3.2.2.1. Fumonisins
Out of the 18,273 analytical results submitted by Member States, 133 results were excluded from
the present analysis due to the following reasons: duplicates, suspected samples, analytical method
not provided, or outliers (i.e. 2 results > 3,000 mg/kg in compound feed, not conﬁrmed by the
Member State laboratory).
Thus, the ﬁnal data set included 18,140 analytical results from 7,970 samples on fumonisins in feed
collected between 2003 and 2016 from 19 European countries available for the assessment.
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The major contributing countries were the Netherlands (42%), France (18%), Belgium (12%) and
Bulgaria (11%) (Table 10). Occurrence data on FB1 were provided by all countries, FB2 by all but one
countries, whereas data on FB3 were provided by three countries, namely Belgium, the UK and the
Netherlands. It should be noted that the origin of the samples was not always the European country.
Analytical methods
Only occurrence data with information on the analytical method and on LOD/LOQ levels that
fulﬁlled the inclusion criteria for the present analysis were included. The CONTAM Panel considered
only quantitative methods able to return a conﬁrmation of the analyte identiﬁcation and with an
adequate sensitivity (Table 11). MS-based methods (Group 1, 68%) were mostly used.
The data set included 77% of left-censored data (results below the LOD/LOQ), of which 50% below
LOD and 27% between LOD and LOQ. LOQs were reported for 54% of the samples. Samples where
the LOQ value was not reported either referred to a sample with quantiﬁable levels or to a sample with
residues below the LOD. Table B.1 of Appendix B gives the distribution of LOD and LOQ for the
Table 10: Frequency distribution of analytical results of fumonisins in feed per sampling country
(2003–2016)
Country
Abbreviations
Total % of total
FB1 FB2 FB3
Belgium 741 741 674 2,156 12
Bulgaria 970 969 – 1,939 11
Cyprus 20 20 – 40 0
Czech Republic 437 435 – 872 5
Estonia 24 24 – 48 0
Spain 1 1 – 2 0
France 1,596 1,596 – 3,192 18
United Kingdom 95 95 34 224 1
Croatia 37 – – 37 0
Hungary 76 69 – 145 1
Ireland 6 6 – 12 0
Italy 193 170 – 363 2
Lithuania 39 39 – 78 0
Luxembourg 14 14 – 28 0
Netherlands 2,869 2,870 1,958 7,697 42
Norway 44 44 – 88 0
Portugal 415 415 – 830 5
Slovenia 158 159 – 317 2
Slovakia 36 36 – 72 0
Total 7,771 7,703 2,666 18,140 100
FB: fumonisin B.
Table 11: Distribution of analytical results by analytical method
Analytical method group(a) FB1 FB2 FB3 N %
Methods based on mass spectrometry 5,228 5,202 1,969
Methods based on spectroscopic detection 2,491 2,486 697 5,674 31
Gas-chromatographic methods 15 15 – 30 0
ELISA 37 – – 37 0
Total 7,771 7,703 2,666 18,140 100
ELISA: enzyme-linked immunosorbent assay; FB: fumonisin B.
(a): Methods based on mass spectrometry: LC–MS/MS, LC–MS, LC–MS quadrupole, HPLC-ESI-MS. Chromatographic methods
based on spectroscopic detection: HPLC-FD, HPLC-UV, HPLC with standard detection methods, HPLC-CF ?. Gas-
chromatographic methods: GC–MS.
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different feed categories and compound feed. Seven samples with LOQ values above 2,000 lg/kg
were considered outliers and were not included in the data set used for this assessment.
Occurrence data on feed by feed group
Table B.2 of Appendix B gives occurrence levels of the feed samples classiﬁed according to the
catalogue of feed materials described in Commission Regulation 68/2013. Overall, 77% of the results
were below the LOD or LOQ, accounting for 67% for FB1, 80% for FB2 and 96% for FB3. Most of the
analytical results were on ‘cereal grains, their products and by products’ (47%), ‘compound feed’
(23%) and ‘forages and roughages, and products derived thereof’ (16%). The highest number of
reported samples in cereal grains were ‘maize’ (n = 4,655), ‘wheat’ (n = 1,504) and ‘barley’ (n = 687).
Other feed groups that were well represented were ‘complementary/complete feed’ (n = 3,643),
forages and roughage (n = 2,280), sunﬂower seed (n = 438) and toasted soya (beans) (n = 1,199).
High fumonisins concentrations were reported mainly in cereal grains in maize grains (mean LB/UB
ranged from 20 to 2,037.7 lg/kg), wheat (mean LB/UB ranged from 0.4 to 2,482.5 lg/kg) and compound
feed (mean LB/UB ranged from 0.3 to 1,678.1 lg/kg). Fumonisins at lower concentrations were also
found in forages, land animal products, legume seeds, minerals, oil seeds and tubers. Concentration levels
higher than 2,000 lg/kg were reported for compound feed, different types of maize, including maize
gluten feed, maize ﬂakes, and maize bran, and plants by-products from spirits production.
About 15% of the samples of the data set were analysed for all the three fumonisins, whereas
more than 90% of the samples were analysed for both FB1 and FB2. Therefore, in order to estimate
the concentrations of all fumonisins in each feed sample, the following approach was used. For
samples in which the compound was analysed, but not quantiﬁed, the substitution method was used
to estimate the LB and the UB (see Section 2.1). For samples in which any of the compounds were not
analysed, the levels were estimated by using the mean concentration of the closest feed group
available.
3.2.2.2. Hidden fumonisins
The occurrence of hidden fumonisins has been often reported in raw maize and maize-derived
products. Their contribution to the overall occurence is usually obtained through the application of an
alkaline hydrolysis treatment to the sample.
According to the previous studies reported in the literature, hidden fumonisins contribute to the overall
fumonisins occurrence by an additional amount ranging from 40% to 70% of the parent compounds, and
in few cases may reach an additional 100% (See Appendix D). The presence of hidden fumonisins is
dependent on the climate conditions during the growing season, on the maize genotype, and on the
processing (Dall’Asta and Battilani, 2016). All these factors may affect not only the overall occurrence, but
also the ratio between parent and hidden forms. As a general observation, the ratio of modiﬁed fumonisins
is higher when the overall contamination is low, while it is lower in highly contaminated samples (Dall’Asta
and Battilani, 2016). Although this percentage can vary depending on the processing, different factors
cannot be derived for single products, due to the lack of sufﬁcient data from the literature.
In order to evaluate the contribution due to hidden forms in the risk assessment, an additional
factor of 1.6 was derived from calculation based on data provided by three research groups located in
Italy, Poland and Brazil. Occurrence data provided by the groups were obtained over several harvest
years and in different geographical area. From a statistical analysis, the average additional contribution
due to hidden forms to the overall contamination was about 60% in the EU-based area, while in South
America the contribution was higher. Taking into account that EFSA risk assessment is based on
European foods and feeds, and that different agronomic and climate conditions apply in the EU, the
CONTAM Panel considered it appropriate to apply an additional factor of 60% with respect to the
parent compound for an exposure assessment. However, this should be considered as an uncertainty.
The distribution of the mean, median, and P95 LB and UB concentrations of the sum of FB1 + FB2 +
FB3 (with and without 1.6 RPFs applied) in feed materials and species-speciﬁc compound feeds used to
estimate exposures for farmed livestock and companion animals are provided in Appendix B
(Tables B.3 and B.4).
3.2.3. Feed processing
Prior to processing, cereal grains are cleaned which removes broken kernels and those having
mould growth, together with ﬁne materials with particle size < 3 mm. It was demonstrated that this
step can reduce the fumonisin amount from 26% to 69% (Sydenham et al., 1994).
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Dry milling of grain is mainly utilised for feed manufacturing, separating the grain into four distinct
physical components: ﬂour (200–300 lm), medium and ﬁne grits (300–1,000 lm), coarse and ﬂaking
grits (1,000–5,000 lm), other products (i.e. germ, bran, broken grains, meal). The effects of dry
milling on fumonisin distribution in maize fractions have been reported (Brera et al., 2004, 2006;
Bullerman and Bianchini, 2007; Vanara et al., 2009) with consistent results.
Fumonisins occurring in maize kernels are not degradated by the milling process, although they
may undergo redistribution among milling fractions. In particular, levels of fumonisins are slightly
reduced in maize ﬂour and signiﬁcantly lowered in grits (up to 70%) compared to raw materials, while
they are increased in bran and middlings. According to Pietri et al. (2009) FB1 tends to accumulate in
the small particles intended for animal consumption (maize-milling fractions). This observation is in
agreement with the possible fractionation of fumonisins according to particle size fractions (Brera
et al., 2004). Fumonisin concentration is signiﬁcantly reduced by extrusion, although reductions vary
depending on the matrix (whole corn, grits, ﬂour, etc.), formulation and speciﬁc process conditions. In
the absence of added sugar or salt, reported reductions have ranged from 2% to 99% (Humpf and
Voss, 2004; Jackson et al., 2012). Reduction of FB1 in corn grits by extrusion is enhanced by glucose
addition, due to the possible formation of Maillard-type modiﬁed forms such as NDF-FB1 or NCM-FB1
(Bullerman et al., 2008; Jackson et al., 2011). Extrusion cooking resulted in greater apparent loss of
fumonisin B1 (degradation product and/or binding not reported) with mixing screws than with
non-mixing screws (Castelo et al., 1998).
No information has been identiﬁed by the CONTAM Panel on the effects on fumonisin levels of
other stages in the chain for feed production. However, it should be underlined that the addition of
sugar-rich ingredients, such as sugar beet pulp and molasses, may favour the formation of modiﬁed
fumonisins due to Maillard-type reaction between the different forms and reducing sugars.
In food production, several studies have demonstrated that fumonisins are removed from corn
during nixtamalisation by a combination of extraction and conversion to their hydrolysed forms (Voss
et al., 2001; Palencia et al., 2003; Burns et al., 2008). However, the CONTAM Panel is not aware of
these processes being applied to animal feed.
For many livestock, compound feeds represent part or all of the daily ration. One of the ﬁnal stages
in the compound feed manufacturing process is the production of feed pellets, which results in an
increase in temperature of the feed. The extent of the temperature rise will depend on a number of
factors, including the types of ingredients used in the formulation, the amount of moisture added and
the equipment used, but pellets generally leave the die at temperatures ranging between 60°C and
95°C (Thomas et al., 1997). Fumonisin appears to be relatively stable at these temperatures
(Bullerman et al., 2002) and therefore compound feed manufacturing is unlikely to affect
concentrations in the ﬁnished product.
For many ruminant livestock, maize silage is an important component of the daily ration, and
typically represents between 30 and 50% of the daily ration, although it may be fed up to
approximately 80% of the diet, especially to beef cattle. Fumonisin degrading microorganisms have
been isolated from silage (Camilo et al., 2000), but it is not known if this degradation is of any
signiﬁcance in reducing the fumonisin concentrations in maize silage.
3.3. Exposure assessment
3.3.1. Previously reported exposure assessments in animals
In 2005, EFSA published an Opinion on fumonisins as undesirable substances in animal feed (EFSA,
2005).
Subsequently, EFSA published a Scientiﬁc Opinion on the risks for human and animal health related
to the presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM Panel,
2014).
In the 2014 Opinion, the highest level of exposure to fumonisins were for fattening chickens
(broilers) (12.6 and 18.3 lg/kg bw per day for LB and UB, respectively, at the mean level) and for
laying hens (11.1 and 16.1 lg/kg bw per day for LB and UB, respectively, at the mean level). However,
the Opinion also noted exposure by dairy cows could reach similar levels (8.2 and 17.7 lg/kg bw per
day for LB and UB, respectively, at the mean level) when fed maize silage-based diets. The lowest
level of exposure 0.1 and 1.7 lg/kg bw per day for LB and UB, respectively, at the mean level) was
estimated for horses. A more detailed comparison between estimates of exposure in this Scientiﬁc
Opinion and EFSA 2014 (EFSA CONTAM Panel, 2014) is shown in Table 6.
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The CONTAM Panel have not identiﬁed any other previously reported estimates of exposure by
livestock.
3.3.2. Dietary exposure assessment for farm and companion animals
Two scenarios have been considered in estimating exposure for farm and companion animals.
Scenario 1 represents the sum of fumonisins (FB1, FB2, FB3), while Scenario 2 includes the sum of
fumonisin and the hidden forms. Scenario 2 has been achieved by multiplying exposures derived in
Scenario 1 by 1.6. This scenario does not include the modiﬁed forms, for which we have no data
concerning both the occurrence or the toxicity.
For all species, P95 and mean exposures have been estimated based on the 95th percentile and
the mean LB and UB concentrations, respectively. According to EFSA (2010b), caution is needed when
calculating chronic exposure (95th percentile) where data on less than 60 samples are available, since
the results may not be statistically robust. Therefore, in this Opinion, there are no acute exposure
estimations where data on < 60 samples are available. Furthermore, EFSA (2010b) has indicated that
estimates of chronic exposure based on data for < 10 samples are unreliable, and therefore, no data
on less than 10 samples have been provided, these have not been used to estimate the mean LB and
UB exposures.
For many livestock in Europe, feeds are supplied in the form of commercially produced species-
speciﬁc blends or compound feeds, and where these data were available, mean exposures have been
calculated using the concentrations reported and assumed intakes given in Appendix C, Table C.6.
For those livestock categories for which insufﬁcient data on species-speciﬁc compound feeds were
provided, the CONTAM Panel identiﬁed example diets and feed inclusion rates (see Appendix C for
details), and used concentrations of fumonisins in individual feed materials to estimate P95 and mean
exposure.
As reported in Appendix C, a wide range of feeds and feeding systems are used for livestock in
Europe. It must be stressed that the feed intakes or diet compositions used in estimating exposures in
this scientiﬁc opinion are not ‘average’ diets, nor are they an attempt to describe ‘worst-case’
scenarios. Rather, they are intended to provide an indication of likely exposure to fumonisins across a
range of feeding systems in Europe.
For ruminants and horses, forages – fed either fresh or conserved - are essential dietary
ingredients. The data submitted to EFSA conﬁrm the presence of fumonisins in certain forages
(Table C.3). Fresh grass and grass silage are important feeds for ruminants and horses, but since no
information on the level of fumonisins in these feeds was available it has not been possible to estimate
their contribution to the exposure. However, data have been provided to EFSA on levels of fumonisins
and their hidden forms in grass hay, maize silage and cereal straws (see Appendix B), and these have
been used to estimate exposure in those ruminant feeding systems where these are the main forages.
In the tables below, the dietary concentrations are presented on a dry matter basis (as lg/kg
dry matter). However, these estimates have been converted to an as-fed (or fresh weight) basis in
Tables 17 and 18 to bring the data in line with the NOAEL/LOAEL values identiﬁed in this Opinion.
3.3.2.1. Estimated exposure by farm and companion animals (cats and dogs) to
fumonisins, and to the sum of fumonisins and the hidden form
Ruminants and horses
For high yielding dairy cows, fattening beef cattle and horses, sufﬁcient data were available to allow
exposure to be made from species-speciﬁc compound feeds. For these, forages are an important
component of their diets, and therefore exposure has been estimated in which grass hay is the sole
forage. In practice, this probably represents a minority of feeding conditions (except for horses) but
insufﬁcient data were available for the more common forages, e.g. grazed grass or silages (grass,
arable or maize) to permit reliable estimates to be made.
Estimated P95 and mean exposures are given below for ruminants and horses to fumonisins
(Table 12a) and the hidden forms (Table 12b).
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Table 12a: Estimated P95 and mean exposure to the sum of fumonisins (imputed) for ruminants
and horses derived from LB and UB concentrations in species-speciﬁc compound feeds
Animal species LB/UB
Diet
concentration
lg/kg dry matter
Exposure
lg/day
Exposure lg/kg
bw per day
P95 Mean P95 Mean P95 Mean
Estimates derived from LB and UB concentrations in species-speciﬁc compound feeds
Dairy cows: high
yielding
LB 136 53.8 2,815 1,114 4.33 1.71
UB 341 125 7,057 2,579 10.9 3.97
Beef: fattening LB –(a) 66.6 –(a) 639 –(a) 1.60
UB –(a) 124 –(a) 1,188 –(a) 2.97
Horses LB 21.7 21.7 195 196 0.43 0.43
UB 223 203 2,011 1,826 4.47 4.06
Estimates derived from LB and UB concentrations in feed materials and their relative proportions in diets
Dairy cows: maize
silage-based diet
LB 1,783 368 48,875 10,043 74.9 15.5
UB 1,894 507 51,710 13,845 79.6 21.3
Beef cattle: cereal-
based diet
LB 754 172 7,543 1,716 18.9 4.29
UB 964 337 9,639 3366 24.1 8.42
Beef cattle: maize
silage-based diet
LB 597 120 3,939 793 13.1 2.64
UB 674 233 4,452 1,537 14.8 5.12
Beef cattle: straw-
based diet
LB 39.8 14.3 318 114 1.06 0.38
UB 270 210 2,160 1,679 7.20 5.60
Lactating sheep(b) LB 41.6 30.1 116 84.4 1.45 1.05
UB 206 152 579 425 7.23 5.32
Lactating goats(b) LB 20.8 20.9 71.0 71.0 1.18 1.18
UB 187 187 638 638 10.6 10.6
Fattening goats(b) LB 612 25.2 918 37.8 22.9 0.95
UB 716 133 1,074 200 26.8 5.01
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
(a): Insufﬁcient samples available to estimate P95 exposure.
(b): Exposures assume that grass hay is the sole forage.
Table 12b: Estimated P95 and mean exposure to the sum of fumonisins and the hidden forms
Animal species LB/UB
Diet concentration
lg/kg dry matter
Exposure lg/day Exposure lg/kg bw
P95 Mean P95 Mean P95 Mean
Estimates derived from LB and UB concentrations in species-speciﬁc compound feeds
Dairy: high yielding LB 218 86 4,504 1783 6.93 2.74
UB 545 199 11,291 4126 17.37 6.35
Beef: fattening LB –(a) 107 –(a) 1023 –(a) 2.56
UB –(a) 198 –(a) 1901 –(a) 4.75
Horses LB 34.8 34.8 312 313 0.70 0.70
UB 358 325 3,218 2,921 7.15 6.49
Estimates derived from LB and UB concentrations in feed materials and their relative proportions in diets
Dairy cows: maize
silage-based diet
LB 2,853 589 77,879 16,068 120 24.7
UB 3,031 811 82,736 22,153 127 34.1
Beef cattle: cereal-
based diet
LB 1,207 275 12,069 2,746 30.2 6.87
UB 1,542 539 15,422 5,386 38.6 13.5
Beef cattle: maize
silage-based diet
LB 955 192 6,303 1,269 21.0 4.23
UB 1,079 373 7,123 2,459 23.7 8.2
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Pigs and poultry
Estimates of P95 and mean exposures by pigs and poultry to fumonisins, and to the sum of
fumonisins, and the hidden forms are given in Tables 13a and 13b, respectively. For pigs, these were
derived from data for species-speciﬁc compound feeds; for poultry, insufﬁcient data on species-speciﬁc
compound feeds were available, and therefore, exposures have been estimated using example rations
and concentrations in individual feed materials (see Appendix C Table C.1 for details of rations used).
Animal species LB/UB
Diet concentration
lg/kg dry matter
Exposure lg/day Exposure lg/kg bw
P95 Mean P95 Mean P95 Mean
Beef cattle: straw-
based diet
LB 63.6 22.9 509 183 1.70 0.61
UB 432 336 3,456 2,686 11.5 8.95
Lactating sheep(b) LB 66.5 48.2 186 135 2.33 1.69
UB 330 243 926 681 11.6 8.51
Lactating goats(b) LB 33.3 33.4 113 113 1.89 1.89
UB 300 300 1,022 1,020 17.0 17.0
Fattening goats(b) LB 979 40.3 1,469 60.5 36.7 1.51
UB 1,146 213 1,719 320 42.9 8.02
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
(a): Insufﬁcient samples were available to estimate P95 exposure.
(b): Exposures assume that grass hay is the sole forage.
Table 13a: Estimates of P95 and mean exposure to fumonisin for pigs and poultry derived from LB
and UB concentrations
Animal species LB/UB
Diet concentration
lg/kg dry feed
matter
Exposure
lg/day
Exposure
lg/kg bw
per day
P95 Mean P95 Mean P95 Mean
Pigs: Estimates derived from LB and UB concentrations in species-speciﬁc compound feeds
Pigs: starter LB 770 159 770 154 38.5 7.69
UB 943 413 943 413 47.2 20.7
Pigs: growing and
fattening
LB 568 164 1,705 492 17.0 4.92
UB 756 321 2,267 963 22.7 9.63
Lactating sow LB –(a) 23.2 –(a) 139 –(a) 0.70
UB –(a) 70.2 –(a) 421 –(a) 2.11
Poultry: Estimates derived from LB and UB concentrations in feeds and their relative proportions in diets
Fattening chickens(a) LB 1,521 367 182 44.1 91.3 22.1
UB 1,749 575 209 69.0 104 34.5
Laying hens(a) LB 1,394 331 167 39.7 83.6 19.9
UB 1,674 556 201 66.8 100 33.4
Fattening turkeys(a) LB 72.3 58.4 28.9 23.3 2.41 1.95
UB 384 273 154 109 12.8 9.09
Fattening ducks(a) LB 78.8 77.8 11.0 10.9 3.68 3.63
UB 452 310 63.4 43.5 21.1 14.5
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
(a): Insufﬁcient samples were available to estimate P95 exposure.
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Farmed ﬁsh (salmonids, carp), rabbits and mink
In the absence of reliable data on concentrations of fumonisin and their hidden forms in species-
speciﬁc compound feeds, estimates of exposure were made by using example rations and
concentrations in individual feed materials (see Appendix C, Table C.2 for details of rations used) and
are reported in Tables 14a (fumonisins) and 14 (the sum of fumonisins and the hidden forms).
Although NOAEL and NOAEL values have been identiﬁed for catﬁsh and Nile tilapia, insufﬁcient data on
diet composition for these species were available to allow estimates of exposures to be calculated.
Table 13b: Estimates of P95 and mean exposure to fumonisins, and the hidden form for pigs and
poultry derived from LB and UB concentrations
Diet concentration
lg/kg dry feed
matter
Exposure
lg/day
Exposure
lg/kg bw
per day
P95 Mean P95 Mean P95 Mean
Pigs: Estimates derived from LB and UB concentrations in species-speciﬁc compound feeds
Pigs: starter LB 1,232 246 1,232 246 61.6 12.3
UB 1,509 661 1,509 661 75.4 33.1
Pigs: growing and
fattening
LB 909 263 2,727 788 27.3 7.88
UB 1,209 514 3,627 1,541 36.3 15.4
Lactating sow LB –(b) 37.1 –(b) 223 –(b) 1.11
UB –(b) 112 –(b) 674 –(b) 3.37
Poultry: Estimates derived from LB and UB concentrations in feeds and their relative proportions in diets
Fattening chickens(a) LB 2,434 588 292 70.6 146 35.3
UB 2,799 920 336 110 168 55.2
Laying hens(a) LB 2,230 529 267.6 63.5 134 31.8
UB 2,679 890 321 107 161 53.4
Fattening turkeys(a) LB 116 93.3 46.3 37.3 3.86 3.11
UB 615 436 246 174 20.5 14.5
Fattening ducks(a) LB 126 124 17.6 17.4 5.88 5.80
UB 724 497 101 69.6 33.8 23.2
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
(a): Insufﬁcient species-speciﬁc samples were provided to allow reliable estimates of exposure to be made, and therefore
example diets have been used (see Appendix C).
(b): Insufﬁcient samples were available to estimate P95 exposure.
Table 14a: Estimated P95 and mean exposure to fumonisins for rabbits, farmed ﬁsh and mink
derived from LB and UB concentrations in individual feed materials and their relative
proportions in diets
Animal species LB/UB
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure lg/kg
bw per day
P95 Mean P95 Mean P95 Mean
Salmonids LB 976 229 39.0 9.16 19.5 4.58
UB 1,110 310 44.4 12.4 22.2 6.20
Carp LB 421 121 9.26 2.66 9.26 2.66
UB 803 370 17.7 8.15 17.7 8.15
Rabbits LB 19.4 6.89 2.91 1.03 1.45 0.52
UB 296 233 44.4 35.0 22.2 17.5
Mink LB 241 58.3 18.1 4.37 8.73 2.11
UB 260 84.1 19.5 6.31 9.43 3.05
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
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Companion animals (dogs and cats)
Few data on levels of fumonisins and their hidden forms in proprietary feeds for dogs and cats
were available, and therefore exposure was estimated using example rations (see Appendix C for
details) and concentrations of these toxins in individual feed materials. The exposures are reported in
Table 15a and 15b for fumonisins and for the sum of fumonisins and the hidden forms, respectively.
3.3.2.2. Concluding remarks
The mean LB and UB exposures to fumonisins and the hidden forms for all species were 6.8/15.0
lg/kg bw per day, while the LB and UB for the 95th percentile were and 31.0/40.9, respectively.
However, there was considerable variation in the estimated exposure by farmed livestock and
companion animals. The lowest exposure to Fumonisins expressed as lg/kg bw per day, was for horses,
both at the mean (LB = 0.70, UB = 6.49) and 95th percentile (LB = 0.70, UB = 7.15) levels. Overall, the
highest estimated exposure was for poultry, and within this category the highest estimates were for
fattening chickens (broilers), with LB and UB estimates of 35.3/55.2 and 146/168 lg/kg bw per day for
chronic and P95 estimates, respectively. Estimated exposure for laying hens were only marginally lower.
Table 14b: Estimated P95 and mean exposure to fumonisins and the hidden forms for rabbits,
farmed ﬁsh and mink
Animal species LB/UB
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure lg/kg
bw per day
P95 Mean P95 Mean P95 Mean
Salmonids LB 1,562 366 62.5 14.7 31.2 7.33
UB 1,776 496 71.0 19.8 35.5 9.92
Carp LB 673 193 14.8 4.25 14.8 4.25
UB 1,284 592 28.2 13.0 28.2 13.0
Rabbits LB 31.0 11.0 4.65 1.65 2.33 0.83
UB 474 373 71.0 56.0 35.5 28.0
Mink LB 385 93.2 28.9 6.99 14.0 3.38
UB 416 135 31.2 10.1 15.1 4.88
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
Table 15a: Estimated P95 and mean exposure to fumonisins by companion animals (dogs and cats)
Companion
animal
LB-UB
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure lg/kg
bw per day
P95 Mean P95 Mean P95 Mean
Cats LB 1,626 365 97.5 21.9 24.4 5.47
UB 1,765 465 106 27.9 26.5 6.98
Dogs LB 1,501 338 540 122 21.6 4.86
UB 1,634 441 588 159 23.5 6.35
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
Table 15b: Estimated P95 and mean exposure to fumonisins and the hidden forms by companion
animals (dogs and cats)
Companion
animal
LB/UB
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure lg/kg
bw per day
P95 Mean P95 Mean P95 Mean
Cats LB 2,601 583 156 35.0 39.0 8.75
UB 2,824 745 169 44.7 42.4 11.2
Dogs LB 2,402 540 865 194 34.6 7.78
UB 2,614 705 941 254 37.6 10.2
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
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For ruminants, the highest estimated exposure was for dairy cows on maize silage-based diets, and
intensively reared beef cattle on cereal-based diets.
The estimates of exposure for cats and dogs are based on example diets provided by the Pet Food
Manufacturers Association. Although these frequently include cereals and oilseed-based feeds, their
diets – and those of farmed mink – may include products of animal origin. However, no data on levels
of fumonisins in these feed materials of animal origin were available, and therefore no estimates of
exposure from these feeds could have been calculated.
Overall, the differences between the different livestock categories were a reﬂection of the higher
levels of fumonisins in cereals or maize silage and the levels of inclusions of these feeds in their diets.
As discussed above, estimates of exposure were previously published by EFSA (EFSA CONTAM
Panel, 2014). A comparison of these with those estimated in this Opinion is given in Table 16.
Table 16: Comparison of estimates of exposure (lg/kg bw per day) reported in this Scientiﬁc
Opinion and in EFSA CONTAM Panel (2014)
Animal species LB/UB
This Opinion
EFSA CONTAM
Panel (2014)
P95 Mean P95 Mean
Dairy: high yielding LB 4.33 1.71 –(a) 8.2
UB 10.86 3.97 –(a) 17.7
Horses LB 0.43 0.43 –(a) 0.0
UB 4.47 4.06 –(a) 1.0
Beef cattle: cereal-based diet LB 18.9 4.29 –(a) 0.6
UB 24.1 8.42 –(a) 8.2
Lactating sheep LB 1.45 1.05 14.5 2.7
UB 7.23 5.32 16.2 4.0
Lactating goats LB 1.18 1.18 33.3 6.3
UB 10.6 10.6 37.2 9.1
Fattening goats LB 22.9 0.95 15.8 3.0
UB 26.8 5.01 17.7 4.3
Pigs: starter LB 38.5 7.69 17.6 3.7
UB 47.2 20.7 22.5 10.3
Pigs: growing and fattening LB 17.0 4.92 –(a) 7.4
UB 22.7 9.63 –(a) 11.1
Lactating sow LB –(a) 0.71 29.1 4.6
UB –(a) 2.11 32.1 11.9
Fattening chickens(a) LB 91.3 22.1 67 12.6
UB 104 34.5 74.6 18.3
Laying hens(a) LB 83.6 19.9 58.9 11.1
UB 100 33.4 65.6 16.1
Fattening turkeys(a) LB 2.41 1.95 32.7 6.2
UB 12.8 9.09 36.4 8.9
Fattening ducks(a) LB 3.68 3.63 50.7 9.5
UB 21.1 14.5 56.5 13.9
Rabbits LB 1.45 0.52 40.7 7.7
UB 22.2 17.5 45.4 11.2
Cats LB 24.4 5.47 12.4 2.3
UB 26.5 6.98 13.9 3.4
Dogs LB 21.6 4.86 14.1 2.7
UB 23.5 6.35 15.7 3.9
bw: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound.
(a): Insufﬁcient samples were available to estimate P95 exposure.
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The CONTAM Panel noted the differences between the two assessments. In general, exposure
estimates by EFSA CONTAM Panel (2014) were higher than for this Opinion (based on mean LB and UB
levels for all species, at both the mean and P95 levels). There were no consistent differences between
the two studies, although marked differences for individual species were observed at both LB and UB
levels. However, a comparison of the database used in these two studies reveals large differences; in
particular, the 2014 assessment was based on fewer feed samples, while in that database the
differences between the LB and UB values were larger, particularly for the 95th percentile data.
3.4. Risk characterisation
There is limited knowledge on the effects of Fumonisins and their modiﬁed and hidden forms on
farm and companion animals. Furthermore, there is no comprehensive database on feed consumption
by livestock in the EU. It has therefore not been possible to fully assess the risks of FBs and its modiﬁed
and hidden forms for farm and companion animal health. Risk characterisation of the modiﬁed forms of
FBs was not performed as no data concerning their occurence and toxicity was available.
However, for a number of farm livestock and companion animal categories the chronic exposure of
fumonisins (expressed as the sum of FB1, FB2 and FB3) in feed could be estimated at the mean and
95th percentile concentrations in animal diets based on expected feed intakes and example diets.
Exposure to the sum of fumonisins and hidden forms was calculated by applying a 1.6 multiplying
factor as described in Section 3.2.2.2. These exposures to fumonisin and to the sum of fumonisin and
their hidden forms have been compared with identiﬁed reference points (NOAELs and LOAELs,
expressed as mg/kg feed) in farm and companion animals. The identiﬁed NOAELs or LOAELs for cattle,
pigs, poultry, ﬁsh, rabbit and horses were used for risk characterisation. For cats, dogs and mink the
health risk from the exposure to FBs could not be assessed as no NOAELs or LOAELs have been
identiﬁed. For sheep and goats, a very limited data set indicate a sensitivity similar to cattle.
In Tables 17 and 18, exposure estimates (UB mean and 95th percentile) are presented together
with NOAELs/LOAELs for the different farm and companion animal species. Exposure is expressed as a
percentage of the NOAEL in the right-hand columns. When a NOAEL is lacking, the LOAEL is used
instead but provides a less conservative basis for comparison with exposure. The estimates of
exposure to FBs and the sum of FBs and their hidden forms are presented in Section 3.3.
For FBs alone, for cattle the highest calculated chronic exposure was used (Table 17), with the UB
mean and UB 95th percentile being 0.35% and 5.01% of the identiﬁed NOAEL, respectively. This
NOAEL was based on lymphocytes blastogenesis and biochemical alterations. The Panel concluded that
the risk of adverse health effects of feed containing FBs was very low for cattle.
Table 17: Comparison of estimated FBs exposure levels and NOAELs/LOAELs for different farm and
companion animal species
Animal species
NOAEL
(mg FBs/kg feed)
LOAEL
(mg FBs/kg feed)
Estimated exposure
(mg FBs/kg feed)(a)
Estimated exposure,
% of NOAEL or LOAEL
P95 (UB) Mean (UB) P95 (UB) Mean (UB)
Cattle(b) 31 – 1.57 0.11 5.01 0.35
Pig 1 5 0.83 0.36 83.0 36.3
Chicken 20 40 1.54 0.51 7.70 2.53
Turkeys(c) 20 – 0.34 0.24 1.69 1.20
Ducks(c) 8 32 0.40 0.27 4.98 3.41
Horses 8.8 44 0.20 0.18 2.23 2.03
Rabbit – 5 0.26 0.20 5.20 4.10
Fish (carp) – 10 0.71 0.33 7.07 3.26
bw: body weight; FB: fumonisin B; NOAEL: no-observed-adverse-effect level; LOAEL: lowest-observed-adverse-effect level;
UB: upper bound; –: not available.
(a): Exposures have been calculated from dietary concentrations expressed on a fresh weight (88% dry matter) basis to make
them comparable with the data from which NOAELs/LOAELs have been derived.
(b): For both the mean and P95 exposure, the highest exposure values were used. For the mean it corresponds to species
speciﬁc compound feed and for the P95 to a maize silage-based diet.
(c): The exposures for turkeys and ducks were calculated for fattening animals. whereas the LOAELs and NOAELs were obtained
from younger birds.
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Sheep and goats are also considered resistant to fumonisins and thus the risk was also considered
as very low.
For poultry, (chickens, fattening turkeys and ducks), the estimated exposures of FBs at the UB mean
or the 95th percentile ranged from 1.2% to 7.7% of the NOAELs. The NOAELs were based on liver lipid
and biochemical alterations for chickens, on zootechnical performances and organ lesions for fattening
turkeys and on serum biochemistry indicative of liver damage for fattening ducks. The Panel concluded
that the estimated risk for chronic adverse health effects from feed containing FBs was low for poultry.
For horses, the calculated chronic exposures at the UB mean and UB 95th percentile were 2.03
and 2.23% of the identiﬁed NOAEL, respectively. This NOAEL was based on neurological abnormalities
and cardiovascular effects. The Panel concluded that the estimated risk for chronic adverse health
effects from feed containing FBs was low for horses.
For pigs, the estimated exposures of FBs at the UB mean and 95th percentile were 36.3% and
83.0%, respectively, of the NOAEL. This NOAEL was based on lung alteration. The Panel concluded
that the estimated risk for chronic adverse health effects from feed containing FBs was low for pigs
exposed to mean levels but of potential concern for animals exposed to the 95th percentile.
For rabbits, only a LOAEL was available. The estimated exposures of FBs at the UB mean and 95th
percentile were 4.1% and 5.2%, respectively, of the LOAEL. This LOAEL was based on decreased
zootechnical performances and alteration of blood haematology and biochemistry. The Panel concluded
that the estimated risk for chronic adverse health effects from feed containing FBs was low for rabbit.
For ﬁsh, LOAEL were available for carp, channel catﬁsh and Nile tilapia, however exposure was
only available for salmonid and carp, and therefore carp were used for risk characterisation. The
estimated chronic exposures of carp to FBs at the UB mean and 95th percentile were 3.3% and 7.1%
of the LOAEL, respectively. This LOAEL was based on reduced weight gain and neuronal apoptosis in
the brain. The Panel concluded that the estimated risk for chronic adverse health effects from feed
containing FBs was low for ﬁsh.
Risk characterisation for FBs and their hidden forms (Table 18) was based on UB exposure. The
estimated exposures were compared with the NOAELs/LOAELs identiﬁed for FBs, as hidden forms can
be disrupted leading to FBs.
For FB1–3 and their hidden forms, for cattle the highest calculated mean exposure was used, with
the UB mean and UB 95th percentile were 0.56% and 8.1% of the identiﬁed NOAEL, respectively. The
Panel concluded that the risk of adverse health effects of feed containing FBs and hidden forms was
very low for cattle.
Sheep and goats are also considered resistant to fumonisins and thus the risk was also considered
as very low.
Table 18: Comparison of estimated FBs + hidden forms exposure levels and NOAELs/LOAELs for
different farm and companion animal species
Animal
species
NOAEL
(mg toxins/kg
feed)
LOAEL
(mg toxin/kg
feed)
Estimated exposure
(mg toxin/kg feed)(a)
Estimated exposure,
% of NOAEL or LOAEL
P95 (UB) Mean (UB) P95 (UB) Mean (UB)
Cattle(b) 31 – 2.51 0.17 8.10 0.56
Pig 1 5 1.33 0.58 132.7 58.2
Chicken 20 40 2.46 0.81 12.3 4.01
Turkeys(c) 20 0.54 0.38 2.71 1.92
Ducks(c) 8 32 0.64 0.44 7.96 5.46
Horses 8.8 44 0.31 0.29 3.58 3.25
Rabbit – 5 0.42 0.33 8.34 6.56
Fish (carp) – 10 1.13 0.52 11.3 5.21
bw: body weight; FB: fumonisin B; NOAEL: no–observed-adverse-effect level; LOAEL: lowest-observed-adverse-effect level;
UB: upper bound; –: not available.
(a): Exposures have been calculated from dietary concentrations expressed on a fresh weight (88% dry matter) basis to make
them comparable with the data from which NOAELs/LOAELs have been derived.
(b): For both the mean and P95 exposure, the highest exposure values were used. For the mean it corresponds to species
speciﬁc compound feed and for the P95 to a maize silage-based diet.
(c): The exposures for turkeys and ducks were calculated for fattening animals. whereas the LOAELs and NOAELs were
obtained from younger birds.
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For poultry (chickens, fattening turkeys and ducks), the estimated exposures to FBs and their
hidden forms at the UB mean or the 95th percentile ranged between 1.9% and 12.3% of the NOAELs.
The Panel concluded that the estimated risk for chronic adverse health effects from feed containing
FBs and hidden forms was low for poultry.
For horses the calculated chronic exposures at the UB mean and UB 95th percentile were 3.3%
and 3.9% of the identiﬁed NOAEL, respectively. The Panel concluded that the estimated risk for
chronic adverse health effects from feed containing FBs and their hidden forms was low for horses.
For pig, the estimated exposures of FBs at the UB mean and the 95th percentile were 58% and
133%, respectively, of the NOAEL. The Panel concluded that the estimated risk for chronic adverse
health effects from feed containing FBs and their hidden forms was low for starter pigs exposed to
mean levels but of concern for animals exposed to the 95th percentile.
For rabbits, only a LOAEL was available. The estimated exposures of FBs and hidden forms at the
UB mean and 95th percentile were 6.6% and 8.3%, respectively, of the LOAEL. The Panel concluded
that the estimated risk for chronic adverse health effects from feed containing FBs and hidden forms
was low for rabbit.
For ﬁsh, LOAEL were available for carp, channel catﬁsh and Nile tilapia; however exposure was only
available for salmonid and carp, and therefore carp were used for risk characterisation. The estimated
chronic exposures of carp to FBs and their hidden forms at the UB mean and 95th percentile were 5.2%
and 11% of the LOAEL, respectively. The Panel concluded that the estimated risk for chronic adverse
health effects from feed containing FBs and their hidden forms was low for ﬁsh.
3.5. Uncertainty analysis
Sections 3.5.1–3.5.3 present in more detail the uncertainties affecting different parts of the risk
assessment. It includes a qualitative assessment of whether each source of uncertainty leads to over/
underestimation of the resulting risk. Table 19 lists the main sources of uncertainty identiﬁed by the Panel.
3.5.1. Uncertainty associated with analytical chemistry
• Fumonisins exhibit a strong interaction with matrix macroconstituents. Therefore, a matrix-
dependent recovery has been often reported. Extraction yield is affected by the matrix
composition and by the extraction parameters. Slight changes in the extraction protocol may
lead to relevant changes in the ﬁnal outcome.
• The determination of hidden forms through alkaline hydrolysis may likely include not only the
release of non-covalently bound fumonisins from the matrix, but also to the cleavage of
modiﬁed forms. Therefore, the occurrence of hidden fumonisins may lead to an
overestimation.
3.5.2. Uncertainty associated with occurrence and exposure
The CONTAM Panel considered it important to estimate the occurrence and the animal exposure to
the total concentration of fumonisins for which data were available (i.e. FB1, FB2, FB3) through feed.
However, estimating the occurrence and exposure with high number of left censored data leads to a
high uncertainty.
An additional factor of 1.6 was applied to the occurrence data, taking into account the possible
occurrence of hidden forms. This factor was derived from the literature, considering data obtained for
maize. However, in this opinion, the 1.6 factor was applied to all feed categories. Although maize is the
main contributor in animal diet, this can lead to an overestimation.
Occurrence
The amount of occurrence data submitted differs considerably depending on feed category and
reporting data provider, with most of the samples (~ 70%) collected in only three Member States,
mostly from northern Europe, and ~ 40% originating from one single Member State. There is therefore
uncertainty on whether possible country-based differences in the levels of fumonisins in diverse feed
commodities are well represented. More than 85% of the data available were on FB1 and FB2, whereas
only 15% were on FB3.
Another uncertainty regarding the occurrence data refers to the high number of left censored data
(about 80%). Estimating the occurrence and exposure with a high number of left censored data can
lead to an underestimation of the LB and an overestimation of the UB. Moreover, the total
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concentration of fumonisins was calculated by summing up the analytical concentrations of FB1, FB2,
FB3 for each sample. This information was available for a small proportion of the analytical samples.
Thus, the levels were estimated by using the mean concentration of the closest feed group available
and therefore adding additional uncertainty.
Fumonisin occurrence is strongly related to climatic conditions, geographical area, and maize genotype.
All these factors may affect not only the overall occurrence, but also the ratio between parent and hidden
forms. Due to the lack of appropriate models, this should be considered as a factor of uncertainty.
The Panel noted that the occurrence data in the EFSA database, used in the exposure assessment,
were mainly from Northern Europe, where occurrence is generally lower than southern Europe. This
could lead to a potential underestimation of exposure.
Exposure
• In estimating exposure to fumonisins various assumptions have been made, particularly in
respect of the types and amounts of feed consumed by livestock and companion animals, and
this will contribute to the uncertainty associated with the estimates of exposure. The main
areas of uncertainty/concern relate to the extent to which the feeds reported are
representative of feeds used for livestock and companion animals in the EU, the composition of
the diets assumed for each of the livestock species/companion animals, and the estimates of
feed consumed (possible over/underestimation).
• Horses appear to be particularly susceptible to fumonisins. Although data on complementary
feeds for horses were available, the lack of data on forages meant that a reliable estimate of
exposure could not be made (possible underestimation).
Feed composition
• Representativeness of feeds analysed: As described above, there is a wide discrepancy in the
geographical spread of samples reported (possible over/underestimation).
• Feed data – concentrate feeds: There were limited or no data available on some key
ingredients, e.g. oilseed meals. The formulations therefore assume no exposure from these
feeds (possible underestimation). Fumonisins occur mainly in maize (corn) and wheat and for
these feeds there were sufﬁcient sample with which to assess exposure, but there was a lack
of data on the by-products of these feeds (possible underestimation).
• Feed data – forages: For ruminants and horses, forages are a major constituent of their diets.
Although data on 888 samples of forages were reported in the category “Forages and
roughages”, these were not sufﬁciently characterised (e.g. as fresh, ensiled or dried grass,
maize silage or legumes) to allow them to be used to assess exposure. However, levels of
fumonisins this general category were higher than in the categories maize silage, grass hay
and cereal straw that were used to estimate exposure (possible underestimation).
• Diet formulations: Single diet formulations have been assumed for each species, although
there are large differences in feeding systems and diet formulations for livestock and
companion animals in the EU (possible over/underestimation).
Feed intakes
• A single level of feed intake has been assumed for each livestock species/companion animal,
but in practice this will vary for a given live weight or level of activity/productivity (possible
over/underestimation).
• Single levels of production or activity have been assumed, but these can vary markedly resulting
in greater or lesser amounts of feed required or consumed (possible over/under estimation).
3.5.3. Uncertainty on the studies used for evaluation of the adverse effect in
farm and companion animals
• No toxicological data are available for farmed mink, cats and dogs; for other animals, such as
goats and sheep, the toxicological data were too limited to allow the establishment of
reference point for FBs
• There is scant information about the FBs adverse effects in ruminants and ﬁsh
• For ﬁsh, there is no data for salmonids which is the main aquaculture species in Europe. The
only toxicological data were obtained for carp, Nile tilapia and channel catﬁsh
• No studies involving the oral administration are available for horses
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• No data were available on the effect of sex and age on the toxicity of FBs. For all the animal
species taken into consideration, no data were available on the possible difference of the
different breeds. This contributed to the overall uncertainty.
• The factor of 1.6 in order to include occurrence of hidden forms might not be appropriate for
all species, the enteric hydrolysis being possibly subjected to interspecies variation
• Concerning the modiﬁed forms of FBs, the toxicological data were either lacking or very
limited. For the different animal species, it was not possible to identify any reference point for
any modiﬁed form of FBs.
• For most animal species, the key studies were performed with naturally contaminated maize
for which the level of FB3 and other mycotoxin was not reported.
3.5.4. Summary of uncertainties
In Table 19, a summary of the uncertainty evaluation is presented, highlighting the main sources of
uncertainty and indicating an estimate of whether the source of uncertainty leads to over/
underestimation of the resulting risk.
The CONTAM Panel noted that the FBs modiﬁed forms were not considered due to very limited
occurrence and toxicity data.
The impact of the uncertainties in the risk assessment of farm and companion animals is large.
4. Conclusions
Fumonisins are mycotoxins produced predominantly by F. verticillioides and F. proliferatum.
In terms of chemical structure, fumonisins are long-chain aminopolyols with two TCA side chains.
The most relevant compounds are the B-type fumonisins FB1–3 which differ in the number and position
of hydroxy-groups at the backbone. The most relevant modiﬁed forms are HFBs and pHFBs.
Fumonisins may react during food processing, giving rise to the formation of Maillard-type modiﬁed
forms, such as NCM-FBs and NDF-FBs.
Table 19: Summary of the qualitative evaluation of the impact of uncertainties on the assessment
Sources of uncertainty Direction(a)
Extraction yield is affected by the matrix composition and by the extraction parameters. Small
changes may have strong effects

Use of alkaline hydrolysis for hidden fumonisins determination +
Extrapolation of the occurrence data mainly from Northern Europe to the whole of Europe 
No occurrence data for modiﬁed forms in EFSA database 
The number of samples were not equally distributed across all feed groups +/
Large proportion of left censored data in the ﬁnal data set +/
Using the substitution method at the lower bound (LB) 
Using the substitution method at the upper bound (UB) +
Imputation of missing results for the calculation of the sum of fumonisins +/
Application of 1.6 factor derived from maize to all feed components +
Applicability of the 1.6 to account for hidden forms to different animal species with different
metabolism
+/
No toxicological/no robust data for some animal species +/
Toxicity data with naturally contaminated material (usually containing other mycotoxins) +/
No data on salmonid, extrapolation from other ﬁsh species +/
No data on differences between ages, sexes and breed +/
The number of samples were not equally distributed across all feed groups +/
Effect of variation between countries, between sampling methods and over time, and
uncertainty about moisture content, on extrapolation from occurrence data to 95th percentile
for the EU
+/
High variability of feedstuffs used and feeding systems for livestock +/
Example animal diets used to calculate animal exposure +/
(a): + = uncertainty with potential to cause overestimation of exposure/risk;  = uncertainty with potential to cause under-
estimation of exposure/risk, +/ = extent of potential over/underestimation might differ in direction.
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Due to the chemical structure, fumonisins may strongly interact through non covalent binding with
the matrix macroconstituents, giving rise to the so-called hidden fumonisins. Hidden forms may be
disrupted released upon digestion, contributing to the total amount of leading to the release of the
unchanged parent forms of fumonisins in the gastrointestinal tract.
Methods of analysis
Analytical methods for FB1–3 are well established and are mainly based on MS. Modiﬁed forms of
FB1 are commonly analysed under the same conditions as their parent compound. However, the strong
physical interaction of fumonisins with the feed matrix, which is well documented in the literature, may
signiﬁcantly affect the analytical performance in a matrix-related way. For the determination of hidden
fumonisins, the food/feed matrix is usually treated under alkaline conditions prior to the analysis.
Only FB1–3 are available on the market as calibrant solutions. Except for HFB1, analytical standards
for modiﬁed forms are not commercially available.
Hazard identiﬁcation and characterisation
Toxicokinetics in farm and companion animals
Fumonisins
• There is poor information on FB1–3 ADME in farm animal species and the available studies are
almost limited to FB1.
• In orally exposed animals, FB1–3 are in general poorly bioavailable, rapidly distributed mainly to
liver and kidney, extensively biotransformed and rapidly excreted mostly via the faecal route.
• Hydrolytic biotransformations largely prevail; the main metabolites are pHFB1 and HFB1; both
may be found in limited amounts in tissues.
• Unlike in rats, no further metabolites (e.g. N-acyl derivatives of FB1 and its hydrolysed forms)
have been isolated in farm and companion animals.
• A very limited excretion of fumonisins in milk and a negligible excretion in eggs have been
documented.
• No information on FB1–3 kinetics could be identiﬁed for farmed rabbits, ﬁsh, horses, farmed
mink, dogs and cats.
Ruminants
• The scant information available indicates poor oral bioavailability and an extensive
biotransformation to the hydrolysed pHFB1 and HFB1.
• Hydrolytic biotransformations appear not to occur in rumen or liver.
• Milk excretion has been investigated and documented in cows only.
Pigs
• In pigs, FB1–3 are poorly bioavailable but extensively hydrolysed to pHFB1 and HFB1 in the
enteric tract. The bioavailability of FB2 is likely to be much lower than that of FB1.
• Measurable amounts of the toxin and of both hydrolysed metabolites are present in liver and
kidneys up to several days after treatment cessation.
• The faecal excretion largely outweighs the urinary one; the extent of biliary excretion might
vary according to the dose and the duration of the exposure.
Poultry
• There is very limited knowledge on FB kinetics in avian species, with no information on FB1
biotransformations.
• Oral bioavailability is poor and in the order turkey>duck>chicken.
• Kinetic studies point to a more rapid elimination in ducks and chickens than in turkeys.
• In birds fed with feed at, or approaching the EU recommended guidance level, residues were
detected only in liver.
• The kinetics of FB2 in ducks and turkeys is similar to that of FB1, with evidence of a lower
bioavailability.
Mode of action
• FBs are structural analogues of sphingoid bases and they inhibit ceramide synthase. This
induces a disruption of sphingolipid metabolism and pathological changes.
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• Even if the disruption of the sphingolipid metabolism at an early stage is closely related with
fumonisin toxicity, there is no evidence that fumonisin-induced ceramide synthase inhibition is
in itself an adverse effect. Therefore, reference points for fumonisins have been derived using
endpoints other than the sole alteration of sphingolipid ratio in serum or organs.
• The implication of the disruption of sphingolipid metabolism in some of the observed critical
adverse effects still remains to be established.
• At the cellular level FB1, FB2 and FB3 have the same mode of action and are considered as
having similar toxicological proﬁles and potencies.
Adverse effects in farm and companion animals
Ruminants
• Based on a limited data set, ruminants are considered less sensitive than horses and pigs.
• Gross and histopathological lesions, as well as changes in serum enzymes and biochemistry
indicate an impairment of liver and possibly kidney function
• A NOAEL (31 mg FB1–3/kg feed) was identiﬁed only for cattle based on the increase in serum
enzymes, cholesterol and bilirubin as well as the decrease in lymphocyte blastogenesis.
• Sheep and goats would not seem to be more susceptible to fumonisins than cattle.
Pigs
• Porcine pulmonary oedema syndrome is the speciﬁc effect produced by FB in pigs and
cardiovascular toxic effects of FBs could play a role in the development of this abnormality.
• Increased Sa/So ratio in serum and tissues, liver and kidney toxicity, delay in sexual maturity
and reproductive functionality alterations, impairment of innate and acquired immune
response, histological lesions in internal organs as well as alterations of brain physiology was
reported in many studies.
• A NOAEL of 1 mg FB1/kg feed and a LOAEL of 5 mg/kg feed based on lung lesions after 8
weeks feeding of FB1 were identiﬁed.
Poultry
• Fumonisins affect the liver, feed intake and the immune system in poultry species. A decreased
feed intake and body weight gain were reported from feeding studies with ducks and Japanese
quail, but not from studies with chickens and turkeys.
• Increased Sa and Sa/So levels in both tissues and serum have also been reported from low
feed concentrations in investigated poultry species.
• A NOAEL of 8 mg/kg feed based on alterations of liver enzymes indicative of liver toxicity was
identiﬁed for ducks.
• A NOAEL of 20 mg/kg feed was identiﬁed for chickens on the basis of an increase in liver
lipids. This was considered as an adverse effect taking the observed liver toxicity in all
investigated species into consideration.
• A NOAEL of 20 mg/kg feed was also identiﬁed for turkeys, the highest dose tested.
Horses
• A NOAEL of 0.2 mg FB1/kg bw per day, recalculated from an i.v study, (corresponding to 8.8
mg FB1 kg/feed) was estimated for horses, based on neurological and cardiovascular effects.
This NOAEL was supported by ﬁeld studies.
Rabbit
• Decreased performance, alterations in serum biochemistry and blood composition, liver and
kidney congestion, impaired spermatogenesis and delay of the onset of puberty, as well as
increased Sa level and the Sa/So ratio in urine, serum and liver were associated with the
exposure to FBs.
• A LOAEL of 5 mg FB1/kg feed was identiﬁed based on alterations in liver.
Fish
• There is limited information available from feeding studies with ﬁsh. There is no information
available on the effects of fumonisins on salmonids.
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• Observed effects of fumonisins in ﬁsh species includes pathological damages in several organs,
reduced body weight gain and haematological and immunological alterations.
• A NOAEL of 10 mg FB1/kg feed was identiﬁed for Nile tilapia based on reduced weight gain.
• A LOAEL of 10 mg FB1/kg feed was identiﬁed for carp, based on pathological alterations,
alterations of haematological parameters and reduced body weight gain.
• A NOAEL of 20 mg FB1/kg feed was identiﬁed for catﬁsh. This was based on reduced body
weight gain and microscopic liver lesions.
Companion animals
• No data could be identiﬁed concerning the effects of FBs in cats and dogs.
Farmed mink
• No data could be identiﬁed concerning the effects of FBs in farmed mink.
Adverse effects and identiﬁcation of reference points for risk characterisation in farm and
companion animals for modiﬁed forms of fumonisins
• No data were available to set up reference points for any modiﬁed form of fumonisins.
Occurrence and exposure
• The dietary exposure was estimated using a ﬁnal data set of 18,140 feed samples on
fumonisins (i.e. FB1, FB2 and FB3) representing most of the feed commodities with potential
presence of fumonisins.
• Samples were collected between 2003 and 2016 in 19 different European countries, but most
of them from four Member States.
• The total concentration of FBs was estimated by summing available concentrations for each
sample. For samples for which no concentration was available, the levels were imputed by
using the mean concentration of available data.
• The percentage of left-censored data reported (results below limit of detection and/or limit of
quantiﬁcation) was high (~ 80%). The highest number of reported analytical results
corresponded to the feed group ‘Cereal grains’ (~ 47%) and in particular to maize, wheat and
barley. Other represented feed groups included forages, animal products, legume seeds,
minerals, oil seeds, and tubers.
• High quantiﬁed values were reported for maize, wheat and compound feed. The compound
feeds with highest levels were for unspeciﬁed species and were therefore not used for the
exposure assessment.
• The animal exposure was presented as dietary concentrations because the animal risk
assessment was carried out on a feed concentration basis.
• Exposure to FBs and the hidden forms is primarily from the consumption of maize (corn), and
its by-products. Except for forage maize, and maize silage produced from it, levels on forages
are generally low.
• The highest estimated dietary concentrations to FBs by cattle was for lactating dairy cows on a
maize silage-based diet (mean LB = 368 and 95th percentile UB = 1,894 lg/kg feed),
reﬂecting both the high levels of FBs in forage maize and the inclusion of cereal grains in the
complementary compound feeds.
• For other cattle, the lowest overall dietary concentration was for beef cattle on a straw-based
ration (LB mean = 14, UB P95 = 270 lg/kg feed).
• For sheep and goats, the calculated lowest LB to highest UB mean dietary concentrations of
FBs were 25 and 187 lg/kg feed, respectively, while at the 95th percentile the range was from
42 (LB) to 716 (UB) lg/kg feed.
• For horses, the calculated mean LB and UB diet concentrations of FBs were 22 and 203 lg/kg
feed, respectively, while for the 95th percentile the range (LB to UB) was 22 to 223 lg/kg
feed.
• The calculated mean LB and UB exposures to FBs by pigs, derived from data for species-
speciﬁc compound feeds, ranged from 23 to 417 lg/kg feed, respectively, while the 95th
percentile exposures ranged from 568 (LB) to 943 (UB) lg/kg feed.
• For poultry, the calculated mean exposure ranged from 58 (LB) to 575 (UB) lg/kg feed, based
on levels in individual feeds and their inclusion in diets. The equivalent range for the 95th
percentile estimates of exposure was 72 and 1,749 lg/kg feed, respectively.
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• For farmed salmonids and carp, the calculated mean LB and UB for dietary concentrations
ranged from 121 to 370 lg/kg feed, respectively. At the 95th percentile, LB and UB estimates
dietary concentrations ranged from 421 (LB) to 1,110 (UB) lg/kg feed.
• The calculated mean diet concentration for farmed rabbits ranged from 7.0 (LB) to 233 (UB)
lg/kg DM, while the equivalent range for the 95th percentile was from 20 to 296 lg/kg DM.
• The mean calculated diet concentration for farmed mink ranged from 58 (LB) to 84 (UB) lg/kg
DM, while the equivalent range for the 95th percentile was 241 and 260 lg/kg DM.
• For companion animals (cats and dogs), the calculated LB and UB mean diet concentrations of
FBs were 365 and 465 lg/kg DM, respectively while at the 95th percentile the range was from
1,501 (LB) to 1,765 (UB) lg/kg feed.
• Fumonisins hidden forms are assumed to be 60% of the dietary concentrations for FBs. The
sum of FBs plus the hidden forms may be calculated by multiplying the values given above (for
FBs) by 1.6.
Farm and companion animal health risk characterisation
• The risk characterisation of exposure to fumonisins is evaluated taking into consideration the
comparison between the exposure of the sum of FB1, FB2 and FB3, and the identiﬁed NOAELs/
LOAELs for chronic adverse effects.
• The risk characterisation of exposure to FBs and their hidden forms is evaluated based on the
comparison between the exposure of FBs and their hidden forms (exposure to FBs multiplied
by a factor of 1.6), and the identiﬁed NOAELs/LOAELs for chronic adverse effects of FBs.
• For dogs, cats and mink, the health risk from the exposure to FBs and to FBs and their hidden
forms could not be assessed as no NOAEL or LOAEL have been identiﬁed.
• For cattle, the risk of adverse health effect of feed containing FBs was considered very low. It
is expected that sheep and goat have similar sensitivity to FBs as cattle and the risk was
considered very low also for those species.
• For poultry, horse, rabbits and ﬁsh, the risk of adverse health effect of feed containing FBs was
considered low.
• For pigs, the risk of adverse health effect of feed containing FBs was considered low for pigs
exposed to mean levels but of potential concern for animals exposed to the 95th percentile.
• The same conclusions apply to the sum of FBs and their hidden forms except for pigs for
which the risk of adverse health effect of feed containing FBs was considered low for pigs
exposed to mean levels and of concern for animals exposed to the 95th percentile.
5. Recommendations
• More studies are needed to reach a consensus method for the analytical determination of
hidden fumonisins under routine conditions.
• Occurrence data using analytical methods with lower LOQs are needed.
• More information on occurrence of FB2–3 and modiﬁed forms in feed are needed.
• More data on the occurrence of hidden forms of FBs are needed in order to reﬁne the
exposure estimates.
• More information is needed on ADME of FBs and their modiﬁed forms especially for horses,
farmed rabbits, farmed mink, ﬁsh and companion animals.
• More information on the adverse effects of FBs in farm and companion animals are needed
especially for horse, salmonids, cats and dogs.
• Studies on the adverse effects of modiﬁed forms of FBs, especially hydrolysed and N-acyl
derivatives, are needed in all farm and companion animals.
Documentation provided to EFSA
Data on fumonisins occurrence (speciﬁcally to evaluate the impact of the hidden fumonisins in the
total fumonisins) used for the modelling in Appendix D were submitted to EFSA by:
• Bryła, M (Department of Food Analysis Prof. Waclaw Dabrowski Institute of Agricultural,
Warsaw, Poland) on 17 July 2017.
• Mallmann, CA (Universidade Federal de Santa Myaria, Laboratorio de Analises Micotoxicologicas –
LAMIC Santa Maria, Brasil) on 11 October 2017.
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• Dall’Asta, C (Dipartimento di Scienze degli Alimenti e del Farmaco, Universita degli studi di
Parma, Italy) on 1 February 2018.
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AUC area under the curve
BALF bronchoalveolar lavage ﬂuid
BUN blood urea nitrogen
bw body weight
Ca calcium
CerS ceramide synthases
CI conﬁdence interval
Chol total cholesterol
CONTAM EFSA Panel on Contaminants in the Food Chain
CYP cytochrome P450
DATA Unit EFSA Evidence Management Unit
DM dry matter
DON deoxynivalenol
DWG daily weight gain
ELEM equine leucoencephalomalacia
ELISA enzyme-linked immunosorbent assay
ESI electrospray ionisation
ETEC enterotoxigenic E. coli
FA fatty acid
FAO/WHO Food and Agriculture Organization of the United Nations/World Health Organization
FBs fumonisins of the B type
FCR feed conversion ratio
FEDIAF European Pet Food Industry Federation
FSA Food Standards Agency
FWC Framework Contract
GC gas chromatography
GGT gamma-glutamyl transferase
GI gastrointestinal
GIT gastrointestinal tract
GM geometric mean
GOT glutamic-oxaloacetic transaminase
GST glutathione S-transferase
Hb haemoglobin concentration
HBGV health-based guidance value
HFB hydrolysed fumonisin B
HPLC high-performance liquid chromatography
HPLC-FLD high-performance liquid chromatography coupled with ﬂuorescence detection
HRMS high-resolution mass spectrometry
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IARC International Agency for Research on Cancer
IFN interferon
Ig immunoglobulin
IL interleukin
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IUPAC International Union of Pure and Applied Chemistry
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JECFA Joint FAO/WHO Committee on Food Additives
LB lower bound
LC liquid chromatography/left-censored
LC–MS/MS LC coupled to tandem mass spectrometry
LDH lactate dehydrogenase
LOAEL lowest-observed-adverse-effect level
LOEL lowest-observed-effect level
LOD limit of detection
LOQ limit of quantiﬁcation
MCH mean cell haemoglobin
MCHC mean cell haemoglobin concentration
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ML maximum level
mRNA messenger Ribonucleic Acid
MRM multiple reaction monitoring
MRT mean residence time
MS mass spectrometry
MW molecular weight
NOAEL no-observed-adverse-effect level
NOEL no-observed-effect level
OECD Organisation for Economic Co-Operation and Development
OPA o-phthaldialdehyde
PCV packed cell variable
pHFB partially hydrolysed fumonisin B
RBC red blood cell
RPF relative potency factor
Sa/So sphinganine-to-sphingosine ratio
SAChE speciﬁc acetylcholinesterase
SCF Scientiﬁc Committee on Food
SD standard deviation
SOP Standard Operating Procedure
t1/2el elimination half-life
Tmax time to maximal plasma concentration
TCA tricarballylic acid
TDI tolerable daily intake
TK toxicokinetics
TLC thin-layer chromatography
TNF tumour necrosis factor
Tri triglycerides
UB upper bound
UV ultraviolet
Vd volume of distribution
WBC white blood cells
WG working group
WHO World Health Organization
ZEN zearalenone
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Appendix A – EFSA guidance documents applied for the risk assessment
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Appendix B – Occurrence data received by EFSA
Table B.1: LOD and LOQ of the concentrations (micrograms/kg) of fumonisins in feed samples
Feed category Fumonisin
LOD LOQ
Mean Min Max Mean Min Max
Cereal grains, their products
and by-products
FB1 56 0 300 106 0.03 1,000
FB2 59 0 300 115 0.3 1,000
FB3 52 0 100 49 10 50
Compound feed FB1 37 0.07 1,000 56 0.03 1,000
FB2 58 0.07 1,000 63 0.3 1,000
FB3 25 25 25 50 50 50
Forages and roughage, and
products derived thereof
FB1 100 20 300 48 2 1,000
FB2 100 20 300 50 3 1,000
FB3 100 100 100 . . .
Land animal products and
products derived thereof
FB1 . . . 10 10 10
FB2 . . . 20 20 20
Legume seeds and products
derived thereof
FB1 92 20 100 20 10 50
FB2 97 30 100 28 20 50
FB3 100 100 100 . . .
Minerals and products derived
thereof
FB1 68 20 100 50 50 50
FB2 88 50 100 100 100 100
FB3 100 100 100 . . .
Miscellaneous FB1 107 20 300 525 50 1,000
FB2 106 30 300 448 50 1,000
FB3 100 100 100 . . .
Oil seeds, oil fruits, and
products derived thereof
FB1 102 0 300 94 0.03 1,000
FB2 102 0 300 94 3 1,000
FB3 99 0 100 19 10 50
Other seeds and fruits, and
products derived thereof
FB1 99 50 100 10 10 10
FB2 100 100 100 20 20 20
FB3 100 100 100 . . .
Tubers, roots, and products
derived thereof
FB1 103 100 300 339 7 1,000
FB2 103 100 300 343 8 1,000
FB3 100 100 100 . . .
LOD: limit of detection; LOQ: limit of quantiﬁcation.
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Table B.2: Statistical description of the concentrations (lg/kg dry matter)(a),(b) of fumonisins in feed samples classiﬁed according to the Catalogue of
feed materials speciﬁed in Commission Regulation (EU) No 68/2013(c)
Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Cereal grains, their
products and by-
products
Barley Barley, unspeciﬁed FB1 266 74 12.7 65.5 0.0 44.0 53.0 142.0
FB2 264 83 9.0 66.6 0.0 50.0 20.3 101.4
FB3 131 99 0.8 64.4 0.0 50.0 0.0 100.0
Barley middlings FB1 3 100 0.0 33.3 0.0 25.0 – –
FB2 3 67 40.0 73.3 0.0 50.0 – –
FB3 2 100 0.0 50.0 0.0 50.0 – –
Barley protein feed FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Malt rootlets FB1 7 29 6.4 13.5 2.0 10.1 – –
FB2 7 29 9.6 23.8 3.0 20.3 – –
FB3 2 100 0.0 50.0 0.0 50.0 – –
Buckwheat Buckwheat,
unspeciﬁed
FB1 4 100 0.0 48.9 0.0 48.9 – –
FB2 4 100 0.0 48.9 0.0 48.9 – –
FB3 4 100 0.0 48.9 0.0 48.9 – –
Cereal grains,
their products
and by-products,
unspeciﬁed
Cereal grains, their
products and
by-products,
unspeciﬁed
FB1 84 62 347.4 367.9 0.0 26.5 826.0 826.0
FB2 83 86 64.7 100.0 0.0 50.0 160.0 160.0
FB3 37 95 3.5 57.5 0.0 50.0 – –
Grains as crops Grains as crops FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Maize Maize bran FB1 2 50 1,400.5 1,450.5 1,400.5 1,450.5 – –
FB2 2 50 293.5 343.5 293.5 343.5 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Maize ﬁbre FB1 5 0.00 444.6 444.6 100.0 100.0 – –
FB2 5 80 20.0 60.0 0.0 50.0 – –
FB3 4 100 0.0 50.0 0.0 50.0 – –
Maize ﬂakes FB1 7 43 907.5 924.7 33.9 76.5 – –
FB2 7 86 64.0 92.5 0.0 32.8 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Maize germ FB1 4 0.00 899.7 899.7 614.4 614.4 – –
FB2 2 0.00 121.6 121.6 121.6 121.6 – –
Maize germ expeller FB1 3 67 40.0 73.3 0.0 50.0 – –
FB2 3 100 0.0 66.7 0.0 50.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Maize germ meal FB1 4 25 159.5 172.0 160.0 160.0 – –
FB2 4 25 52.8 65.3 55.5 55.5 – –
FB3 1 100 0.0 50.0 0.0 50.0 – –
Maize gluten FB1 3 0.00 2,037.7 2,037.7 2,678.3 2,678.3 – –
FB2 1 0.00 126.8 126.8 126.8 126.8 – –
Maize gluten feed FB1 110 14 1,078.1 1,090.3 271.5 271.5 5,465.8 5,465.8
FB2 108 31 378.5 406.1 164.0 164.0 1,700.0 1,700.0
FB3 36 61 129.4 189.2 0.0 100.0 – –
Maize middlings FB1 9 22 270.2 275.2 52.3 52.3 – –
FB2 9 56 115.0 160.9 0.0 56.6 – –
Maize screenings FB1 1 100 0.0 21.9 0.0 21.9 – –
FB2 1 100 0.0 21.9 0.0 21.9 – –
Maize, unspeciﬁed FB1 1,978 54 496.7 549.8 0.0 100.0 2,600.0 2,600.0
FB2 1,941 70 165.8 229.3 0.0 88.0 841.7 861.5
FB3 399 84 44.2 119.1 0.0 100.0 260.0 260.0
Sweet corn silage FB1 2 100 0.0 54.7 0.0 54.7 – –
FB2 2 100 0.0 49.2 0.0 49.2 – –
Millet Millet FB1 14 79 19.5 80.5 0.0 100.0 – –
FB2 14 100 0.0 75.3 0.0 76.1 – –
FB3 13 100 0.0 73.4 0.0 52.2 – –
Mixed grains Brewers’ grains FB1 18 83 83.3 158.3 0.0 100.0 – –
FB2 18 83 51.1 128.9 0.0 100.0 – –
FB3 16 88 26.3 107.5 0.0 100.0 – –
Distillers’ dark grains;
[Distillers’ dried grains
and solubles]
FB1 27 11 421.9 424.7 210.0 210.0 – –
FB2 27 41 105.9 126.2 64.0 64.0 – –
FB3 19 84 9.8 52.0 0.0 50.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Distillers’ dried grains FB1 2 50 524.5 674.5 524.5 674.5 – –
FB2 2 50 177.2 327.2 177.2 327.2 – –
Grain ﬂour FB1 1 0.00 141.5 141.5 141.5 141.5 – –
FB2 1 0.00 59.9 59.9 59.9 59.9 – –
Mixed grains,
unspeciﬁed
FB1 31 94 17.9 50.8 0.0 10.0 – –
FB2 31 97 0.7 36.8 0.0 10.0 – –
FB3 7 100 0.0 100.0 0.0 100.0 – –
Oats Oat feed FB1 61 100 0.0 15.0 0.0 15.0 0.0 15.0
FB2 61 100 0.0 15.0 0.0 15.0 0.0 15.0
Oat groats (Feed) FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Oats, unspeciﬁed FB1 78 67 15.7 61.9 0.0 44.0 90.0 100.0
FB2 78 74 7.8 58.2 0.0 50.0 20.0 100.0
FB3 48 100 0.0 70.9 0.0 50.0 – –
Rice, broken Rice bran FB1 6 83 4.2 79.2 0.0 100.0 – –
FB2 6 83 1.7 76.7 0.0 100.0 – –
FB3 4 100 0.0 100.0 0.0 100.0 – –
Rice middlings FB1 2 100 0.0 25.0 0.0 25.0 – –
FB2 2 100 0.0 50.0 0.0 50.0 – –
FB3 2 100 0.0 50.0 0.0 50.0 – –
Rice, broken,
unspeciﬁed
FB1 196 99 0.5 45.8 0.0 44.1 0.0 44.1
FB2 196 100 0.0 45.5 0.0 44.1 0.0 44.1
FB3 196 100 0.0 45.5 0.0 44.1 0.0 44.1
Rice, milled FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Rye Rye, unspeciﬁed FB1 25 88 0.9 52.6 0.0 50.0 – –
FB2 25 84 7.1 51.1 0.0 50.0 – –
FB3 18 100 0.0 52.8 0.0 50.0 – –
Rye middlings FB1 2 50 22.5 72.5 22.5 72.5 – –
FB2 2 100 0.0 75.0 0.0 75.0 – –
FB3 2 100 0.0 75.0 0.0 75.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Sorghum; [Milo] Sorghum; [Milo] FB1 15 80 27.3 95.9 0.0 100.0 – –2 10 0 0 3
FB3 12 100 0.0 95.8 0.0 100.0 – –
Spelt Spelt FB1 19 47 66.9 82.7 10.2 25.0 – –
FB2 19 84 3.2 48.0 0.0 50.0 – –
FB3 15 100 0.0 53.3 0.0 50.0 – –
Triticale Triticale FB1 35 54 20.8 67.5 0.0 83.0 – –
FB2 35 0.60 10.8 59.3 0.0 50.0 – –
FB3 13 100 0.0 80.8 0.0 100.0 – –
Wheat Vital wheat gluten(d) FB1 2 0.00 2,482.5 2,482.5 2,482.5 2,482.5 – –
FB2 2 0.00 1,417.0 1,417.0 1,417.0 1,417.0 – –
Wheat, unspeciﬁed FB1 347 65 76.2 116.6 0.0 34.0 100.0 100.9
FB2 347 79 66.3 117.1 0.0 50.0 30.0 100.9
FB3 158 99 0.4 67.8 0.0 50.0 0.0 100.0
Wheat bran (Feed) FB1 164 95 122.9 171.2 0.0 50.0 2.0 50.0
FB2 166 96 120.7 171.1 0.0 50.0 0.0 50.0
FB3 11 100 0.0 59.1 0.0 50.0 – –
Wheat feed FB1 109 93 7.9 56.5 0.0 50.0 30.0 100.0
FB2 109 95 3.1 54.2 0.0 50.0 0.0 100.0
FB3 10 100 0.0 75.0 0.0 75.0 – –
Wheat germ (Feed) FB1 2 100 0.0 62.5 0.0 62.5 – –
FB2 2 100 0.0 75.0 0.0 75.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Wheat gluten feed FB1 7 57 26.0 61.3 0.0 58.0 – –
FB2 7 100 0.0 61.7 0.0 50.0 – –
FB3 4 75 22.0 59.5 0.0 50.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Wheat middlings FB1 21 95 4.8 89.6 0.0 100.0 – –
FB2 21 95 4.8 93.2 0.0 100.0 – –
FB3 11 100 0.0 86.4 0.0 100.0 – –
Wheat starch
containing
protein,
partially de-sugared
FB1 1 100 0.0 25.0 0.0 25.0 – –
FB2 1 100 0.0 25.0 0.0 25.0 – –
FB3 1 100 0.0 50.0 0.0 50.0 – –
Compound feed Complementary/
Complete feed
Breeding pigs FB1 32 66 15.1 34.7 0.0 10.0 – –
FB2 32 75 5.3 27.1 0.0 10.0 – –
Calves FB1 15 67 81.7 110.5 0.0 50.0 – –
FB2 15 87 7.8 47.2 0.0 50.0 – –
Complementary feed
(incomplete diet)
FB1 139 28 314.7 323.9 57.0 58.0 1,179.6 1,179.6
FB2 139 94 53.3 101.7 0.0 50.0 230.0 300.0
FB3 121 99 0.5 50.1 0.0 50.0 0.0 50.0
Complete feed FB1 290 49 225.5 237.8 1.8 25.0 240.0 240.0
FB2 285 84 65.6 103.8 0.0 50.0 86.0 86.0
FB3 196 99 0.3 50.1 0.0 50.0 0.0 50.0
Dairy cows FB1 160 44 49.5 99.0 1.7 50.0 194.0 300.0
FB2 146 67 29.2 84.0 0.0 50.0 50.0 300.0
Fattening calves FB1 6 50 167.5 190.2 11.8 48.6 – –
FB2 6 67 47.9 95.5 0.0 64.7 – –
Fattening cattle FB1 31 52 212.7 265.0 0.0 100.0 – –
FB2 31 81 28.0 116.8 0.0 50.0 – –
Fattening chickens FB1 11 64 54.2 193.1 0.0 117.3 – –
FB2 11 82 10.4 113.3 0.0 58.7 – –
Fattening
ducks/Complete feed
FB1 9 0.00 309.1 309.1 148.4 148.4 – –
FB2 9 56 68.3 90.1 0.0 39.1 – –
Fattening rabbits FB1 2 100 0.0 30.0 0.0 30.0 – –
FB2 2 100 0.0 30.0 0.0 30.0 – –
Fattening sheep FB1 2 100 0.0 97.8 0.0 97.8 – –
FB2 2 100 0.0 195.6 0.0 195.6 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Fattening
turkeys/Complete feed
FB1 2 50 220.0 268.9 220.0 268.9 – –
FB2 2 50 65.0 109.0 65.0 109.0 – –
Fish/Complete feed FB1 6 33 306.0 406.0 200.6 345.6 – –
FB2 6 67 50.5 159.0 0.0 151.4 – –
Fur animals/Complete feed FB1 1 0.00 365.0 365.0 365.0 365.0 – –
FB2 1 0.00 115.0 115.0 115.0 115.0 – –
Goat (kids) (weaning diets)/
Complementary feed
FB1 1 0.00 424.7 424.7 424.7 424.7 – –
FB2 1 100 0.0 70.8 0.0 70.8 – –
Growing/fattening pigs FB1 119 58 119.8 182.0 0.0 47.2 401.1 405.0
FB2 119 75 24.6 100.5 0.0 58.7 104.2 300.0
Horses FB1 115 96 9.0 104.3 0.0 97.8 0.0 97.8
FB2 115 98 2.8 192.1 0.0 195.6 0.0 195.6
Lactating/dairy sheep FB1 7 86 27.0 99.0 0.0 118.0 – –
FB2 7 100 0.0 111.2 0.0 50.0 – –
Lambs FB1 1 0.00 112.0 112.0 112.0 112.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Laying hens FB1 18 44 168.6 243.1 2.1 108.7 – –
FB2 17 65 46.5 177.6 0.0 74.3 – –
Pet food, birds FB1 18 6 66.4 69.1 19.6 21.6 – –
FB2 18 6 39.3 42.1 39.1 39.1 – –
Pet food, dogs FB1 4 75 53.8 102.7 0.0 78.2 – –
FB2 4 100 0.0 58.7 0.0 58.7 – –
Poultry (starter diets) FB1 151 39 203.7 221.2 25.0 50.0 1,145.0 1,145.0
FB2 151 68 44.8 71.8 0.0 50.0 287.1 287.1
Rabbits/Complete feed FB1 3 33 83.4 86.8 19.6 19.6 – –
FB2 3 67 13.0 35.9 0.0 39.1 – –
Sows/Complete feed FB1 13 54 173.2 200.5 0.0 60.3 – –
FB2 13 62 58.8 107.2 0.0 65.1 – –
Unspeciﬁed
Complementary/
Complete feed
FB1 117 44 86.0 98.0 10.0 30.0 290.0 290.0
FB2 117 62 43.2 59.8 0.0 15.0 155.0 170.0
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Weaning pigs FB1 400 83 120.6 196.6 0.0 97.8 641.4 667.3
FB2 400 95 14.7 167.0 0.0 195.6 0.0 199.5
Compound feed Compound feed(e) FB1 229 41 1,657.5 1,678.1 81.0 81.0 9,250.5 9,250.5
FB2 227 56 454.8 482.1 0.0 50.0 2,554.8 2,554.8
FB3 1 100 0.0 50.0 0.0 50.0 – –
Forages and
roughage, and
products derived
thereof
Cereals straw Cereal straw, treated FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Cereals straw, unspeciﬁed FB1 42 100 0.0 50.0 0.0 50.0 – –
FB2 42 100 0.0 50.0 0.0 50.0 – –
Clover meal Clover meal FB1 2 100 0.0 75.0 0.0 75.0 – –
FB2 2 50 38.0 88.0 38.0 88.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Forage meal;
[Grass meal];
[Green meal]
Forage meal;
[Grass meal];
[Green meal]
FB1 61 100 0.0 99.7 0.0 100.0 0.0 100.0
FB2 61 100 0.0 99.7 0.0 100.0 0.0 100.0
FB3 47 100 0.0 100.0 0.0 100.0 – –
Forages and roughage,
and products derived
thereof, unspeciﬁed
Forages and roughage,
and products derived
thereof, unspeciﬁed
FB1 887 76 276.1 422.1 0.0 100.0 1,357.0 1,357.0
FB2 888 90 53.6 234.4 0.0 100.0 250.0 411.2
FB3 505 99 2.0 100.7 0.0 100.0 0.0 100.0
Grass, ﬁeld dried, [Hay] Grass, ﬁeld dried,
[Hay] unspeciﬁed
FB1 35 20 11.2 28.3 9.6 19.1 – –
FB2 35 20 15.3 32.4 19.1 19.1 – –
Grass, herbs,
legume plants,
[green forage]
FB1 20 0.00 30.4 30.4 40.3 40.3 – –
FB2 20 0.00 38.6 38.6 40.3 40.3 – –
Lucerne; [Alfalfa] Lucerne ﬁeld dried;
[Alfalfa ﬁeld dried]
FB1 6 100 0.0 100.0 0.0 100.0 – –
FB2 6 100 0.0 100.0 0.0 100.0 – –
FB3 6 100 0.0 100.0 0.0 100.0 – –
Lucerne meal;
[Alfalfa meal]
FB1 20 100 0.0 101.3 0.0 100.0 – –
FB2 20 100 0.0 101.3 0.0 100.0 – –
FB3 18 100 0.0 100.0 0.0 100.0 – –
Lucerne, high temperature dried;
[Alfalfa, high temperature dried]
FB1 1 0.00 17.6 17.6 17.6 17.6 – –
FB2 1 0.00 17.6 17.6 17.6 17.6 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Maize silage Maize silage FB1 46 26 106.4 127.1 38.8 38.8 – –
FB2 46 30 34.2 56.1 38.8 38.8 – –
Pea Straw Pea Straw FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Land animal
products and
products derived
thereof
Animal by-products Animal by-products FB1 1 0.00 9.1 9.1 9.1 9.1 – –
FB2 1 0.00 18.2 18.2 18.2 18.2 – –
Legume seeds and
products derived
thereof
Carob, dried Carob pods, dried FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Dried carob pod meal,
micronised
FB1 1 0.00 10.0 10.0 10.0 10.0 – –
FB2 1 0.00 20.0 20.0 20.0 20.0 – –
Horse beans Horse beans FB1 1 0.00 10.0 10.0 10.0 10.0 – –
FB2 1 0.00 20.0 20.0 20.0 20.0 – –
Mung beans Mung beans FB1 4 100 0.0 87.5 0.0 100.0 – –
FB2 4 100 0.0 100.0 0.0 100.0 – –
FB3 3 100 0.0 100.0 0.0 100.0 – –
Peas Peas FB1 14 100 0.0 98.0 0.0 100.0 – –
FB2 14 100 0.0 98.0 0.0 100.0 – –
FB3 5 100 0.0 100.0 0.0 100.0 – –
Sweet lupins Sweet lupins FB1 4 75 2.5 57.5 0.0 60.0 – –
FB2 4 75 5.0 62.5 0.0 65.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Vetches Vetches FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Minerals and
products derived
thereof
Minerals and products
derived thereof
Minerals and products
derived thereof
FB1 4 75 42.5 90.8 0.0 73.3 – –
FB2 4 100 0.0 96.6 0.0 96.6 – –
FB3 2 100 0.0 100.0 0.0 100.0 – –
Miscellaneous Miscellaneous Miscellaneous FB1 2 100 0.0 101.8 0.0 101.8 – –
FB2 2 100 0.0 101.8 0.0 101.8 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Products from the
bakery and
pasta industry
Feed beer FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
Plants by-products
from spirits production
FB1 6 17 1,203.3 1,206.7 190.0 190.0 – –
FB2 6 50 238.3 263.3 35.0 80.0 – –
Products from the bakery
and pasta industry, unspeciﬁed
FB1 27 100 0.0 119.5 0.0 100.0 – –
FB2 27 100 0.0 119.5 0.0 100.0 – –
FB3 18 100 0.0 100.0 0.0 100.0 – –
Starch Starch FB1 3 100 0.0 83.3 0.0 100.0 – –
FB2 3 100 0.0 100.0 0.0 100.0 – –
Oil seeds, oil fruits,
and products
derived thereof
Cocoa husks Cocoa hulls FB1 2 100 0.0 100.0 0.0 100.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
Cocoa husks FB1 3 33 6.7 13.3 10.0 10.0 – –
FB2 3 33 13.3 23.3 20.0 20.0 – –
Cotton seed Cotton seed, unspeciﬁed FB1 3 0.00 7.4 7.4 10.0 10.0 – –
FB2 3 0.00 14.4 14.4 20.1 20.1 – –
Cotton seed expeller FB1 1 0.00 10.0 10.0 10.0 10.0 – –
FB2 1 0.00 20.1 20.1 20.1 20.1 – –
Groundnut expeller,
partially decorticated
Groundnut expeller,
partially decorticated
unspeciﬁed
FB1 10 100 0.0 100.0 0.0 100.0 – –
FB2 10 100 0.0 100.0 0.0 100.0 – –
FB3 7 100 0.0 100.0 0.0 100.0 – –
Groundnut meal,
decorticated
FB1 2 100 0.0 100.0 0.0 100.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
FB3 2 100 0.0 100.0 0.0 100.0 – –
Groundnut meal, partially
decorticated
FB1 2 100 0.0 100.0 0.0 100.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
FB3 2 100 0.0 100.0 0.0 100.0 – –
Linseed Linseed, unspeciﬁed FB1 6 100 0.0 98.4 0.0 100.0 – –
FB2 6 100 0.0 98.4 0.0 100.0 – –
FB3 4 100 0.0 100.0 0.0 100.0 – –
Linseed expeller FB1 4 75 25.0 99.3 0.0 100.0 – –
FB2 4 100 0.0 99.3 0.0 100.0 – –
FB3 3 100 0.0 100.0 0.0 100.0 – –
Niger seed Niger seed FB1 2 100 0.0 75.0 0.0 75.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Oil seeds, oil fruits,
and products derived thereof
Oil seeds, oil fruits,
and products
derived thereof
FB1 1 100 0.0 25.0 0.0 25.0 – –
FB2 1 100 0.0 50.0 0.0 50.0 – –
FB3 1 100 0.0 50.0 0.0 50.0 – –
Palm kernel expeller Palm kernel expeller,
unspeciﬁed
FB1 78 100 0.0 100.0 0.0 100.0 0.0 100.0
FB2 78 100 0.0 100.0 0.0 100.0 0.0 100.0
FB3 55 100 0.0 100.0 0.0 100.0 – –
Palm kernel meal FB1 3 100 0.0 82.9 0.0 100.0 – –
FB2 3 100 0.0 99.2 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Rape seed Rape seed,
unspeciﬁed
FB1 21 95 0.5 82.5 0.0 100.0 – –
FB2 21 95 1.0 83.4 0.0 100.0 – –
FB3 10 100 0.0 100.0 0.0 100.0 – –
Rape seed meal FB1 7 14 6.3 13.5 10.0 10.0 – –
FB2 7 14 12.3 19.5 20.1 20.1 – –
Rape seed, expeller FB1 17 82 15.4 93.6 0.0 100.0 – –
FB2 17 88 1.4 77.7 0.0 100.0 – –
FB3 12 100 0.0 100.0 0.0 100.0 – –
Rape seed, extruded FB1 35 97 5.7 103.0 0.0 100.0 – –
FB2 35 100 0.0 100.1 0.0 100.0 – –
FB3 19 100 0.0 100.0 0.0 100.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Safﬂower seed Safﬂower seed FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Sunﬂower seed Sunﬂower seed,
unspeciﬁed
FB1 145 99 0.4 70.8 0.0 50.0 0.0 100.0
FB2 145 99 0.1 71.5 0.0 96.9 0.0 100.0
FB3 61 100 0.0 83.7 0.0 100.0 0.0 100.0
Sunﬂower seed expeller FB1 34 97 2.3 58.2 0.0 50.0 – –
FB2 34 100 0.0 57.4 0.0 50.0 – –
Sunﬂower seed meal FB1 8 63 2.4 64.9 0.0 50.0 – –
FB2 7 71 5.5 77.0 0.0 50.0 – –
Sunﬂower seed
meal, dehulled
FB1 2 0.00 9.7 9.7 9.7 9.7 – –
FB2 2 0.00 19.4 19.4 19.4 19.4 – –
Toasted soya (beans) Soya (bean) expeller FB1 16 88 1.3 51.8 0.0 50.0 – –
FB2 16 94 1.3 52.4 0.0 50.0 – –
Soya (bean) hulls FB1 14 100 0.0 99.8 0.0 100.0 – –
FB2 14 100 0.0 99.8 0.0 100.0 – –
FB3 9 100 0.0 100.0 0.0 100.0 – –
Soya (bean) meal FB1 97 96 1.6 108.7 0.0 100.0 0.0 300.0
FB2 95 98 0.1 110.5 0.0 100.0 0.0 300.0
FB3 58 100 0.0 100.0 0.0 100.0 – –
Soya (bean)
meal, dehulled
FB1 5 20 6.4 66.4 10.0 10.0 – –
FB2 5 20 12.6 72.6 19.9 19.9 – –
Soya (bean) protein
concentrate
FB1 3 67 3.3 33.6 0.0 45.4 – –
FB2 3 67 6.6 36.9 0.0 45.4 – –
FB3 2 100 0.0 45.4 0.0 45.4 – –
Soya beans, extruded FB1 306 98 5.6 103.8 0.0 100.0 0.0 100.0
FB2 306 99 2.0 100.4 0.0 100.0 0.0 100.0
FB3 234 100 0.0 100.0 0.0 100.0 0.0 100.0
Toasted soya (beans),
unspeciﬁed
FB1 8 100 0.0 81.0 0.0 99.7 – –
FB2 8 100 0.0 81.0 0.0 99.7 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Vegetable oil and fat Vegetable oil and fat FB1 2 100 0.0 100.0 0.0 100.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Other seeds and
fruits, and products
derived thereof
Buckwheat Buckwheat FB1 2 100 0.0 74.4 0.0 74.4 – –
FB2 2 100 0.0 98.9 0.0 98.9 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Citrus pulp Citrus pulp FB1 60 98 12.9 109.8 0.0 98.5 0.0 100.0
FB2 60 98 6.0 102.9 0.0 98.5 0.0 100.0
FB3 23 100 0.0 100.0 0.0 100.0 – –
Fruit kernels Fruit pulp, dried FB1 2 0.00 8.8 8.8 8.8 8.8 – –
FB2 2 0.00 17.6 17.6 17.6 17.6 – –
Grape pips Grape pips FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Other seeds and
fruits, and products
derived thereof
Other seeds and
fruits, and
products derived thereof
FB1 10 100 0.0 98.9 0.0 100.0 – –
FB2 10 100 0.0 98.9 0.0 100.0 – –
FB3 7 100 0.0 100.0 0.0 100.0 – –
Perilla seed Perilla seed FB1 1 100 0.0 50.0 0.0 50.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
Pine nut Pine nut FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Tubers, roots, and
products derived
thereof
Potatoes Potato protein FB1 2 100 0.0 100.0 0.0 100.0 – –
FB2 2 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Potato pulp FB1 4 100 0.0 100.0 0.0 100.0 – –
FB2 4 100 0.0 100.0 0.0 100.0 – –
FB3 2 100 0.0 100.0 0.0 100.0 – –
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Feed category Fumonisin N % LC
Mean Median P95
LB UB LB UB LB UB
Sugar beet Dried (sugar) beet pulp FB1 23 96 0.5 106.2 0.0 102.4 – –
FB2 23 96 0.9 106.7 0.0 102.4 – –
FB3 6 100 0.0 100.0 0.0 100.0 – –
Sugar beet, unspeciﬁed FB1 30 97 3.7 97.2 0.0 100.0 – –
FB2 30 100 0.0 96.9 0.0 100.0 – –
FB3 22 100 0.0 100.0 0.0 100.0 – –
Sweet potato Sweet potato FB1 1 100 0.0 100.0 0.0 100.0 – –
FB2 1 100 0.0 100.0 0.0 100.0 – –
FB3 1 100 0.0 100.0 0.0 100.0 – –
Tubers, roots, and
products derived thereof
Tubers, roots, and
products derived thereof
FB1 21 100 0.0 103.8 0.0 100.0 – –
FB2 21 100 0.0 103.8 0.0 100.0 – –
FB3 12 100 0.0 100.0 0.0 100.0 – –
N: number of samples; LC: left censored; LB: lower bound; UB: upper bound.
(a): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011). Those estimates were not included in this table.
(b): Values were rounded to 1 decimal place.
(c): Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials Text with EEA relevance. OJ L 29, 16.1.2013, p. 1–64.
(d): Protein fraction.
(e): The livestock species for which these were intended were not speciﬁed.
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Table B.3: Mean, median and P95 LB and UB concentrations of the sum of FB1 + FB2 + FB3 (without 1.6 Factor applied) in feed materials and species-
speciﬁc compound feeds used to estimate exposures for farmed livestock and companion animals(a),(b)
Feed category N
Mean Median P95
LB UB LB UB LB UB
Cereal grains, their
products and by-
products
Barley Barley 295 22.5 196.4 0.8 139.9 67.8 300.0
Barley middlings 3 40.0 156.7 0.0 150.0 – –
Barley protein feed 1 0.0 100.0 0.0 100.0 – –
Malt rootlets 7 15.9 87.4 5.1 80.4 – –
Buckwheat Buckwheat 4 0.0 146.7 0.0 146.7 – –
Cereal grains,
their products
and by-products
Cereal grains, their
products
and by-products
85 415.5 525.3 3.5 145.0 1,041.5 1,095.5
Grains as crops Grains as crops 1 0.0 100.0 0.0 100.0 – –
Maize and Corn Maize bran 2 1,694.0 1,894.0 1,694.0 1,894.0 – –
Maize ﬁbre 5 464.6 554.6 200.0 250.0 – –
Maize ﬂakes 10 971.5 1,017.1 595.1 628.8 – –
Maize germ 4 1,021.3 1,021.3 756.6 756.6 – –
Maize germ expeller 3 40.0 240.0 0.0 200.0 – –
Maize germ meal 4 212.3 287.3 240.0 290.0 – –
Maize gluten 3 2,164.5 2,164.5 2,805.1 2,805.1 – –
Maize gluten feed 111 1,586.1 1,685.5 585.4 652.2 7,320.0 7,400.0
Maize middlings 9 385.2 436.0 183.4 183.4 – –
Maize screenings 2 0.0 43.7 0.0 43.7 – –
Maize and Corn 2,035 707.7 899.2 44.2 319.1 3,391.7 3,466.6
Sweet corn silage 2 0.0 103.9 0.0 103.9 – –
Millet Millet 14 19.5 229.3 0.0 241.7 – –
Mixed grains Brewers’ grains 18 160.7 394.7 0.0 300.0 – –
Distillers’ dark grains; [Distillers’
dried grains and solubles]
27 537.6 602.8 210.0 310.0 – –
Distillers’ dried grains 2 701.8 1,001.8 701.8 1,001.8 – –
Grain ﬂour 1 201.4 201.4 201.4 201.4 – –
Mixed grains 31 18.5 187.6 0.0 120.0 – –
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Feed category N
Mean Median P95
LB UB LB UB LB UB
Oats Oat feed 61 0.0 30.0 0.0 30.0 0.0 30.0
Oat groats (Feed) 1 0.0 100.0 0.0 100.0 – –
Oats 78 23.5 191.1 0.0 132.0 97.0 300.0
Rice, broken Rice bran 7 5.8 255.8 0.0 300.0 – –
Rice middlings 2 0.0 125.0 0.0 125.0 – –
Rice, broken 196 0.5 136.7 0.0 132.2 0.0 132.2
Rice, milled 1 0.0 100.0 0.0 100.0 – –
Rye Rye 25 8.0 156.5 0.0 150.0 – –
Rye middlings 2 22.5 222.5 22.5 222.5 – –
Sorghum; [Milo] Sorghum; [Milo] 15 27.3 285.5 0.0 300.0 – –
Spelt Spelt 19 70.1 184.0 30.6 125.0 – –
Triticale Triticale 36 31.5 207.6 15.8 217.0 – –
Wheat Vital wheat gluten 2 3,899.5 3,899.5 3,899.5 3,899.5 – –
Wheat 376 142.9 301.6 0.4 177.9 130.0 300.0
Wheat bran (Feed) 166 243.5 401.4 0.0 159.1 5.0 159.1
Wheat feed 109 10.9 185.7 0.0 175.0 30.3 300.0
Wheat germ (Feed) 2 0.0 237.5 0.0 237.5 – –
Wheat gluten feed 7 48.0 182.5 22.0 171.0 – –
Wheat middlings 21 9.5 269.1 0.0 288.2 – –
Wheat starch containing
protein, partially de-sugared
1 0.0 100.0 0.0 100.0 – –
Compound feed Complementary/
Complete feed
Breeding pigs 33 20.4 61.8 0.0 20.0 – –
Calves 15 89.6 157.7 0.0 100.0 – –
Complementary feed
(incomplete diet)
139 368.4 475.6 57.0 165.0 1,651.9 1,701.5
Complete feed 290 291.5 391.7 4.9 125.0 270.0 370.0
Dairy cows 160 78.7 182.9 2.4 100.0 241.9 600.0
Fattening calves 6 215.4 285.7 35.4 109.0 – –
Fattening cattle 31 240.7 381.9 40.0 151.0 – –
Fattening chickens 11 64.6 306.4 0.0 176.0 – –
Fattening ducks/Complete feed 9 377.4 399.2 148.4 187.5 – –
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Feed category N
Mean Median P95
LB UB LB UB LB UB
Fattening rabbits 2 0.0 60.0 0.0 60.0 – –
Fattening sheep 2 0.0 293.3 0.0 293.3 – –
Fattening turkeys/Complete feed 2 285.0 377.9 285.0 377.9 – –
Fish/Complete feed 6 356.4 564.9 200.6 600.0 – –
Fur animals/Complete feed 1 480.0 480.0 480.0 480.0 – –
Goat (kids) (weaning diets)/
Complementary feed
1 424.7 495.4 424.7 495.4 – –
Growing/fattening pigs 128 144.4 282.5 15.0 117.6 500.0 664.9
Horses 115 11.8 296.3 0.0 293.3 0.0 293.3
Lactating/dairy sheep 7 27.0 210.1 0.0 224.1 – –
Lambs 1 112.0 162.0 112.0 162.0 – –
Laying hens 18 215.1 420.7 21.5 185.5 – –
Pet food, birds 18 105.7 111.2 58.7 58.7 – –
Pet food, dogs 4 53.8 161.3 0.0 136.9 – –
Poultry (starter diets) 175 248.4 293.0 79.8 110.0 1,230.0 1,230.0
Rabbits/Complete feed 3 96.5 122.7 58.7 58.7 – –
Sows/Complete feed 16 232.0 307.6 146.1 220.7 – –
Unspeciﬁed Complementary/
Complete feed
141 129.1 157.8 43.2 97.5 400.0 420.0
Weaning pigs 411 135.3 363.7 0.0 293.3 677.6 829.9
Compound feed Compound feed 231 2,112.4 2,210.2 90.7 190.7 11,867.3 11,917.3
Forages and
roughage, and
products derived
thereof
Cereals straw Cereal straw, treated 1 0.0 100.0 0.0 100.0 – –
Cereals straw 42 0.0 100.0 0.0 100.0 – –
Clover meal Clover meal 2 38.0 263.0 38.0 263.0 – –
Forage meal; [Grass meal];
[Green meal]
Forage meal; [Grass meal];
[Green meal]
61 0.0 299.4 0.0 300.0 0.0 300.0
Forages and roughage,
and products
derived thereof
Forages and roughage, and
products derived thereof
888 331.7 757.1 2.0 300.7 1,600.0 1,910.0
Grass, ﬁeld dried, [Hay] Grass, ﬁeld dried, [Hay] 35 26.5 60.7 28.6 38.2 – –
Grass, herbs, legume plants,
[green forage]
20 69.0 69.0 80.5 80.5 – –
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Feed category N
Mean Median P95
LB UB LB UB LB UB
Lucerne; [Alfalfa] Lucerne ﬁeld dried;
[Alfalfa ﬁeld dried]
6 0.0 300.0 0.0 300.0 – –
Lucerne meal; [Alfalfa meal] 20 0.0 302.6 0.0 300.0 – –
Lucerne, high temperature dried;
[Alfalfa, high temperature dried]
1 35.2 35.2 35.2 35.2 – –
Maize silage Maize silage 46 140.7 183.2 68.8 77.5 – –
Pea straw Pea straw 1 0.0 300.0 0.0 300.0 – –
Land animal
products and
products derived
thereof
Animal by-products Animal by-products 1 27.3 27.3 27.3 27.3 – –
Legume seeds and
products derived
thereof
Carob, dried Carob pods, dried 1 0.0 300.0 0.0 300.0 – –
Dried carob pod meal,
micronised
1 30.0 30.0 30.0 30.0 – –
Horse beans Horse beans 1 30.0 30.0 30.0 30.0 – –
Mung beans Mung beans 4 0.0 287.5 0.0 300.0 – –
Peas Peas 14 0.0 296.0 0.0 300.0 – –
Sweet lupins Sweet lupins 4 7.5 220.0 0.0 225.0 – –
Vetches Vetches 1 0.0 150.0 0.0 150.0 – –
Minerals and
products derived
thereof
Minerals and
products derived
thereof
Minerals and products
derived thereof
4 42.5 287.4 0.0 269.9 – –
Miscellaneous Miscellaneous Miscellaneous 2 0.0 303.7 0.0 303.7 – –
Products from
the bakery and
pasta industry
Feed beer 1 0.0 100.0 0.0 100.0 – –
Plants by-products from
spirits production
6 1,441.7 1,470.0 225.0 270.0 – –
Products from the bakery
and pasta industry
27 0.0 339.1 0.0 300.0 – –
Starch Starch 3 0.0 183.3 0.0 200.0 – –
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Feed category N
Mean Median P95
LB UB LB UB LB UB
Oil seeds, oil fruits,
and products
derived thereof
Cocoa husks Cocoa hulls 2 0.0 200.0 0.0 200.0 – –
Cocoa husks 3 20.0 36.7 30.0 30.0 – –
Cotton seed Cotton seed 3 21.7 21.7 30.1 30.1 – –
Cotton seed expeller 1 30.1 30.1 30.1 30.1 – –
Groundnut expeller,
partially decorticated
Groundnut expeller,
partially decorticated
10 0.0 300.0 0.0 300.0 – –
Groundnut meal,
decorticated
2 0.0 300.0 0.0 300.0 – –
Groundnut meal,
partially decorticated
2 0.0 300.0 0.0 300.0 – –
Linseed Linseed 6 0.0 296.8 0.0 300.0 – –
Linseed expeller 4 25.0 298.5 0.0 300.0 – –
Niger seed Niger seed 2 0.0 275.0 0.0 275.0 – –
Oil seeds, oil fruits,
and products derived thereof
Oil seeds, oil fruits,
and products derived thereof
1 0.0 125.0 0.0 125.0 – –
Palm kernel expeller Palm kernel expeller 78 0.0 300.0 0.0 300.0 0.0 300.0
Palm kernel meal 3 0.0 282.2 0.0 300.0 – –
Rape seed Rape seed 21 1.4 265.9 0.0 300.0 – –
Rape seed meal 7 18.6 32.9 30.1 30.1 – –
Rape seed, expeller 17 16.7 271.3 0.0 300.0 – –
Rape seed, extruded 35 5.7 303.1 0.0 300.0 – –
Safﬂower seed Safﬂower seed 1 0.0 300.0 0.0 300.0 – –
Sunﬂower seed Sunﬂower seed 145 0.5 226.1 0.0 229.1 0.0 300.0
Sunﬂower seed expeller 34 2.3 115.5 0.0 100.0 – –
Sunﬂower seed meal 8 8.0 141.9 0.0 100.0 – –
Sunﬂower seed meal, dehulled 2 29.1 29.1 29.1 29.1 – –
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Feed category N
Mean Median P95
LB UB LB UB LB UB
Toasted soya (beans) Soya (bean) expeller 16 2.5 104.2 0.0 100.0 – –
Soya (bean) hulls 14 0.0 299.7 0.0 300.0 – –
Soya (bean) meal 97 1.7 319.2 0.0 300.0 0.1 700.0
Soya (bean) meal, dehulled 5 18.9 138.9 29.9 29.9 – –
Soya (bean) protein concentrate 3 10.0 115.8 0.0 136.1 – –
Soya beans, extruded 306 7.6 304.2 0.0 300.0 0.0 300.0
Toasted soya (beans) 8 0.0 162.1 0.0 199.3 – –
Vegetable oil and fat Vegetable oil and fat 2 0.0 300.0 0.0 300.0 – –
Other seeds and
fruits, and products
derived thereof
Buckwheat Buckwheat 2 0.0 252.9 0.0 252.9 – –
Citrus pulp Citrus pulp 60 18.9 312.6 0.0 297.1 0.0 300.0
Fruit kernels Fruit pulp, dried 2 26.4 26.4 26.4 26.4 – –
Grape pips Grape pips 1 0.0 300.0 0.0 300.0 – –
Other seeds and fruits,
and products derived thereof
Other seeds and fruits,
and products derived thereof
10 0.0 297.7 0.0 300.0 – –
Perilla seed Perilla seed 1 0.0 150.0 0.0 150.0 – –
Pine nut Pine nut 1 0.0 300.0 0.0 300.0 – –
Tubers, roots, and
products derived
thereof
Potatoes Potato protein 2 0.0 300.0 0.0 300.0 – –
Potato pulp 4 0.0 300.0 0.0 300.0 – –
Sugar beet Dried (sugar) beet pulp 23 1.3 312.9 0.0 304.7 – –
Sugar beet 30 3.7 294.1 0.0 300.0 – –
Sweet potato Sweet potato 1 0.0 300.0 0.0 300.0 – –
Tubers, roots, and products
derived thereof
Tubers, roots, and products
derived thereof
21 0.0 307.6 0.0 300.0 – –
N: number of samples; LB: lower bound; UB: upper bound.
(a): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011). Those estimates were not included in this table.
(b): Values were rounded to 1 decimal place.
Fumonisins in feed
www.efsa.europa.eu/efsajournal 128 EFSA Journal 2018;16(5):5242
Table B.4: Mean, median and P95 LB and UB concentrations of the sum of FB1 + FB2 + FB3 (with 1.6 Factor applied) in feed materials and species-
speciﬁc compound feeds used to estimate exposures for farmed livestock and companion animals(a),(b)
Feed group N
Mean Median P95
LB UB LB UB LB UB
Cereal grains, their
products and by-
products
Barley Barley 295 36.0 314.3 1.3 223.8 108.5 480.0
Barley middlings 3 64.0 250.7 0.0 240.0 – –
Barley protein feed 1 0.0 160.0 0.0 160.0 – –
Malt rootlets 7 25.5 139.8 8.1 128.7 – –
Buckwheat Buckwheat 4 0.0 234.7 0.0 234.7 – –
Cereal grains, their
products and by-products
Cereal grains, their
products and by-products
85 664.8 840.5 5.6 232.0 1,666.4 1,752.9
Grains as crops Grains as crops 1 0.0 160.0 0.0 160.0 – –
Maize and Corn Maize bran 2 2,710.4 3,030.4 2,710.4 3,030.4 – –
Maize ﬁbre 5 743.4 887.4 320.0 400.0 – –
Maize ﬂakes 10 1,554.4 1,627.4 952.1 1,006.1 – –
Maize germ 4 1,634.1 1,634.1 1,210.6 1,210.6 – –
Maize germ expeller 3 64.0 384.0 0.0 320.0 – –
Maize germ meal 4 339.6 459.6 384.0 464.0 – –
Maize gluten 3 3,463.2 3,463.2 4,488.1 4,488.1 – –
Maize gluten feed 111 2,537.8 2,696.8 936.7 1,043.5 11,712.0 11,840.0
Maize middlings 9 616.3 697.6 293.5 293.5 – –
Maize screenings 2 0.0 70.0 0.0 70.0 – –
Maize_&_Corn 2,035 1,132.3 1,438.7 70.7 510.5 5,426.7 5,546.5
Sweet corn silage 2 0.0 166.2 0.0 166.2 – –
Millet Millet 14 31.2 366.8 0.0 386.7 – –
Mixed grains Brewers’ grains 18 257.1 631.6 0.0 480.0 – –
Distillers’ dark grains;
[Distillers’ dried grains
and solubles]
27 860.2 964.6 336.0 496.0 – –
Distillers’ dried grains 2 1,122.8 1,602.8 1,122.8 1,602.8 – –
Grain ﬂour 1 322.3 322.3 322.3 322.3 – –
Mixed grains 31 29.7 300.1 0.0 192.0 – –
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Feed group N
Mean Median P95
LB UB LB UB LB UB
Oats Oat feed 61 0.0 48.0 0.0 48.0 0.0 48.0
Oat groats (Feed) 1 0.0 160.0 0.0 160.0 – –
Oats 78 37.6 305.7 0.0 211.2 155.2 480.0
Rice, broken Rice bran 7 9.3 409.3 0.0 480.0 – –
Rice middlings 2 0.0 200.0 0.0 200.0 – –
Rice, broken 196 0.8 218.7 0.0 211.5 0.0 211.5
Rice, milled 1 0.0 160.0 0.0 160.0 – –
Rye Rye 25 12.8 250.4 0.0 240.0 – –
Rye middlings 2 36.0 356.0 36.0 356.0 – –
Sorghum; [Milo] Sorghum; [Milo] 15 43.6 456.9 0.0 480.0 – –
Spelt Spelt 19 112.2 294.3 49.0 200.0 – –
Triticale Triticale 36 50.4 332.1 25.2 347.2 – –
Wheat Vital wheat gluten 2 6,239.2 6,239.2 6,239.2 6,239.2 – –
Wheat 376 228.7 482.5 0.7 284.7 208.0 480.0
Wheat bran (Feed) 166 389.7 642.2 0.0 254.5 8.1 254.5
Wheat feed 109 17.4 297.2 0.0 280.0 48.4 480.0
Wheat germ (Feed) 2 0.0 380.0 0.0 380.0 – –
Wheat gluten feed 7 76.8 292.0 35.2 273.6 – –
Wheat middlings 21 15.2 430.6 0.0 461.1 – –
Wheat starch containing
protein, partially de-sugared
1 0.0 160.0 0.0 160.0 – –
Compound feed Complementary/
Complete feed
Breeding pigs 33 32.6 98.9 0.0 32.0 – –
Calves 15 143.3 252.3 0.0 160.0 – –
Complementary feed
(incomplete diet)
139 589.4 760.9 91.2 264.0 2,643.1 2,722.4
Complete feed 290 466.4 626.8 7.9 200.0 432.0 592.0
Dairy cows 160 126.0 292.7 3.8 160.0 387.1 960.0
Fattening calves 6 344.6 457.1 56.6 174.4 – –
Fattening cattle 31 385.2 611.0 64.0 241.6 – –
Fattening chickens 11 103.4 490.3 0.0 281.6 – –
Fattening ducks/Complete feed 9 603.9 638.7 237.5 300.1 – –
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Feed group N
Mean Median P95
LB UB LB UB LB UB
Fattening rabbits 2 0.0 96.0 0.0 96.0 – –
Fattening sheep 2 0.0 469.3 0.0 469.3 – –
Fattening turkeys/Complete feed 2 456.0 604.6 456.0 604.6 – –
Fish/Complete feed 6 570.3 903.9 320.9 960.0 – –
Fur animals/Complete feed 1 768.0 768.0 768.0 768.0 – –
Goat (kids) (weaning diets)/
Complementary feed
1 679.5 792.7 679.5 792.7 – –
Growing/fattening pigs 128 231.0 452.0 24.0 188.2 800.0 1,063.8
Horses 115 18.9 474.1 0.0 469.3 0.0 469.3
Lactating/dairy sheep 7 43.2 336.2 0.0 358.6 – –
Lambs 1 179.2 259.2 179.2 259.2 – –
Laying hens 18 344.2 673.1 34.4 296.9 – –
Pet food, birds 18 169.1 178.0 93.9 93.9 – –
Pet food, dogs 4 86.0 258.1 0.0 219.0 – –
Poultry (starter diets) 175 397.5 468.8 127.7 176.0 1,968.0 1,968.0
Rabbits/Complete feed 3 154.4 196.3 93.9 93.9 – –
Sows/Complete feed 16 371.1 492.2 233.7 353.2 – –
Unspeciﬁed Complementary/
Complete feed
141 206.6 252.5 69.1 155.9 640.0 672.0
Weaning pigs 411 216.5 581.8 0.0 469.3 1,084.2 1,327.9
Compound feed Compound feed 231 3,379.8 3,536.3 145.1 305.1 18,987.7 19,067.7
Forages and
roughage, and
products derived
thereof
Cereals straw Cereal straw, treated 1 0.0 160.0 0.0 160.0 – –
Cereals straw 42 0.0 160.0 0.0 160.0 – –
Clover meal Clover meal 2 60.8 420.8 60.8 420.8 – –
Forage meal; [Grass meal];
[Green meal]
Forage meal; [Grass meal];
[Green meal]
61 0.0 479.1 0.0 480.0 0.0 480.0
Forages and roughage,
and products derived thereof
Forages and roughage, and
products derived thereof
888 530.7 1,211.4 3.3 481.0 2,560.0 3,056.0
Grass, ﬁeld dried, [Hay] Grass, ﬁeld dried, [Hay] 35 42.3 97.2 45.8 61.1 – –
Grass, herbs, legume plants,
[green forage]
20 110.4 110.4 128.9 128.9 – –
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Feed group N
Mean Median P95
LB UB LB UB LB UB
Lucerne; [Alfalfa] Lucerne ﬁeld dried;
[Alfalfa ﬁeld dried]
6 0.0 480.0 0.0 480.0 – –
Lucerne meal; [Alfalfa meal] 20 0.0 484.1 0.0 480.0 – –
Lucerne, high temperature dried;
[Alfalfa, high temperature dried]
1 56.3 56.3 56.3 56.3 – –
Maize silage Maize silage 46 225.1 293.1 110.0 124.1 – –
Pea Straw Pea Straw 1 0.0 480.0 0.0 480.0 – –
Land animal
products and
products derived
thereof
Animal by-products Animal by-products 1 43.7 43.7 43.7 43.7 – –
Legume seeds and
products derived
thereof
Carob, dried Carob pods, dried 1 0.0 480.0 0.0 480.0 – –
Dried carob pod meal,
micronised
1 48.0 48.0 48.0 48.0 – –
Horse beans Horse beans 1 48.0 48.0 48.0 48.0 – –
Mung beans Mung beans 4 0.0 460.0 0.0 480.0 – –
Peas Peas 14 0.0 473.6 0.0 480.0 – –
Sweet lupins Sweet lupins 4 12.0 352.0 0.0 360.0 – –
Vetches Vetches 1 0.0 240.0 0.0 240.0 – –
Minerals and
products derived
thereof
Minerals and products
derived thereof
Minerals and products
derived thereof
4 68.0 459.8 0.0 431.8 – –
Miscellaneous Miscellaneous Miscellaneous 2 0.0 485.8 0.0 485.8 – –
Products from the bakery
and pasta industry
Feed beer 1 0.0 160.0 0.0 160.0 – –
Plants by-products from
spirits production
6 2,306.7 2,352.0 360.0 432.0 – –
Products from the bakery
and pasta industry
27 0.0 542.5 0.0 480.0 – –
Starch Starch 3 0.0 293.3 0.0 320.0 – –
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Feed group N
Mean Median P95
LB UB LB UB LB UB
Oil seeds, oil fruits,
and products
derived thereof
Cocoa husks Cocoa hulls 2 0.0 320.0 0.0 320.0 – –
Cocoa husks 3 32.0 58.7 48.0 48.0 – –
Cotton seed Cotton seed 3 34.8 34.8 48.2 48.2 – –
Cotton seed expeller 1 48.2 48.2 48.2 48.2 – –
Groundnut expeller,
partially decorticated
Groundnut expeller,
partially decorticated
10 0.0 480.0 0.0 480.0 – –
Groundnut meal, decorticated 2 0.0 480.0 0.0 480.0 – –
Groundnut meal,
partially decorticated
2 0.0 480.0 0.0 480.0 – –
Linseed Linseed 6 0.0 474.8 0.0 480.0 – –
Linseed expeller 4 40.0 477.6 0.0 480.0 – –
Niger seed Niger seed 2 0.0 440.0 0.0 440.0 – –
Oil seeds, oil fruits, and
products derived thereof
Oil seeds, oil fruits, and
products derived thereof
1 0.0 200.0 0.0 200.0 – –
Palm kernel expeller Palm kernel expeller 78 0.0 480.0 0.0 480.0 0.0 480.0
Palm kernel meal 3 0.0 451.5 0.0 480.0 – –
Rape seed Rape seed 21 2.3 425.4 0.0 480.0 – –
Rape seed meal 7 29.8 52.7 48.2 48.2 – –
Rape seed, expeller 17 26.7 434.1 0.0 480.0 – –
Rape seed, extruded 35 9.2 485.0 0.0 480.0 – –
Safﬂower seed Safﬂower seed 1 0.0 480.0 0.0 480.0 – –
Sunﬂower seed Sunﬂower seed 145 0.9 361.7 0.0 366.5 0.0 480.0
Sunﬂower seed expeller 34 3.7 184.9 0.0 160.0 – –
Sunﬂower seed meal 8 12.7 227.0 0.0 160.0 – –
Sunﬂower seed meal, dehulled 2 46.5 46.5 46.5 46.5 – –
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Feed group N
Mean Median P95
LB UB LB UB LB UB
Toasted soya (beans) Soya (bean) expeller 16 4.0 166.8 0.0 160.0 – –
Soya (bean) hulls 14 0.0 479.5 0.0 480.0 – –
Soya (bean) meal 97 2.8 510.6 0.0 480.0 0.1 1,120.0
Soya (bean) meal, dehulled 5 30.3 222.3 47.8 47.8 – –
Soya (bean) protein concentrate 3 15.9 185.3 0.0 217.7 – –
Soya beans, extruded 306 12.2 486.8 0.0 480.0 0.0 480.0
Toasted soya (beans) 8 0.0 259.3 0.0 318.9 – –
Vegetable oil and fat Vegetable oil and fat 2 0.0 480.0 0.0 480.0 – –
Other seeds and
fruits, and products
derived thereof
Buckwheat Buckwheat 2 0.0 404.6 0.0 404.6 – –
Citrus pulp Citrus pulp 60 30.3 500.2 0.0 475.3 0.0 480.0
Fruit kernels Fruit pulp, dried 2 42.2 42.2 42.2 42.2 – –
Grape pips Grape pips 1 0.0 480.0 0.0 480.0 – –
Other seeds and fruits,
and products derived thereof
Other seeds and fruits,
and products derived thereof
10 0.0 476.3 0.0 480.0 – –
Perilla seed Perilla seed 1 0.0 240.0 0.0 240.0 – –
Pine nut Pine nut 1 0.0 480.0 0.0 480.0 – –
Tubers, roots, and
products derived
thereof
Potatoes Potato protein 2 0.0 480.0 0.0 480.0 – –
Potatoes Potato pulp 4 0.0 480.0 0.0 480.0 – –
Sugar beet Dried (sugar) beet pulp 23 2.1 500.6 0.0 487.6 – –
Sugar beet 30 5.9 470.5 0.0 480.0 – –
Sweet potato Sweet potato 1 0.0 480.0 0.0 480.0 – –
Tubers, roots, and products
derived thereof
Tubers, roots, and
products derived thereof
21 0.0 492.1 0.0 480.0 – –
N: number of samples; LB: lower bound; UB: upper bound.
(a): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011). Those estimates were not included in this table.
(b): Values were rounded to 1 decimal place.
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Appendix C – Feed intakes and diet composition (livestock)
This Appendix gives details of the feed intakes, live weights and diet compositions for different
livestock, ﬁsh and companion animals used as the basis to estimate exposures. These are based on
published guidelines on nutrition and feeding (e.g. Carabano and Piquer, 1998; NRC, 2000, 2007a,b;
Ewing, 2002; Leeson and Summers, 2008; OECD, 2009; McDonald et al., 2011; EBLEX, 2008, 2012;
EFSA, 2012) and information provided by European feed manufacturers. They are therefore estimates of
the Panel on Contaminants in the Food Chain (CONTAM Panel), but agree with common practice. In
Table C.6 the concentrations of fumonisins and its hidden forms in feeds used to estimate exposure are
presented.
C.1. Feed intakes
C.1.1. Cattle, sheep, goats and horses
Dairy cows
The amounts of feed given to lactating dairy cows varies according to the amount and quality of
forages and other feeds available, the weight of the cow and its milk yield. In this Opinion, it is
assumed that non-forage (i.e. complementary) feeds are fed at the rate of 0.3 kg/kg of milk produced
(Nix, 2010). Exposures to fumonisins and the sum of its hidden forms have been estimated for a 650-
kg dairy cow, with a milk yield of 40 kg/day. Assumptions on the amounts of forages and non-forage
feed are given in Table C.1.
Beef cattle
There are a wide variety of beef production and husbandry systems in Europe. They may be
categorised broadly as forage-based or cereal-based systems, although combinations of these systems
are commonly found. In this opinion, four feeding systems are considered, in which the forages are
(1) grass hay (2) maize silage and (3) cereal straw with, in each case, appropriate supplementation
with non-forage feed materials. A fourth system, commonly known as ‘cereal beef’, is also considered.
For exposure estimates, live weights of 300 or 400 kg, and feed intakes of between 6.6 and 10 kg dry
matter per day have been assumed, depending on the feeding regime, based on guidelines published
by EBLEX (2008, 2012), and details are given in Table C.1.
Sheep and goats
Many breeds and systems of management have been developed for sheep and goats to suit the
land, climate and husbandry conditions in the EU. As for other ruminants, forages may be the only
feeds used after weaning (NRC, 2007a). Common exceptions to this are pregnant and lactating animals,
whose feed is usually supplemented with non-forage feeds or commercial compound (complementary)
feeds (AFRC, 1993; NRC, 2007a). In this Opinion, exposure estimates have been made for lactating
sheep and goats. The CONTAM Panel has used a daily dry matter intake of 2.8 kg for an 80-kg lactating
sheep feeding twin lambs to estimate the exposures. For lactating goats, the CONTAM Panel has used a
daily dry matter intakes of 3.3 kg for a 60-kg goat for milking (4 kg milk/day); for fattening goats, a
body weight of 40 kg and feed intakes of 1.5 kg DM/day has been assumed, of which 60% is forage
(Table C.1).
Horses
Horses are non-ruminant herbivores. They generally consume 2–3.5% of their body weight in feed
(dry matter) each day, of which a minimum of 50% should be as forage (pasture grass or hay) (NRC,
2007b). Assumed intakes are given in Table C.1.
Fumonisins in feed
www.efsa.europa.eu/efsajournal 135 EFSA Journal 2018;16(5):5242
C.1.2. Non-ruminant animals
Pigs
Although there is a considerable range of pig production systems in Europe, exposure estimates
have been made for piglets (pig starter), ﬁnishing pigs and lactating sows (using feed intakes
proposed by EFSA (2012). Details are given in Table C.2.
Poultry
The CONTAM Panel applied the live weights and feed intakes reported for fattening chickens
(broilers), laying hens and turkeys proposed by EFSA FEEDAP Panel (2012) and for ducks by Leeson
and Summers (2008) (Table C.2).
Farmed ﬁsh (salmonids and carp)
Commercially reared species include Atlantic salmon, rainbow trout, sea bass, sea bream, cod,
halibut, tuna, eel and turbot. In this Scientiﬁc Opinion, exposures to fumonisins and their hidden forms
have been made for farmed salmon and carp. Details of the body weights and feed intakes used are
given in Table C.2.
Table C.1: Live weights, growth rate/productivity, dry matter intake for cattle, sheep, goats and
horses, and the proportions of the diet as non-forage
Animal species
Live
weight
(kg)
Growth rate or
productivity
Dry matter
intake
(kg/day)
% of diet as
non-forage
feed
Reference
Dairy cows, lactating(a) 650 40 kg milk/day 20.7 40 OECD (2009)
Fattening cattle: beef(b) 400 1 kg/day 9.6 15 AFRC (1993)
Fattening cattle: maize
silage-based ration
300 1.4 kg/day 6.6 25 Browne et al. (2004)
Fattening cattle: cereal
straw-based diet
300 0.9 kg/day 8.0 68 EBLEX (2008)
Fattening cattle: cereal
beef
400 1.4 kg/day 10.0 85 EBLEX (2012)
Sheep: lactating 80 Feeding twin lambs 2.8 50 OECD (2009)
Goats: milking 60 6 kg milk/day 3.4 65 NRC (2007a)
Goats: fattening 40 0.3 kg/day 1.5 40
Horses 450 Moderate activity 9.0 50 NRC (2007b)
(a): Months 2–3 of lactation;
(b): Housed castrate cattle, medium maturing breed.
Table C.2: Live weights and feed intake for pigs, poultry (EFSA FEEDAP Panel, 2012), ducks
(Leeson and Summers, 2008) and ﬁsh
Species
Live weight
(kg)
Feed intake (kg dry
matter/day)
Reference
Pigs: starter 20 1.0 EFSA FEEDAP Panel (2012)
Pigs: ﬁnishing 100 3.0 EFSA FEEDAP Panel (2012)
Pigs: lactating sows 200 6.0 EFSA FEEDAP Panel (2012)
Poultry: broilers(a) 2 0.12 EFSA FEEDAP Panel (2012)
Poultry: laying hens 2 0.12 EFSA FEEDAP Panel (2012)
Turkeys: fattening turkeys 12 0.40 EFSA FEEDAP Panel (2012)
Ducks: fattening ducks 3 0.14 Leeson and Summers (2008)
Salmonids 2 0.04 EFSA FEEDAP Panel (2012)
Carp 1 0.02 Schultz et al. (2012)
(a): Fattening chickens.
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Rabbits
Feed intakes of 65–80 g/kg bw per day have been reported (Carabano and Piquer, 1998). For the
exposure estimates, the CONTAM Panel have assumed a live weight of 2 kg, and a daily feed intake of
75 g/kg bw (derived from Carabano and Piquer, 1998).
Farmed mink
For estimating exposure, the CONTAM Panel have assumed a live weight of 2.07 kg for a male mink
at pelting, and with a feed intake of 227 g fresh weight/day (75 g dry matter) (NRC, 1982).
Companion animals: Dogs and cats
The amount of food consumed is largely a function of the mature weight of the animal, level of
activity, physiological status (e.g. pregnancy or lactation) and the energy content of the diet. In this
Scientiﬁc Opinion, the CONTAM Panel assumed body weights (kg) and feed intakes (g dry matter/day)
for dogs and cats of 25/360 and 4/60, respectively (derived from NRC, 2006).
C.2. Diet composition
Many livestock in the European countries are fed proprietary commercial compound feeds. Where
sufﬁcient data have been provided on species-speciﬁc compound feeds, estimates of exposure have
been made using these data (given in Table C.6) together with estimated intakes given in
Appendices C.1 and C.2. Where data on proprietary compound feeds were not available, or were
available but in insufﬁcient numbers, estimates of exposure have been made using dietary inclusion
rates of feed materials given in this section. Levels of fumonisins, and fumonisins + hidden forms in
species-speciﬁc compound/complementary feeds or feed materials used to estimate exposure are
given in Table C.6.
C.2.1. Cattle, sheep, goats and horses
For most ruminants and horses, forages (either fresh or conserved as silage or hay) are essential
ingredients in their diet, but they are normally supplemented with non-forage feeds such as cereals,
cereal by-products, oilseed meals and by-products of human food production. These may be fed either
as individual feeds, mixtures of feed materials, or as species-speciﬁc complementary feeds in the form
of compound feeds. In some situations, however, forages may represent the total diet.
Fresh (grazed) grass or grass silage are the principal forages for ruminants and horses in the EU.
As reported elsewhere in this Opinion (Section 3.3) fumonisins and its modiﬁed forms have not been
reported in these feeds, and therefore, it has been assumed that where they are fed they make no
contribution to exposure. For other forages, however, notably grass hay, maize silage and cereal straw,
the presence of fumonisins has been reported. Therefore, two estimates of exposure have been
reported for ruminants and horses, the ﬁrst of which assumes no exposure from forages (i.e. the main
forages are fresh grass and/or grass silage). Exposures have also been estimated for diets in which
grass hay, maize silage or cereal straw are the forage.
For lactating dairy cows and fattening beef cattle, data for species-speciﬁc compound feeds were
provided (Table C.6) and these were used to estimate exposure to fumonisins in these diets. AFSSA
(2009) have provided example intakes of dairy cows fed maize silage supplemented with maize grain
and soybean meal, while example diets of beef cattle on maize silage or cereal straw-based diets are
taken from EBLEX (2008, 2012), and these are given in Table C.3.
For lactating sheep and goats, and for fattening goats, levels of fumonisins and its hidden forms in
species-speciﬁc compound feed data were not available and therefore example diets (Table C.4) and
levels of fumonisins and fumonisins + hidden forms in individual feeds (Table C.6) have been used to
estimate exposure.
Horses are non-ruminant herbivores, and consequently their diet should contain a minimum of 50%
forages. While mature horses with minimal activity can be fed forage alone (NRC, 2007b), for growing
and active horses supplementary feeding with cereal grains, cereal by-products (e.g. oats, barley, and
wheat bran) and vegetable proteins is necessary. In this Opinion, the CONTAM Panel have used data
available on levels of fumonisins in complementary feeds for horses (Table C.6) to estimate exposure.
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For lactating sheep, milking goats and fattening goats, no information on levels of fumonisins or its
hidden forms in species-speciﬁc compound feed were available and therefore example diets have been
used to estimate exposure (Table C.4).
Concentrations calculated by using the mean concentrations of fumonisins reported for the
individual feeds in Appendix Table C.6.
Concentrations calculated by using the 95th percentile concentrations of the sum of fumonisins and
its hidden forms reported for the individual feeds in Appendix Table C.6.
C.2.2. Pigs and poultry
Sufﬁcient data for species-speciﬁc compound feeds for pigs, and for most categories of poultry
(fattening chickens, ducks and turkeys, and for laying hens), were provided (Table C.2) and these were
used to estimate exposure to the sum of fumonisins and FBs hidden forms.
Table C.3: Assumed diet compositions and feed intake of lactating dairy cows (40 L/day) and
fattening beef cattle fed diets based on different forages
Animal species
Quantities of feed consumed (kg dry matter/day)
Reference
Forage
Maize
grain
Soybean
meal
Barley
grain
Rapeseed
meal
Lactating dairy cows: maize
silage-based diet
15.0 9.5 2.8 ni ni AFSSA (2009)
Fattening beef cattle: maize
silage-based diet
4.9 ni ni ni 1.5 EBLEX (2012)
Fattening beef cattle: cereal
straw-based diet
2.5 ni ni 4.1 1.4 EBLEX (2008)
Fattening beef cattle: intensive
cereal-based diet
1.5 ni ni 5.5 1.5 EBLEX (2008)
ni: not included in the diet formulations.
Table C.4: Assumed diet compositions (%) for lactating sheep and goats, and fattening goats, and
the calculated mean lower bound and upper bound concentrations of fumonisins and
the sum of fumonisins + hidden forms in these diets
Non-forage feed materials Lactating sheep Lactating goats Fattening goats
Wheat (%) 14 ni ni
Barley (%) 18 25 20
Oats (%) ni 35 40
Soybean meal (%) 5 10 10
Rapeseed meal (%) 10 10 10
Sunﬂower meal (%) 5 ni ni
Beans (%)(b) 10 ni ni
Maize gluten feed (%) ni ni ni
Wheat feed (%)(a) 15 10 10
Oat feed (%)(a) ni ni ni
Sugar beet pulp (%)(b) 14 1 1
Molasses (%)(b) 4 4 4
Vegetable oils (%)(b) 5 5 5
Minerals, vitamins etc. (%)(b) ni ni ni
% of non-forage feeds in the diet 50 75 40
ni: not included in the diet formulations.
(a): By-products of processing these grains See Commission Regulation (EU) No 575/2011 of June 2011 for full description.14
(b): No data for the sum of fumonisins concentration were available, and therefore no contribution from these feeds has been
assumed.
14 Commission Regulation (EU) No 575/2011 of 16 June 2011 on the Catalogue of feed materials. OJ L 159, 17.6.2011, p. 25–65.
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C.2.3. Rabbits
Rabbits are usually fed a pelleted diet (in the form of complete feedingstuffs) consisting of dried
forages, cereals and vegetable proteins supplemented with minerals, vitamins and trace elements.
Lebas and Renouf (2009) reviewed diet formulations used in experimental studies: in 58 diets, cereals
and cereal by-products (mostly wheat bran) accounted for up to 40% of all ingredients. In these
studies, maize was a major cereal grain and was included in more than one-third of all diets. In
northern Europe, however, maize may be replaced by barley and wheat. In this opinion, the feed
ingredients used in a typical French commercial rabbit compound, as provided by T. Gidenne, (Personal
communication, 2011) have been used, details of which are given in Table C.5.
C.2.4. Farmed ﬁsh (salmonids and carp)
Traditionally, the principal raw materials used for the manufacture of ﬁsh feeds in Europe have
been ﬁshmeal and ﬁsh oils, and although alternative sources of oil and protein (e.g. soybean meals
and vegetable oils) are increasingly being used ﬁsh-derived feeds still remain the major ingredients.
For many ﬁsh species, digestion of complex carbohydrates and the metabolic utilisation of the
absorbed glucose is low, reﬂecting the scarcity of carbohydrates in the aquatic environment (Guillaume
et al., 2001). Instead, ﬁsh obtain much of their energy from protein in the diet. Where carbohydrates
are used, they generally require some form of pre-treatment (e.g. cooking, ﬂaking or toasting).
Berntssen et al. (2010) provided details of the composition of a diet for growing salmonids, and the
CONTAM Panel used this feed formulation to estimate the exposures (Table C.5).
In contrast, studies with the common carp (Cyprinus cardio) have demonstrated greater intestinal
amylase activity than in carnivorous ﬁsh, which accounts for the better utilisation of carbohydrates by
these ﬁsh. The optimum level of carbohydrates appears to be 30–40% (Food and Agriculture
Organization of the United Nations (FAO), Aquaculture Feed and Fertiliser Resources Information
System15), which allows for higher levels of cereals than in diets for salmonids. The CONTAM
Panel used the ingredients of commercial compound feeds for carp reported by Schultz et al. (2012) to
estimate exposure to the sum of FBs and FBs hidden forms.
C.2.5. Farmed mink
Mink are carnivorous animals and are fed high protein diets consisting mainly of meat and meat by-
products. Commercially manufactured mink feed consists largely of ﬁsh and land animal by-products,
with lesser amounts of cereals and cereal by-products, and supplemented with mineral/vitamin
premixtures. Mink are fed diets high in protein, although their nutritional requirements vary according
to the animal’s physiological stage (e.g. gestating, lactating and growing) and climatic conditions,
particularly temperature. The proportions of cereal grains, their products and by-products used in
estimating the exposure are given in Table C.5.
C.2.6. Companion animals (dogs and cats)
Most small companion animals derive their nutritional needs from processed food, and in 2010 EU
annual sales of pet food products was approximately 8.3 million tonnes.16 Although a wide range of
ingredients is used in commercial diets, most dog and cat diets contain at least some animal protein.
Other ingredients include cereals (predominantly wheat, rice or maize), cereal by-products, vegetable
proteins and by-products of human food production. The ingredients will vary depending both on the
availability of feed materials and the nutrient requirements of the animals.
The European Pet Food Industry Federation (FEDIAF) has provided information on typical inclusion
levels of cereals, cereal by-products and other feed materials in dry cat and dog food.17 In the absence of
sufﬁcient data on species-speciﬁc manufactured complete feedingstuffs, the CONTAM Panel has used
example diets based on information provided by FEDIAF16 (details given in Appendix C, Table C.5).
15 http://www.fao.org/ﬁshery/affris/affris-home/en/
16 Available online: www.Fediaf.org
17 The European Pet Food Industry Federation (FEDIAF), Personal communication by email, May 2016.
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Concentrations calculated by using the mean concentrations of the sum of FBs reported for the
individual feeds in Table C.6.
Concentrations calculated by using the 95th percentile concentrations of the sum of FBs and its
hidden forms reported for the individual feeds in Table C.6.
Table C.5: Assumed diet composition (%) for farmed ﬁsh (salmonids and carp), farmed rabbits,
farmed mink and companion animals (cats and dogs), and the calculated mean lower
bound and upper bound levels of FBs and FBs + hidden forms in these diets
Feed materials
Farmed ﬁsh Farmed
rabbits
Farmed
mink(b)
Companion animals
Salmonids Carp Cats Dogs
Wheat (%) 13.2 24 ni 6 10 10
Barley (%) ni ni 1 ni ni
Maize (%) ni 10 17.6 6 5 6
Oats (%) ni ni ni ni 1 0.5
Soybean meal (%) 12.3 32.4 ni ni 8 4
Rapeseed meal (%) ni 12.5 ni ni ni ni
Maize gluten meal (%) 11.5 ni ni ni 17 15
Sunﬂower meal (%)(a) ni ni 20.0 ni ni ni
Lucerne meal (%)(a) ni ni 19.1 ni ni ni
Beans (%)(a) ni ni 10.4 ni 1 2
Peas (%) ni ni ni ni ni ni
Wheat feed (%) ni ni 18.3 ni 12 20
Sugar beet pulp (%) ni ni 11.9 ni ni ni
Fishmeal (%)(a) 30.5 6.7 ni ni 6 0.5
Meat meal (%)(a) ni ni ni 40 38 40
Molasses (%)(a) ni ni ni ni ni ni
Fish and vegetable oils (%)(a) 31.9 2.3 ni 8 ni ni
Other feeds (unspeciﬁed) (%)(a) ni 1 ni ni ni ni
Minerals, vitamins etc. (%)(a) 0.6 3.6 2.7 3 2.0 2.0
ni: not included in the diet formulations.
(a): No data for FBs or FBs or its hidden forms concentration were available, and therefore no contribution from these feeds has
been assumed.
(b): Diet formulation based on data provided by the Finnish Fur Breeders Association in 2015 and translated from Finnish to
English, www.profur.fi
Table C.6: Levels of fumonisins and the sum of fumonisins and its hidden forms (lg/kg DM) in
species-speciﬁc compound/complementary feeds and feed materials used to estimate
exposure by farmed livestock and companion animals
Compound/
complementary feeds
Fumonisins Fumonisins + hidden forms
P95 Mean P95 Mean
LB UB LB UB LB UB LB UB
Dairy cows: high yielding 89 208 275 682 143 333 440 1,091
Beef cattle: fattening 274 434 1,436 1,436 434 694 2,298 2,298
Horses 13 337 0.0 333 21 539 0.0 533
Pig: starter 154 413 770 943 246 661 1,232 1,509
Pig: ﬁnisher 164 321 568 756 262 514 909 1,209
Pig: breeding 23 70.2 125 178 37 112 200 286
Feed materials
Wheat 162 343 148 341 260 548 236 545
Barley 25 223 77 341 40.9 357 123 545
Oats 26 217 110 341 43 347 176 545
Maize (corn) 804 1,022 3,854 3,939 1,287 1,635 6,167 6,303
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Compound/
complementary feeds
Fumonisins Fumonisins + hidden forms
P95 Mean P95 Mean
LB UB LB UB LB UB LB UB
Soybean meal 2.0 363 0.1 796 3.1 580 0.1 1,273
Rapeseed meal 6.5 344 0.0 342 10 551 0.0 547
Sunﬂower meal 0.6 257 0.0 341 1.0 411 0.0 545
Peas 0.0 336 0.0 351 0.0 538 0.0 561
Maize gluten feed 1,802 1,915 8,318 8,409 2,884 3,065 13,309 13,454
Wheat feed 12.4 211 34 341 20 338 55 545
Oat feed 0.0 34.1 0.0 34.1 0.0 54.5 0.0 54.5
Sugar beet pulp 1.5 356 0.0 346 2.4 569 0.0 554
Maize silage 160 208 804 804 256 333 1,286 1,286
Grass hay 30 69 43 114 48 110 69 182
Cereal straw 0.0 114 0.0 113 603 1,377 2,909 3,473
LB: lower bound; DM: dry matter; UB: upper bound.
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Appendix D – Derivation of the additional factor for hidden fumonisins
The additional factor accounting for hidden fumonisins has been calculated based on raw data
obtained on maize and products thereof and reported in the following studies:
• Bryła M, Jezdrzejczak R, Roszko M, Szymczyk K, Obiedzinski MW, Sekul J and Rzepkowska M,
2013. Application of molecularly imprinted polymers to determine B1, B2, and B3 fumonisins in
cereal products. Journal of Separation Science, 36, 578–584.
• Bryła M, Roszko M, Szymczyk K, Jezdrzejczak R, Słowik E and Obiedzinski MW, 2014. Effect of
baking on reduction of free and hidden fumonisins in gluten-free bread. Journal of Agricultural
and Food Chemistry, 62, 10341–10347.
• Bryła M, Szymczyk K, Jezdrzejczak R and Obiedzinski MW, 2015. Free and hidden fumonisins in
various fractions of maize dry milled under model conditions. LWT-Food Science and
Technology, 64, 171–176.
• Dall’Asta C, Falavigna C, Galaverna G, Dossena A and Marchelli R, 2010. In vitro digestion
assay for determination of hidden fumonisins in maize. Journal of Agricultural and Food
Chemistry, 58, 12042–12047.
• Dall’Asta C, Falavigna C, Galaverna G and Battilani P, 2012. Role of maize hybrids and their
chemical composition in Fusarium infection and fumonisin production. Journal of Agricultural
and Food Chemistry, 60, 3800–3808.
• Oliveira MS, Diel ACL, Rauber RH, Fontoura FP, Mallmann A, Dilkin P and Mallmann CA, 2015.
Free and hidden fumonisins in Brazilian raw maize samples. Food Control, 53, 217–221.
Data were given as the sum of FB1 + FB2 + FB3, for a total of n = 316 samples, collected over 6
years (2009–2015) with a wide geographical distribution (Italy, Poland, Brazil).
All the studies were based on the double determination of free and total fumonisins. Brieﬂy, the
sample was splitted into two subsamples. One was directly analysed for free fumonisins, the second
underwent alkaline hydrolysis before detection of HFBs (total fumonisins). The stoichiometrical
difference between free and total fumonisins returned the content of hidden fumonisins. Although the
applied strategy was the same, analytical methods were slightly different in terms of extraction solvent
composition, pH, and instrumental set up.
As ﬁrst remark, free and total fumonisins were strongly correlated in the three data set as well as
in the overall data set, as reported in Figure D.1.
Table D.1: Fumonisins B data by geographical distribution, years and type of data
Country Years Number of data Type of data
Italy 2009–2015 195 Field studies, natural infection
Poland 2010–2012 49 Marketed products
Brazil 2011–2012 72 Field studies, natural infection
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Data were described using box plot (see Figure D.2), pointing out the strong variability of the
Italian and Brazilian data set compared to the Polish one. Besides sample size, this can be explained
considering that Polish data were obtained from marketed samples, while Italian and Brazilian samples
came from open ﬁeld studies. It can be noticed as well that data set from Brazil showed higher mean
concentration values and a higher variability. This can be explained considering possible differences in
the agronomic and environmental conditions that can be found in South America and in Europe.
The overall factor obtained from the contribution of hidden fumonisins was 1.73 (see Table D.2).
However, once Brazilian data are taken out, the additional factor was 1.63. Therefore, also in
consideration of the previous EFSA Opinion (EFSA CONTAM Panel, 2014), the additional factor used for
the exposure assessment was 1.6.
Plot was obtained considering the full data set (n = 316).
Figure D.1: Correlation plot between total fumonisins (Var2) and free fumonisins (Var1)
Figure D.2: Box Plot of data considered for the model set up
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Table D.2: FBs data by geographical distribution, concentrations and derivation of factor for FBs
hidden forms
Country
Mean concentration of free
FBs
Mean concentration of total
FBs
Italy 5,277 7,865
Brazil 3,873 10,441
Poland 202 361
Factor
Factor for hidden FBs (overall data set) 1.74
Factor for hidden FBs (Italy+Poland) 1.63
FB: fumonisin B.
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